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Stroke
Stroke is the second most common cause of death and major cause of disability 
worldwide.1 Eighty percent of all strokes are ischemic and are caused by an occlusion 
of a blood vessel, leading to an ischemic area and accompanying stroke-related 
neurologic deficit. Besides possible debilitating physical impairments, ischemic stroke 
has been frequently associated with cognitive impairments2-5 and dementia in stroke 
survivors aged 60 years and over.6 Although stroke often occurs in these older 
individuals, up to 14% of all ischemic strokes occur in young adults (18 through 50 
years of age).7-13 Furthermore, the incidence of ischemic stroke in the young seems to 
rise over time.14
Cognitive outcome after ischemic stroke in young adults
The traditionally held view is that the younger the patient with stroke, the more likely 
the patient will recover. However, studies on stroke outcome are often limited to motor 
recovery. Although physical disabilities are the most visible disabilities after an 
ischemic stroke, cognitive impairments, which are often less apparent to others, could 
have devastating consequences for these young adults. That is, these patients are in 
a period of life where they start forming a family, will get an education or are preparing 
for future career steps. 
Surprisingly, only a handful of studies focused on cognitive outcome up to one year 
after stroke in young adults.15, 16 These studies showed that cognitive impairments were 
frequent in these young patients, but motor recovery was generally favorable.15, 16 
As young stroke patients have a long life expectancy, information on long-term cognitive 
performance exceeding one year is very important to these young individuals.17 
Currently, data on the long-term follow-up prognosis of cognitive performance (ten 
years or more) are lacking. Therefore, it remains unknown if, or to what extent, cognitive 
decrements can be found years after their ischemic stroke. Providing adequate 
information is one of the first steps in treatment and management of patients, making 
it relevant for rehabilitation services. 
14
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Cognitive performance and the association with 
neuroimaging markers after stroke 
Apart from identifying the spectrum of cognitive impairment after ischemic stroke, 
knowledge on its underlying cerebral substrate is of utmost importance to get insight 
in post-stroke cognitive performance and perhaps compensatory mechanisms. As an 
ischemic stroke is a focal event, cognitive impairment cannot always be explained by 
lesion characteristics itself. This is nicely illustrated by the frequent occurrence of 
episodic memory impairment after stroke, in the absence of a stroke in brain structures 
known to be important for memory formation: the medial temporal lobe. Furthermore, 
often multiple cognitive domains are affected in a patient, suggesting that brain 
regions that are remote from the site of the infarction may be affected by the stroke. 
Despite the existing literature on neuroimaging markers for post-stroke cognitive 
impairments, these studies are often limited to stroke in older individuals (≥60 years 
of age).2, 3 In these older stroke patients post-stroke cognitive deficits may also be 
explained by co-existing neurodegenerative pathology, which is less likely to occur in 
younger patients, such as cerebral small vessel disease,18 amyloid pathology,19, 20 and 
other comorbidities that affect cognitive functioning. Therefore, newer techniques that 
can assess subclinical brain injury, such as diffusion tensor imaging, are potentially 
important tools in the assessment of cognitive impairments after ischemic stroke, since 
remote white matter integrity might play a role in cognitive outcome after ischemic 
stroke.2 This could therefore be another target for prevention.2 
Aims of the thesis and the study design
The aim of this thesis was to describe the spectrum of long-term cognitive impairments 
after first-ever ischemic stroke in young adults and to better understand cognitive 
impairments using neuroimaging techniques. This thesis is part of the ‘Follow-Up of 
Transient ischemic attack and stroke patients and Unelucidated Risk factor Evaluation’ 
(FUTURE) study.21-25 This is a large, prospective cohort study designed to investigate 
causes and consequences of stroke in young adults (18 through 50 years of age). For 
the studies reported in this thesis, first-ever ischemic stroke patients were recruited 
that were admitted to the Radboud University Medical Centre between January 1, 1980 
until November 1, 2010. Exclusion criteria for ischemic stroke in the FUTURE study were 
cerebral venous sinus thrombosis and retinal infarction. Follow-up cognitive assessment 
was conducted between November, 2009 and January 1, 2012, with subsequent MRI 
scanning.
15
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Outline of this thesis
Part I of the present thesis consists of the study design and protocol of the FUTURE 
study (chapter 2). Chapter 3 reviews the literature on stroke in young adults and 
addresses the underlying etiology of young stroke. 
Part II, chapter 4 addresses the prevalence and mean cognitive outcome after 
first-ever ischemic stroke in young adults compared with a non-stroke population 
about 11 years after stroke. Part III describes the relationship between long-term 
memory performance and remote hippocampal volume (chapter 5) and hippocampal 
integrity (chapter 6) after ischemic stroke in young adults. Chapter 7 describes the 
white matter integrity remote from the stroke location and the association with 
long-term cognitive impairment in multiple cognitive domains, incorporating cerebral 
small vessel disease (lacunes, microbleeds, and white-matter hyperintensities). 
Finally, part IV addresses the summary of this thesis and general discussion (chapter 8). 
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Chapter 2
Abstract
Background and objective 
Young stroke can have devastating consequences with respect to quality of life, the 
ability to work, plan or run a family, and social participation. Better insight into risk 
factors and the long-term prognosis is extremely important, especially in young stroke 
patients with a life expectancy of decades. To date, detailed information on risk factors 
and the long-term prognosis in young stroke patients, and more specific risk of mortality 
or recurrent vascular events, remains scarce.
Methods
The FUTURE study is a prospective cohort study on risk factors and prognosis of young 
ischemic and hemorrhagic stroke among 1006 patients, aged 18 through 50 years, 
included in our study database between January 1, 1980 and November 1, 2010. 
Follow-up visits at our research center take place from the end of 2009 until the end 
of 2011. Control subjects will be recruited among the patients’ spouses, relatives, 
or social environment. Information on mortality and incident vascular events will be 
retrieved via structured questionnaires. In addition, participants are invited to the 
research center to undergo an extensive sub study including MRI.
Conclusion
The FUTURE study has the potential to make an important contribution to increase the 
knowledge on risk factors and long-term prognosis in young stroke patients. Our study 
differs from previous studies by having a maximal follow-up of more than 30 years, 
including not only TIA and ischemic stroke but also hemorrhagic stroke, the addition 
of healthy controls and prospectively collect data during an extensive follow-up visit. 
Completion of the FUTURE study may provide better information for treating physicians 
and patients with respect to the prognosis of young stroke.
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Introduction
Up to 12% of all strokes occur in patients between 18-50 years (‘young stroke’),26 
affecting about 5000 patients each year in the Netherlands and about 2 million young 
people each year worldwide. In a substantial proportion of roughly one third the etiology 
remains unelucidated. In terms of prognosis a young stroke has a dramatic influence 
on independency and quality of life as it occurs in the period of life that people start to 
form families, make decisive career moves, and have an active social life. Uncertainty 
about long-term prognosis affects choices and planning affiliated with these life events.
Whereas risk factors and prognosis in patients who develop a stroke at higher ages 
(usually over 70 years) are among the best studied topics in clinical medicine, this 
does not hold true for young stroke. At higher ages, almost all risk factors have athero-
sclerosis in their final common pathway. However, this cannot simply be extrapolated 
to young stroke as the underlying cause of stroke is usually different from that in 
elderly and may therefore also have a different prognosis both with respect to 
functional stroke outcome as to risks of recurrent stroke or other major vascular 
events. Even more, the identification of risk factors for young stroke so far has often 
been based on the occurrence of presumed risk factors in consecutive series of young 
stroke patients, without methodological sound comparison with controls.
The ‘long-term’ perspective in an on average over 70 years old stroke patient differs 
from that of a 30 years young stroke patient, and particularly studies with a long-term 
follow-up of more than 10 years are lacking in the young stroke field. Studies thus far, 
usually with a mean follow-up duration of less than 7 years, report highly variable 
post-stroke mortality and risk of incident vascular disease.26-31 These large differences 
across studies are well explained because young stroke is a heterogeneous disease and 
most studies were small, had different selection criteria, did not investigate patients in 
person but relied on telephone interviews, and outcome assessments and follow-up 
planning was not uniform and often suboptimal. Although stroke includes both 
ischemic and hemorrhagic stroke, almost all studies have excluded the investigation of 
etiology and prognosis of young hemorrhagic stroke.
Except for recurrent vascular disease and persistent motor and language impairments, 
post-young stroke quality of life will most likely also be determined by cognitive 
dysfunction, depressive symptoms, fatigue, and specific post-stroke complications 
such as epilepsy, because those determine the ability to (return to) work and to have 
a normal family and social life. Data on those aspects in the very long-term follow-up 
of young stroke patients are even more scarce.
Although the absolute number of young stroke is lower than stroke among the elderly, 
the total number of years that young stroke patients as a whole will live with the 
consequences of the stroke exceeds that of older stroke survivors due to far longer 
survival.
20
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This justifies a properly designed and executed study on risk factors and prognosis of 
young stroke, compared with controls. We therefore set up the FUTURE study 
(Follow-Up of Transient ischemic attack and stroke patients and Unelucidated Risk 
factor Evaluation study), the largest single-center prospective cohort study on risk 
factors and prognosis of young TIA, ischemic stroke and hemorrhagic stroke patients 
(n=1006) and controls.
Methods
The FUTURE study is a prospective cohort study that aims to investigate the causes 
and consequences of a young stroke. The Medical Review Ethics Committee region 
Arnhem-Nijmegen approved the study.
Patients
The department of neurology has a long-standing interest in the etiology and prognosis 
of young stroke and therefore maintains a prospective registry of all consecutive 
young stroke patients with a standardized collection of baseline and clinical charac-
teristics (see ‘baseline’) since the 1970’ies.32 For the current FUTURE study, all 
consecutive TIA, ischemic stroke patients with presumed arterial origin or those with 
an intracerebral hemorrhage that sought medical attention for these disorders at the 
department of neurology of the Radboud University Medical Centre between 1-1-1980 
and 1-11-2010 will be eligible for participation in the study.
Inclusion criteria
1. TIA, ischemic stroke of presumed arterial origin or intracerebral hemorrhage
2. Date of onset between 1-1-1980 and 1-11-2010
3. Age 18-50 at onset
Exclusion criteria
1. Traumatic hemorrhagic stroke
2. Intracerebral hemorrhage in known cerebral metastasis or primary brain tumor
3. Ischemic/hemorrhagic stroke due to cerebral venous sinus thrombosis
4. Intracerebral hemorrhage due to ruptured cerebral aneurysm
5. Any subarachnoid hemorrhage 
6. Retinal infarct
TIA was defined as a rapidly evolving focal neurological deficit with no other than a 
vascular cause lasting less than 24 hours. Stroke was defined similarly, but with 
symptoms lasting more than 24 hours. On the basis of radiological findings, stroke 
was further subdivided into hemorrhagic and ischemic stroke.
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As the diagnostic process may have changed during a more than 30-year period all 
initial diagnoses were reviewed by a panel of 2 experts from a pool of 4 (FEdL, EvD, RA, 
LJD) and in cases of disagreement a consensus meeting was held to adjudicate the 
event.
1006 patients who had sought medical attention at our University Medical Centre 
between 1-1-1980 and 1-11-2010 fulfilled inclusion and exclusion criteria for our study. 
Characteristics of our baseline population (at the time of their qualifying event) are 
reported in Table 1.
Controls
Control subjects will be recruited among the patients’ spouses, relatives or social 
environment. They have to be at least 18 years old without a history of any TIA or 
stroke before the age of 50 at the moment of inclusion.
Baseline
At baseline (during the occurrence of the qualifying event for the study) a minimal 
dataset has been collected that consists of demographics, stroke subtype, risk factors, 
and additional investigations (Table 2). The completeness of the baseline dataset 
varies among patients due to changes in standard diagnostic procedures over the last 
30 years.
Current common rating scales for the severity and cause of stroke did not exist at the 
time when a substantial proportion of our patients experienced their qualifying event. 
Therefore, a rating of both the severity (NIHSS) and cause (TOAST) was done for all 
cases retrospectively by a validated approach.33
Table 1 | Baseline population characteristics
 Total  
population
Time of index event
1980-1989 1990-1999 2000-2010
No. 1006 223 249 534
Men, No. (%) 470 (46.7) 110 (49.3) 128 (51.4) 232 (43.4)
Age at index event, mean (SD), y 40.2 (7.9) 39.3 (8.3) 39.7 (8.6) 40.8 (7.4)
Index event
TIA, No. (%) 277 (27.5) 52 (23.3) 40 (16.1) 185 (34.6)
Ischemic stroke, No. (%) 630 (62.6) 146 (65.6) 189 (75.9) 295 (55.2)
Hemorrhage, No. (%) 99 (9.8) 25 (11.2) 20 (8.0) 54 (10.1)
22
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Follow-up
Information on the vital status will be available either from hospital data or through 
coupling of patient records with data from the municipality registry. All patients alive 
will be approached for the follow-up assessment according to a 2-step approach.
First, all patients will be contacted by letter to inform them about the study; 
subsequently they will be contacted by phone. In case the patient has moved, the 
municipality register of the last known residence will be contacted to trace the patient. 
In cases of an invalid phone number, a second letter will be sent asking the patient to 
contact our center to provide a correct phone number. Subsequently, when a patient 
does not respond to the second letter, the last known general practitioner will be 
contacted to provide us with updated contact details. The patient will be considered 
lost to follow-up when known alive, but when untraceable via the procedure described 
above.
Subsequently, patients will be given the opportunity to participate in an extensive sub 
study. If they agree to do so, they will be invited to visit our research center for 
additional investigations including a structured interview, cognitive assessment, 
physical and neurological examination, an extensive MRI protocol, an electrocardio-
gram, and an ultrasonography of the carotid arteries (Table 2). In addition, blood 
samples (serum/plasma/DNA) will be taken for future analysis. When patients are not 
able to visit our research center the same investigations will be performed at their 
homes, except for the ultrasonography of the carotid arteries, electrocardiogram, and 
MRI scan. Controls will undergo the same protocol as patients.
The follow-up has started at the end of 2009 and is planned to finish at the end 
of 2011. All these participants signed an informed consent.
Outcome events
The primary outcome of the study will be all-cause mortality and the composite 
endpoint of death from all vascular causes; non-fatal stroke, non-fatal (silent) 
myocardial infarction, cardiovascular procedures (coronary artery bypass grafting, 
percutaneous transluminal coronary angioplasty, carotid endarterectomy, and other 
arterial revascularisation procedures), whichever occurred first. We will perform 
separate analysis for the occurrence of fatal or non-fatal stroke. Causes of death will 
be categorized into ischemic stroke, intracerebral hemorrhage, cardiac causes, other 
vascular causes or non-vascular causes. If we cannot obtain information about the 
cause of death, the event will be classified as unspecified.
Secondary outcomes are seizures (classified according to the ILAE34) and dementia 
(according to DSM-IV).
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Table 2 | Schedule of assessments in the FUTURE study
Assessment Baseline Follow-up
Demographics
Ethnicity X
Education X
Marital status X
Social/living status X
Stroke Characteristics
Qualifying event X
Symptoms at onset X
Discharge date and destination X
TOAST X
NIHSS at admission and at discharge X
Modified Ranking Scale at discharge X
Medical History
History of any cardiovascular disease X   Xa
Cardiovascular risk factors X   Xa
Family history of cardiovascular disease X X 
Medication use X   Xa
Stroke related surgical procedures X   Xa
Epilepsy X   Xa
Neuropsychologic examination
Global cognitive function
        Mini Mental State Examination (MMSE) X
Verbal memory function
        Rey Auditory Verbal Learning Test X
Visuospatial memory
        Rey’s Complex Figure Test X
Speed of information processing
        Symbol-Digit Substitution Task X
        Stroop test X
Working memory
        Paper and Pencil Memory Scanning Tasks X
Executive functioning
        Animal Fluency task X
24
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Table 2 | Continued
Assessment Baseline Follow-up
Neuropsychologic examination
Attention
       Verbal series attention test X
Subjective cognitive failures
      Cognitive failures questionnaire X
Depressive symptoms
Structured questionnaire depressive symptoms   Xa
      Mini International Neuropsychiatric Interview (MINI) X
      Centre of Epidemiological Studies Depression Scale (CES-D) X
      Hospital Anxiety and Depression Scale (HADS) X
Physical examination
Length and weight X X
Waist circumference X
Blood pressure X X
Heart rate X X
Neurological examination
Babinski sign X
Sensory system
      Quantitative measurement by vibration tuning fork X
Muscle strength 
      Medical Research Council Scale (MRC) X
Mobility and activities of daily living
TUG-test X
Exercise expressed in metabolic equivalent value  Xa
Tinetti test (body balance and gait) X
Modified Rankin Scale (mRS) X X
Barthel Index X
Instrumental activities of daily living questionnaire (IADL) X
Additional questionnaires
Fatigue
     CIS-20R X
25
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Whenever an outcome event is suspected with the aid of a standardized, structured 
questionnaire, information retrieved will be verified and adjudicated by physicians 
from the appropriate specialty. In case a patient has died, this information will be 
retrieved from their general practitioner or a relative. If there is no information 
available, the event will be classified as a possible event.
Table 2 | Continued
Assessment Baseline Follow-up
Additional questionnaires
Health related quality of life
     Short Form 36 X
     EQ-5D X
     Stroke impact scale 3.0 X
Sleep disturbances   Xa
List of Threatening Experiences (LTE)   Xa
Work   Xa
Radiological examination
Confirmation of index event (CT or MRI) X
Angiography X
MRI
     T1 magnetization-prepared rapid gradient echo X
     FLAIR pulse sequences X
     Transversal T2* weighted gradient echo sequence X
     Diffusion Tensor imaging X
     Resting state imaging X
     Time-of-flight angiography X
Ancillary investigation
Electrocardiogram X X
Ultrasonography of the carotid arteries X X
a Variables were collected both for the period before and after the index event.
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Assessment of variables during follow-up
Demographics and life style
Standardized questionnaires on demographics, education (classified using 7 categories; 
‘1’ being less than primary school and ‘7’ reflecting an academic degree),35 marital 
status, living conditions, and life style habits (alcohol consumption, smoking, exercise) 
will be administered. Alcohol consumption will be defined as units per day and the age 
at which alcohol consumption had started (and ended if stopped) will be noted. 
Cigarette smoking behavior will be defined as never, former, and current. Subsequently, 
former and current smoking behavior will be quantified as the number of pack-years, 
calculated as the number of packs of cigarettes smoked per day multiplied by the 
number of years a participant had smoked. Exercise will be expressed in the metabolic 
equivalent value (MET) according to accepted standards.36
Medical history
Structured, standardized questionnaires will be used to assess participants history 
of hypertension, diabetes mellitus, atrial fibrillation, TIA, stroke, myocardial infarction, 
coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, 
carotid endarterectomy and other arterial revascularization procedures, 37-40 migraine 
with or without aura,41 pregnancy, and malignancy. Whenever a primary or secondary 
outcome event is suspected with the aid of this standardized, structured questionnaire, 
information retrieved will be verified and adjudicated by physicians from the appropriate 
specialty (see outcome events). The presence of a family history of myocardial infarction, 
cerebrovascular disease, and diabetes mellitus in next of kin will be recorded.
Epilepsy
Each patient will be evaluated for a history of epilepsy by means of a standardized, 
structured questionnaire. Whenever epilepsy is suspected, information will be retrieved 
from the treating physician and verified and adjudicated by a neurologist (FEdL). 
Epilepsy will be classified according to the ILAE criteria.34 Post-stroke epilepsy will 
be subdivided into early (≤7 days post-stroke) and late (>7 days) post-stroke epilepsy.
Current medication
Current medication use and the age at which medication use started will be noted 
and classified according to the Anatomical Therapeutic Chemical (ATC) classification 
system (World Health Organization, WHO Collaborating Centre for drug statistics and 
methodology, http://www.whocc.no/atcddd/).
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Neuropsychological assessment
We will administer an extensive neuropsychological test battery that encompasses 
items from other large-scale epidemiological studies covering the main cognitive 
domains.42, 43 Global cognitive function will be assessed using the Mini Mental State 
Examination (MMSE).44 Verbal episodic memory function will be assessed by the 
3-trial version of the Rey Auditory Verbal Learning Test (RAVLT) that also includes a 
delayed free-recall and recognition trial, a test used to evaluate the ability to acquire 
and retain new verbal information.45 Visuospatial episodic memory will be administered 
by the Rey Complex Figure Test (RCFT), that consists of 3 trials: a copy trial, an immediate 
recall trial after 3 minutes and a delayed-recall trial after 30 minutes.46 To evaluate 
speed of information processing and executive function, 2 tests will be used; the 
abbreviated Stroop Color Word Test (3 subtasks, the interference trial measuring 
response inhibition)47 and the Symbol-Digit Substitution Task, which is a modified 
version of the Symbol Digit Modalities Test.48 A verbal fluency task in which as many 
animals as possible have to be named within 60 seconds will be used to test semantic 
memory and executive functioning (response generation). To assess working memory, 
the Paper and Pencil Memory Scanning Task (4 subtasks)49 will be used. To evaluate 
attention, the verbal series attention test (VSAT) will be used. 50 To register subjective 
cognitive failures we will administer the modified Cognitive Failures Questionnaire 
(CFQ).51 The assessments will be carried out under standardized circumstances in 
quiet rooms.
A standardized structured questionnaire used in previous large-scale epidemiological 
studies will be used to assess the history of depressive symptoms; normal reactions to 
stressful events or normal grief will carefully be excluded.52 In case of a depressive 
episode, age of onset, the medical advice and medication use will be registered. 
We defined ‘depression’ as those depressive episodes that have required attention of 
a general practitioner, psychologist or psychiatrist. This definition includes minor 
depression, as well as more severe depression syndromes such as major depression 
and bipolar depression.52
In addition, participants will be screened for current depressive symptoms by means 
of the Mini International Neuropsychiatric Interview (MINI), part A, which is a short 
diagnostic structured interview based on the DSM IV.53 Additionally, presence 
of actual depressive symptoms will be assessed by 2 self report questionnaires, 
the Centre of Epidemiologic Studies Depression Scale (CES-D)54 and the Hospital 
Anxiety and Depression Scale (HADS).55
Physical and Neurological Examination
Height and weight will be measured without shoes in light clothing. The body mass 
index (BMI) will be calculated as weight divided by height (in meters) squared. The 
maximal waist circumference will be measured without shirt, in standing position, 
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between the lowest rib and the iliac crest, at the end of normal expiration.56 Blood 
pressure and pulse rate will be measured in triplicate in supine position after 5 minutes 
rest. Subsequently, one measurement is performed after 1 minute in upright position.39
The strength of the biceps, hand grip, iliopsoas, quadriceps, and foot extensor muscles 
on both sides will be scored according to the medical research council scale (MRC).
The sensory system will be assessed by a quantitative measurement by vibration tuning 
fork (Rydel-Seiffer®) on both first toes and both medial malleolus, also registering ankle 
edema and the ankle jerk reflex.
Gait and balance
We will use a widely used modified version of the original Tinetti test with 17 items: 
9 for body balance (score 0-16) and 8 for gait (score 0-12), with a maximum score of 
28.57 It grades balance while sitting, standing with eyes open and closed, nudging 
and turning, gait initiation, stride length and width and symmetry. Functional mobility 
will be classified by using the widely-used timed-up-and-go(TUG)-test which is a timed 
test during which the participant is asked to rise from a standard armchair, walk 3 m, 
turn, walk back, and sit down again.58 Each participant will perform the test 3 times.
Functional performance
As a measure of disability the Barthel Index and modified Rankin Scale will be used.59 
The activities of daily living will be assessed by the instrumental activities of daily 
living questionnaire.60
Additional self-report questionnaires
Several primary sleep disorders are addressed using a number of screening questions. 
The presence of possible sleep disordered breathing is based on a history of snoring, 
witnessed sleep-related apneas, and non-restorative sleep. Non-REM and REM 
parasomnias are addressed based on a history of sleepwalking or dream-enacting 
behavior. Excessive daytime sleepiness will be assessed based on the presence of 
continuous feelings of sleepiness, sleep attacks or a combination of both. Finally, the 
presence of sleep-onset and/or sleep-maintenance insomnia is recorded. 
For the assessment of fatigue we will use the Checklist on Individual Strength 
(CIS-20R).61 The overall health status (quality of life) will be assessed with the Short 
Form 36 (SF-36),62, 63 the EQ-5D,64 and the Stroke Impact Scale 3 (SIS-3).65
Adverse life events will be assessed with the 12-item List of Threatening Events (LTE), 
6 months before the index event and subsequently the period after the index event.66
Patients will be asked for their employment status in the month before their index 
event, within the first year after their index event and at time of the follow-up visit. Each 
period includes a description of occupation, working hours a week, adjustments in 
tasks, use of supporting devices and reasons for not working.
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Ancillary Investigations
MRI protocol
MRI scanning will be performed on a 1.5-Tesla Magnetom scanner (Siemens, Erlangen, 
Germany). The scanning protocol includes whole brain 3D T1 magnetization-prepared 
rapid gradient-echo (MPRAGE) sequence (TR/TE/TI 2730/2.95/1000ms; flip angle 7°; 
voxel size 1.0x1.0x1.0mm); FLAIR pulse sequences (TR/TE/TI 12220/85/2200ms; voxel 
size 1.0x1.2x3.0mm; slice gap 0.6mm); transversal T2-weighted turbo spin echo 
sequence (TR/TE 7440/96ms; voxel size 0.9x0.9x3.0 mm; slice gap 0.6 mm); Multi-slab 
3D time of flight angiography sequence (TR/TE 24/7ms; voxel size 0.8x0.5x1.0mm) will 
be made of the carotid arteries and the circle of Willis. Gradient echo susceptibility 
weighted imaging sequence (TR/TE 49/40ms; voxel size 0.8x0.7x1.0mm); DTI (TR/TE 
9100/98ms; voxel size 2.2x2.2x2.2mm; 7 unweighted scans, 61 diffusion weighted 
scans, with non co-linear orientation of the diffusion-weighting gradient, and b value 
1000s/mm²) and resting state imaging using a gradient echo EPI (TR/TE 1870/35ms; 
voxel size 3.5x3.5x3.0 mm; slice gap 0.5mm). During resting state, participants will be 
told not to concentrate on any particular subject, but just to relax with their eyes 
closed. The complete scanning protocol takes approximately 60 minutes.
ECG
An electrocardiogram (ECG) will be performed and evaluated by a standardized 
assessment by an experienced cardiologist, registering frequency, cardiac rhythm, 
cardiac ectopias, cardiac axis, conduction time over the PQ, QRS, and QTC intervals, 
conduction disturbances, left ventricle hypertrophy, pathologic Qs, infarction, repolarization 
disturbances, and acute ischemia. A final diagnosis is defined as normal, abnormal 
without clinical significance, abnormal with clinical consequences or pathologic ECG 
with immediate consultation of a cardiologist when necessary.
Carotid ultrasound
A carotid ultrasound assessment will be performed at which the intima media 
thickness (IMT) will be measured in the distal (near the bulbus) left and right common 
carotid artery. All measurements will be performed using a phased array real-time 
scanner (Philips i-u22, The Netherlands) with a 17-5 MHz broadband linear transducer. 
The IMT will be automatically measured by QLab® qualification software (V.4.2.1.) 
according to previously described procedures.67 All ultrasound measurements will be 
performed by 3 experienced and specific trained clinical neurophysiology technicians.
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Vena puncture
Fasting blood samples will be taken. Immediate analysis will include glucose, creatinine, 
lipid profile and complete blood count. Additional serum, plasma and DNA will be 
stored (-80°C) for future biochemical and genetic analyses.
Statistical analyses
Cumulative risk of primary and secondary outcomes will be estimated with Kaplan- 
Meier analysis. In the analysis of vascular events, patients who had died from other 
than the defined fatal endpoints will be censored at the time of death. Cox proportional 
hazard models will be used to calculate the risk of suffering from any of the primary 
or secondary outcomes in the follow-up period, with adjustments for the necessary 
covariates. The relative risk (hazards ratios) will be calculated with their corresponding 
95% confidence intervals.
Cross-sectional analysis (for example in the comparison between patients and controls 
of data acquired during the follow-up) of continuous variables will be done with 
Student’s t-test or analysis of variance or in case of skewed distributions which cannot 
be normalized corresponding non-parametric tests will be used. Chi-squared test will 
be used for cross-sectional analysis of categorical variables.
Discussion
Detailed information on risk factors and the long-term prognosis in young stroke 
patients, and more specific the risk of mortality and recurrent vascular events, remains 
scarce. These data are often derived from selected patients (often with the exclusion 
of TIA and hemorrhagic stroke patients) in small sized studies with short follow-up 
without in person assessment of risk factors and outcomes. We therefore performed 
the FUTURE study, designed to investigate risk factors and to prospectively assess 
prognosis in a large cohort of young stroke patients.
Strong elements of our study are the inclusion of both TIA and hemorrhagic and 
ischemic stroke patients, the very long follow-up (up to 30 years), its sample size of 
over 1 000 potential participants and the availability of baseline data of all consecutive 
patients in a single university medical center. In addition, the extensive investigation 
during a follow-up visit, including advanced neuroimaging has the potential of major 
contributions to the field. Our study differs from many other young stroke studies due 
to the inclusion of controls that enable us to compare the frequency of some presumed, 
but also unknown, risk factors between patients and controls. Detailed risk factor 
analysis can be done, not only for commonly documented risk factors but also for 
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those that are rarely documented in medical records, like physical inactivity and sleep 
disturbances. Moreover, the inclusion of healthy controls provides the opportunity to 
distinguish consequences of a young stroke from other factors like ageing effects.
We feel that completion of our study may contribute to a better understanding of the 
etiology of young stroke and may provide better information for treating physicians 
and patients with respect to the prognosis of young stroke.

Maaijwee NA,* Rutten-Jacobs LC,* Schaapsmeerders P, van Dijk EJ, de Leeuw FE.
Ischaemic stroke in young adults: risk factors and long-term consequences. 
Nature Reviews Neurology. 2014; 10(6): 315-325
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Abstract
Contrary to trends in most other diseases, the average age of ischemic stroke onset 
is decreasing, owing to a rise in the incidence of stroke among ‘young’ individuals 
(under 50 years of age). This review provides a critical overview of the risk factors and 
etiology of young ischemic stroke and addresses its long-term prognosis, including 
cardiovascular risk, functional outcome and psychosocial consequences. We highlight 
the diminishing role of ‘rare’ risk factors in the pathophysiology of young stroke in light 
of the rising prevalence of ‘traditional’ vascular risk factors in younger age groups. Long- 
term prognosis is of particular interest to young patients, because of their long life 
expectancy and major responsibilities during a demanding phase of life. The prognosis 
of young stroke is not as favorable as previously thought, with respect either to 
mortality or cardiovascular disease, or to psychosocial consequences. Therefore, 
secondary stroke prevention is probably a lifelong endeavor in most young stroke 
survivors. Due to under-representation of young patients in past trials, new randomized 
trials focusing on this age group are needed to confirm the benefits of long-term 
secondary preventive medication. The high prevalence of poor functional outcome and 
psychosocial problems warrants further study to optimize treatment and rehabilitation 
for these young patients.
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Introduction
Stroke is a devastating disease that affects 15 million patients worldwide each year, 
resulting in death in about one-third of patients and severe disability in two-thirds of 
the survivors.68, 69 Approximately 80% of all strokes are ischemic strokes, of which 
roughly 10% occur in individuals under the age of 50 years — so-called ‘young stroke’.30 
In this article, we review the literature on ischemic stroke in these young patients. 
Age limits defining young stroke differ across studies,12, 25, 30, 70 but we chose to define 
young stroke as an ischemic stroke in adults aged 18-49 years, as this was the age 
range generally used in large studies.12, 71, 72 For the sake of inclusivity, however, we will 
also report on results from some studies that used upper age limits of 45, 50 or 
55 years.25, 73 Risk factors and management strategies for young stroke differ across 
the world, depending on factors such as genetic differences, environmental influences, 
and the development and accessibility of health services. In this review, we will focus 
on the situation in Western societies, unless otherwise specified.
In recent years, we have witnessed a remarkable, unprecedented decrease in the 
average age of onset of ischemic stroke in the overall population, which is mainly 
attributable to an increased incidence of stroke in young adults.14, 74 Ischemic stroke in 
young adults is often thought to be related to ‘rare’ risk factors and etiological features 
that are very different from the ‘traditional’ vascular risk factors and etiology seen in 
older stroke patients. However, the increase in stroke incidence in young adults has 
been found to be associated with a rising prevalence of some important ‘traditional’ 
vascular risk factors, including hypertension, hypercholesterolemia, diabetes mellitus, 
and obesity, in this age group.14, 75 We will discuss the role of these risk factors from 
the perspective of the increased incidence of young stroke.
In addition to the identification of risk factors and etiology, long-term prognosis after 
stroke is of particular interest from the perspective of young patients, as they usually 
have a life expectancy of several decades. Following a stroke, these individuals are 
suddenly confronted with uncertainties about their future in a period of life during 
which they might be preparing for decisive career moves or planning a family. Therefore, 
information on long-term prognosis should include not only the risk of vascular and 
other diseases, but also the expected psychosocial consequences related to life after 
stroke — a topic reported to be among the top 10 research priorities for patients.76
In the first part of this review, we provide a critical overview of the existing literature on 
risk factors and etiology of young ischemic stroke. This section will include a 
methodological discussion on the rare risk factors and etiology that have conventionally 
been regarded as specific for young stroke, followed by a discussion of the growing 
prevalence of traditional vascular risk factors among younger individuals. We will then 
review the lifelong consequences of stroke in young adults, not only in terms of 
cardiovascular disease recurrence, but also with respect to less frequently studied 
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but equally relevant consequences, including cognitive and social impairments, mood 
disorders, and fatigue.
Risk factors and etiology 
The view that ischemic stroke in young adults is different from ‘old stroke’ with respect 
to risk factors and etiology originated predominantly from the many publications — 
mainly based on case series from tertiary hospitals — that reported on the high 
prevalence of unusual, rare conditions and risk factors among young patients with 
stroke.77 These rare risk factors and etiologies are extensively summarized in previous 
reviews and textbooks,77, 78 and will not be outlined in detail here. The term ‘risk factor’ 
is used to indicate that a certain factor was found to be associated with stroke in 
young adults. However, the mere identification of a risk factor does not imply that the 
etiology is fully understood. Sometimes the risk factor is somewhere in the ‘causal 
pathway’ of the disease, and may give rise to a certain etiology that in turn is associated 
with the disease; for example, hypertension is a risk factor, but atherosclerosis might 
be the underlying causal etiology of the stroke. For the purposes of this review, we will 
categorize the etiology according to the Trial of Org 10172 Acute Stroke Treatment 
(TOAST) classification, with ‘large-artery atherosclerosis’, ‘small-vessel disease’, ‘cardio - 
embolic’, ‘other determined’, and ‘cryptogenic’ as important etiological subgroups.79
‘Rare’ risk factors and etiologies
In Tables 1 and 2, we summarize data on 5 rare risk factors and 5 rare etiologies that 
have been linked chiefly to stroke in young patients. The choice was based on the 
relatively high prevalence of these factors and etiologies in large, Western young 
stroke cohorts.12, 72 In other populations, the distribution of conditions in the TOAST 
category ‘other determined etiologies’ differs. For example, in Japan, moyamoya disease 
will be diagnosed more frequently in young patients with stroke, because the incidence 
and prevalence of this disease is much higher there than in other parts of the world, 
such as Europe.80
Etiological subgroups, as described in Table 2, vary across sex and age categories. 
Extracranial arterial dissections are the most common ‘rare’ etiological subgroup. 
Dissections are found throughout all age categories and account for approximately 
20% of strokes in patients under 45 years of age, but only for 2% of all ischemic strokes. 
The highest incidence of dissections lies in the fifth decade; men and women are 
about equally affected, although women are, on average, 5 years younger when the 
dissection manifests.108, 109
Inflammatory arteriopathies, such as vasculitis, are a heterogeneous group, mostly 
consisting of multisystemic inflammatory disorders affecting arteries of all sizes, 
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depending on the disease.116 Some of these conditions virtually never occur in young 
adults; for example, giant cell arteriitis almost exclusively affects individuals over 50 
years of age. However, other conditions, such as Takayasu disease, predominate in 
young females.116 Of note, infectious diseases underlie a considerable proportion of 
cases of secondary vasculitis. In the developed world, hepatitis B and C remain the 
most common underlying infections, whereas HIV is a large problem in the developing 
world.126
Within the subgroup of cardioembolic stroke, cardiomyopathy is one of the most 
prevalent conditions in young patients with ischemic stroke.12, 72 One would expect 
cardiomyopathy to be associated with strokes earlier in life, because this condition 
often has an early age of onset. However, one study that stratified young patients with 
Table 2 | Top 5 most prevalent ‘rare’ etiologies for stroke in younga  
Western populations
Etiology TOAST  
classificationb
Prevalence in young patients with strokec Strength of 
association
Highest level of  
evidenced
Non-inflammatory arteriopathies
Arterial dissection (cervical or intracranial)108-112 Other (rare) causes 10-25% Not reported A2
Reversible cerebral vasoconstriction syndrome72, 113-115 Other (rare) causes 1-5% Not reported B
Inflammatory arteriopathies
Inflammatory arteriitis116, e Other (rare) causes 3-5% (all autoimmune vasculitides combined) Not reported B or C, depending on the 
underlying autoimmune 
disorder
Cardioembolic
Cardiomyopathy12, 72, 117 Cardioembolism, high-risk source 2-3% Not reported A2
Prothrombotic state
Coagulation factors118-124 Other (rare) cause/unknown Antiphospholipid syndrome: 10%f
Factor V Leiden: 3.0-7.5%
Antithrombin III deficiency: 5-8%
Protein C deficiency: 4-11%
Protein S deficiency: 6% (up to 23% in occasional studies)
Prothrombin mutation: 2-6%
OR 2.2125
OR 1.02118
Not reported 
Not reported
Not reported
Not reported
A2 for antiphospholipid 
syndrome, conflicting 
results; B for other factors, 
conflicting results
a Under 50 years of age;
b TOAST classification, according to Ay et al. (2005)79; 
c  Sum of all prevalences exceeds 100%, because data were extracted from different study populations. 
In addition, conditions are not mutually exclusive in an individual patient; 
d  Levels of evidence: A1, systematic review, based on at least 2 independent A2-level studies; A2, 
prospective cohort study of sufficient sample size and duration of follow-up, adequately adjusted for 
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stroke by age category found no significant difference in prevalence between patients 
under 42 years of age and those aged 42 years or older. In this study, cardiomyopathy 
was more than twice as prevalent in men than in women (15.5% versus 6.1%).72
Antiphospholipid syndrome is an important example of a prothrombotic state that is 
related to stroke in young adults. This condition has predominantly been studied in 
women. An increased risk of ischemic stroke was found in association with this 
condition in women under 50 years of age (OR 43.1, 95%-CI 12.2-152.0).127 Although 
some studies showed a clearer relationship in younger women than in older 
populations, another study showed no age differences in a young stroke population.128
Of note, some of the risk factors mentioned in Table 1, such as illicit drug abuse or the 
presence of a patent foramen ovale (PFO), are seen as being quite specific to young 
Table 2 | Top 5 most prevalent ‘rare’ etiologies for stroke in younga  
Western populations
Etiology TOAST  
classificationb
Prevalence in young patients with strokec Strength of 
association
Highest level of  
evidenced
Non-inflammatory arteriopathies
Arterial dissection (cervical or intracranial)108-112 Other (rare) causes 10-25% Not reported A2
Reversible cerebral vasoconstriction syndrome72, 113-115 Other (rare) causes 1-5% Not reported B
Inflammatory arteriopathies
Inflammatory arteriitis116, e Other (rare) causes 3-5% (all autoimmune vasculitides combined) Not reported B or C, depending on the 
underlying autoimmune 
disorder
Cardioembolic
Cardiomyopathy12, 72, 117 Cardioembolism, high-risk source 2-3% Not reported A2
Prothrombotic state
Coagulation factors118-124 Other (rare) cause/unknown Antiphospholipid syndrome: 10%f
Factor V Leiden: 3.0-7.5%
Antithrombin III deficiency: 5-8%
Protein C deficiency: 4-11%
Protein S deficiency: 6% (up to 23% in occasional studies)
Prothrombin mutation: 2-6%
OR 2.2125
OR 1.02118
Not reported 
Not reported
Not reported
Not reported
A2 for antiphospholipid 
syndrome, conflicting 
results; B for other factors, 
conflicting results
confounding and selective follow-up sufficiently excluded. B, prospective cohort study, not meeting the 
criteria of A2, or retrospective cohort study, or case-control study; C, non-comparative study; D, expert 
opinion; 
e  Including primary vasculitis and vasculitis secondary to collagen vascular diseases, and other systemic 
conditions (excluding those secondary to infections)116; 
f   Up to 46% in selected populations.
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adults, but they can actually occur throughout the human life span. In older adults, 
however, the relative presence of these risk factors is much lower than in young adults, 
as the absolute numbers of patients with traditional cardiovascular risk factors and a 
proven etiology, such as large-artery atherosclerosis, small-vessel disease or 
cardioembolic stroke, is much higher.
For most of the risk factors in Table 1, only weak associations with respect to young 
stroke have been reported. Moreover, the extent to which a risk factor is judged to be 
causal in the origin of a disease might depend on the quality of the study. To increase 
the likelihood of causality, studies would have to show that the effects of risk factors 
are, among other criteria, dose-dependent and time-dependent.129 Double-blind 
randomized trials or large, prospective cohort studies would be needed to meet these 
requirements. 
Associations for most of the reported risk factors were derived from case-control 
studies or case series, which are prone to various forms of bias because they are 
hospital-based and often limited with respect to sample size. First, information bias 
— in particular, recall bias — needs to be considered. Remarkable events in the recent 
past, such as infections, might be more readily remembered by a patient in the 
aftermath of a stroke than by a person who has not experienced a stroke. Acute 
respiratory tract infections have been implicated as trigger factors for stroke, as have 
chronic infections, such as chronic bronchitis.130 The potential role of these infections 
as trigger factors was supported by the fact that their association with stroke was 
time-dependent and dose-dependent. However, the evidence derives mostly from 
case-control studies with methodological limitations.
Second, referral bias could be an issue. Young stroke cases described in the literature 
are often selected from a population that was referred for a second opinion to a tertiary 
academic center. These cases usually represent a selection of patients in whom no 
etiology could be established on the initial investigations. Subsequent additional 
investigations may have revealed incidental or presumed abnormal findings (for 
example, a PFO) that were not necessarily causal factors.
Last, confounding can contribute to bias; for example, in many small studies, traditional 
risk factors were not appropriately adjusted for in the analysis.
Traditional vascular risk factors
Whereas the role of rare risk factors in the pathophysiology of young stroke seems 
overestimated, the role of traditional vascular risk factors may have been 
underestimated.8, 12, 14, 24, 26, 30, 73, 131-133 The rising incidence of stroke in young adults 
coincides with an increasing prevalence of traditional vascular risk factors in this age 
group,12, 73, 113, 132 which is at least supportive of a relationship between the two, but 
causality remains to be proven. Hypertension is reported in 19-39% of all young 
patients with stroke, dyslipidemia in 17-60%, diabetes in 2-10%, smoking in 42-57%, 
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and obesity in 10-20%.12, 24, 26, 30, 73, 131, 132 Figure 1 illustrates the increase in prevalence of 
the traditional vascular risk factors with age, indicating a sharp rise in the prevalence 
of hypertension — and, to a lesser extent, hypercholesterolemia — over the age of 
35 years. 
Figure 2 shows that the number of traditional vascular risk factors per patient increases 
with age: in patients over 35 years of age, only a small fraction of patients has no 
vascular risk factors.
Despite the high prevalence of traditional vascular risk factors in young adults with 
stroke, a proven causal etiology, such as large-artery atherosclerosis, remains to be 
identified in a large proportion of cases.113 However, improved diagnostics, including 
high-resolution plaque and vessel wall imaging, might increase the likelihood of 
diagnosing a causal etiology, especially among patients with vascular risk factors, by 
enabling detection of earlier stages of atherosclerosis.134
Given the abundance of traditional vascular risk factors, the proven presence of 
large-artery atherosclerosis might obviate the need for further diagnostic work-up, 
although the safety of this strategy requires confirmation in diagnostic studies. In 
patients without any proven etiology, ancillary investigations are indicated to further 
unravel potentially treatable rare risk factors and etiologies.
Figure 1 | Prevalence of traditional vascular risk factors in young patients with stroke
Graphs show the prevalence of various traditional vascular risk factors by age category, for (A) 
men and (B) women. Data were pooled from the 15 Cities study,132 FUTURE study,24 and SIFAP1 
study.73
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Cardiovascular prognosis
Mortality
Prognosis in terms of mortality was usually considered to be favorable in young 
patients with stroke, given the lower short-term mortality rates compared with older 
patients.135 However, long-term follow-up studies in young patients found 5-year 
cumulative mortality ranging from 9-11%, while the 10-year cumulative risk of death 
ranged from 12-17%.23, 26, 70, 136-138 In 30-day survivors of a young ischemic stroke, 
20-year cumulative mortality was reported to be 27%, which is 4 times higher than 
that of individuals in the general population matched for age and sex.23 As Figure 3 
shows, excess mortality is present across all age groups of young patients with stroke, 
but especially in those over 35 years of age, in whom vascular risk factors are also 
highly prevalent.
In young adults who died during a 5-year137 or a 20-year23 follow-up period after stroke, 
vascular disease was the main cause of death. More than half of the deaths resulting 
from vascular disease were attributable to a vascular cause other than stroke. These 
findings suggest that the underlying (vascular) disease that caused stroke at a 
relatively young age continues to put these patients at an increased long-term risk of 
vascular disease.
Figure 2 | Age-specific proportions of patients with traditional vascular risk factors, 
stratified by sex
Graphs show the prevalence of no, 1, or 2 or more traditional vascular risk factors in different age 
categories, for (A) men and (B) women. Traditional vascular risk factors that were considered 
were diabetes, hypertension, smoking, and hypercholesterolemia. Data are extracted from the 
SIFAP1 study.73
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Recurrent vascular events
In the first few years following a young stroke, patients are at a substantial risk of 
stroke recurrence (annual risk 1-3%)24, 27, 29-31, 70 and, to a lesser extent, other cardio-
vascular vascular events (annual risk 0.5-1.0%).24, 29, 31 In the decades that follow, the 
risk of recurrent events continues to be elevated, leading to a cumulative risk of 20% 
for recurrent stroke and 17% for other cardiovascular events.24, 26, 29
Identification of high-risk groups 
High-risk groups in terms of recurrent mortality and cardiovascular events were 
identified on the basis of the TOAST classification.79 The atherothrombotic stroke 
category was found to have the highest risk of mortality and recurrent stroke, 
compared with the other TOAST categories.23, 24, 107, 139 
Risk factors that were associated with the highest 5-year risk of recurrent stroke 
predominantly included the traditional vascular risk factors, including age over 40 
years, history of transient ischemic attack, type 1 diabetes, and the use of antihyper-
tensive medication.31 The studies available found that the risk of mortality137, 138, 140 and 
recurrent vascular events24, 31 increased in parallel with the number of traditional 
Figure 3 | Long-term cumulative mortality in young patients with stroke and the 
general population with similar age, sex and calendar-year characteristics
Figure shows the excess mortality of young patients with stroke, compared with the general 
population, stratified by age <35 years or ≥35 years. Based on data from the FUTURE study.23
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cardiovascular risk factors present (Figure 4). Cardioembolic strokes were also 
associated with higher risks of mortality and recurrent vascular events.23, 24
Racial disparities in cardiovascular prognosis after young stroke have also been 
observed. In a short-term follow-up study of young stroke patients aged 18-45 years, 
black individuals had the highest 30-day risk of mortality: 10%, about 4 times the risk 
in Asians.141 White individuals had an approximately 3.5-fold increased risk of 30-day 
mortality compared with Asians. These differences were independent of the presence 
of traditional vascular risk factors. 
These findings indicate that prognosis in terms of long-term risk of cardiovascular 
disease after a young stroke is not as favorable as previously thought.70, 136, 140, 142 Young 
patients with stroke, especially those who resemble older stroke patients with respect 
to the presence of traditional vascular risk factors and etiology, also seem to show 
similarity to older patients in terms of long-term cardiovascular mortality and disease.
Figure 4 | Risk of death or recurrent vascular events, stratified by number of 
 traditional vascular risk factors 
Figure shows risk of (A) mortality and (B) recurrent vascular events, stratified by the number of 
risk factors present. Risks are adjusted for age and sex. Traditional vascular risk factors that 
were considered were diabetes, hypertension, smoking, and hypercholesterolemie. Based on 
data from the FUTURE study.23, 24
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Of note, the prognosis for stroke patients in the ‘other determined’ category, which 
includes arterial dissection, seemed relatively favorable compared with the other 
categories.24, 109, 139 However, one must keep in mind that this category includes a 
mixture of conditions, each with a different disease course and treatment options and, 
thus, variable prognoses. 
Secondary prevention
Young patients with stroke are often under-represented in large secondary prevention 
trials on antiplatelet drugs, statins and blood pressure lowering agents.107 Nonetheless, 
it is common practice to treat young stroke patients in accordance with guidelines 
based on extrapolated data from elderly patients with stroke.143 This might be a 
sensible approach, given that a considerable proportion of these young patients have 
the risk factors that are targeted in these trials, and some of the trials showed greater 
benefits in younger individuals (under 65 years) than in the older ones (65 years or 
over).144 These conclusions are, however, mainly based on post hoc analyses, as no 
studies were specifically designed to investigate secondary prevention strategies in 
young adults with stroke. Although no evidence exists that long-term secondary 
prevention is particularly harmful in young patients, the question of whether these 
long-term prevention strategies are truly beneficial in all young adults with stroke — 
for example, in those patients in whom no risk factor or presumed etiology could be 
found — remains to be answered. In addition, treatment strategies without proven 
benefit are not particularly cost-effective.
Secondary prevention strategies in some subgroups with a specific risk factor or 
etiology have been investigated in young adults, for example, those with PFO or anti-
phospholipid syndrome. For a PFO, current evidence does not show superiority of 
closure, compared with medical treatment, in preventing recurrent strokes in adults 
under 60 years of age.145 Two randomized controlled trials included post hoc subgroup 
analyses in patients aged 45 years or younger (approximately 45% of the study cohort), 
which showed no beneficial effects of closure in this subgroup.146, 147 For patients with 
antiphospholipid syndrome, guidelines from the American Heart Association and 
American Stroke Association recommend treatment with oral anticoagulants, with an 
international normalized ratio (INR) between 2.0 and 3.0.148 However, an expert panel 
could not reach consensus and noted that the evidence supporting higher or lower INR 
intensities or other strategies, such as antiplatelet therapy, was uniformly weak.149
To discover which patients will benefit the most from secondary prevention strategies, 
we suggest that recruitment of patients for future (multicenter) trials should be based on 
etiological subgroups rather than age, so that younger patients are not excluded.
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Physical impairments and complications
The risk factors and etiology underlying a stroke have a substantial impact on 
cardiovascular mortality and morbidity. With respect to functional outcome and 
psychosocial consequences, however, the prognosis is more likely to be determined 
by a combination of factors, including not only etiology, but also stroke severity and 
subsequent cerebral damage, co morbidity, demands from the patient’s environment, 
and the patient’s coping strategies. The sections that follow provide an overview 
of prognosis in terms of physical problems (functional outcome, pain, and epilepsy) 
and psychosocial consequences (cognitive impairment, depression, anxiety, fatigue, 
sexual dysfunction, and return to work) after a young stroke.
Functional outcome 
Neurological deficits due to a stroke are often registered during hospital admission 
and discharge, as a measure of stroke severity on the NIH Stroke Scale. However, as 
no studies have described these neurological deficits in the years after discharge, the 
frequency of neurological deficit over time is not known.
Functional outcome is assessed in terms of disability, most commonly with the 
modified Rankin Scale (mRS), a scale that predominantly assesses motor function. 
Using this scale, functional outcome is usually found to be better in younger than in 
older adults after short-term follow-up.150 For young adults, however, information on 
long-term physical disability is equally important, because of their long life expectancy. 
Only a few studies have reported long-term functional outcomes after young ischemic 
stroke. Proportions of individuals with poor functional outcome (mRS score >2) 
among young stroke survivors range from 6-20% after a mean follow-up duration 
of 3-12 years,26, 142, 151, 152 compared with 40% after short-term follow-up in older stroke 
survivors.153
Independence with regard to basic activities of daily living may not necessarily mean 
a good outcome for young patients: the ability to live independently as a young adult 
also requires independence in performing more complex tasks. In addition, demands 
from society on these young patients might be higher than in the elderly, because of 
occupational obligations and, in many cases, their role as a caregiver for 
a young family. The studies performed to date have not addressed these issues. 
Moreover, one must keep in mind that young stroke survivors with a poor functional 
outcome have to cope with this consequence for a considerable number of years, 
given their generally long life expectancy.
Epilepsy
Post-stroke epilepsy is reported to affect 2.4-14.4% of young patients with ischemic 
stroke.26, 29, 142, 154-156 The highest prevalence was found in a study that included patients 
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aged 50 years and under;156 most other studies only included patients up to 45 years 
of age. The lowest prevalence was found in a study that only included cryptogenic 
stroke.154 Factors that were associated with epilepsy, either with or without recurrent 
seizures, included a more severe stroke and involvement of cortical structures.29, 156 
A study with a decade of follow-up revealed a long-term association between post- 
stroke epilepsy and a poor functional outcome, as measured with the mRS.152
Pain
The prevalence of post-stroke pain has frequently been studied in the older stroke 
population, and estimates vary considerably, from as low as 1% to as high as almost 
50%.157-160 This broad range is probably explained by the wide variation in methods 
used to assess post-stroke pain. Moreover, post-stroke pain originates from multiple 
sources, including central pain from both thalamic and extrathalamic lesions, and 
peripheral pain from musculoskeletal abnormalities, such as joint contractures.157 No 
studies have specifically addressed the prevalence of pain after stroke in young adults. 
A recent report suggested a link between post-stroke pain and increased mortality in 
young patients with stroke.161
Psychosocial consequences
Cognitive impairment
Cognitive performance is an important determinant of social functioning in a young 
patient with stroke.162 One year after stroke, up to 60% of young stroke patients had 
impaired cognitive performance compared with stroke-free controls, depending on 
the cognitive domain tested.15, 16 In younger patients in particular, cognitive recovery is 
likely to continue beyond one year after stroke. However, one study reported that after 
a mean follow-up of 11 years, 50% of young patients with stroke still had to cope with 
impairment or below average performance on at least one cognitive domain.163 Elderly 
patients with stroke commonly exhibit prominent frontal executive impairment,5 whereas 
young patients generally show deficits in multiple cognitive domains, including visuo-
construction, delayed verbal memory, attention, and executive function. Most of 
these deficits are especially pronounced in patients with left-hemispheric lesions, with 
the exception of visuoconstruction, which seems to be more impaired after right- 
hemispheric strokes.163 These findings suggest that cognitive impairment in young 
patients with stroke displays a more global pattern than one would expect on the 
basis of a focal lesion,163 perhaps as a result of diffuse network dysfunction remote 
from the site of the lesion.163, 164
Aphasia has not been specifically tested in long-term follow-up studies.163 One study 
that assessed language disturbances in the subacute phase after stroke found 
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that young patients (under 51 years) were prone to non-fluent aphasia, whereas older 
patients were more likely to exhibit fluent aphasia, probably owing to a higher 
proportion of posterior infarcts in the older age group.165
Cognitive impairment can have life-changing consequences for young adults. 
For example, return to work may be impaired due to memory problems.71 A short-term 
follow-up study found that the number of cognitive deficits predicted later inability to 
return to work.166 This is not a surprising finding, as disturbances in multiple domains 
might interact, thereby diminishing the ability to compensate for impairments. 
For example, visual field defects can lead to reading disorders, and alexia could 
exaggerate this effect.167
Depression
Depressive symptoms are present in 28-46% of young patients with stroke70, 71, 168 after 
follow-up durations of 6-12 years. Depressive symptoms can have a large impact on 
recovery and daily life after stroke. These symptoms have been associated with poor 
functional outcome in an unadjusted analysis, but this association might have been 
confounded, for example, by recurrent vascular events.71
Patients with stroke were also found to have an increased risk of suicide (up to 7%), or 
suicidal ideations (6-15%) in both the acute and the chronic phase, especially when 
patients had current or past mood disorders.169, 170 Young adults seemed to be at 
particular risk.170
In one study conducted in the general population, younger individuals tended to be 
classified as having a ‘non-vascular depression’ profile, which was characterized by a 
higher risk of suicide and more psychotic features, whereas older individuals more 
often displayed a ‘vascular depression’ profile, with a higher prevalence of functional 
disability and anhedonia.171 The small study sample resulted in large confidence 
intervals, and the findings need further confirmation in large stroke cohorts. One 
might expect that the proportions of vascular and non-vascular depression profiles 
would not differ markedly between young and older patients in a stroke cohort, since 
both age groups have vascular lesions. However, elderly individuals might still exhibit 
a greater propensity towards a vascular depression profile owing to accumulation of 
vascular damage with age.
Depressive symptoms should not be confused with emotionalism (that is, emotional 
expressions outside a patient’s normal control), which was reported in 22.5% of the 
general stroke population the first month post-stroke.172 Although the 2 conditions 
co-occurred in 1 patient, and depressed mood was more likely to be present in patients 
with emotionalism, most patients with emotionalism were found not to be depressed. 
No studies on emotionalism versus depression have been conducted specifically in 
young patients with stroke.
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Anxiety
Anxiety is present in 19% of patients with young ischemic stroke after 12 years of 
follow-up,71 but no studies exist on its influence on daily life.
Fatigue
Post-stroke fatigue is present in about 50% of young patients with stroke,173 and seems 
to be associated with poor functional outcome173 and inability to regain pre-stroke 
activities.174, 175 However, most of the studies that assessed this complaint were limited 
with respect to sample size175 or follow-up duration.174, 175
Some short-term follow-up studies in older stroke patients found fatigue to be 
associated with certain lesion locations.176, 177 In young patients with stroke, however, 
fatigue could be the result of an imbalance between demands from society and 
reduced cognitive or physical capacity after stroke. Moreover, factors that underlie 
fatigue in the short term after stroke may differ from those in the long term, but these 
factors remain to be clarified.
Sexual dysfunction
One short-term follow-up study on sexual dysfunction, focusing on young patients 
with stroke (aged 18-45 years), found diminished sexual function in 22.5% of patients.155 
In the general stroke population, sexual dysfunction is caused by multiple factors, 
varying from neurological deficits (for example, hemisensory neglect178 or aphasia) to 
psychological problems such as depression.179 The relative contributions and long-term 
effects of the various factors in a young stroke population are unknown.
Hypersexuality may also be an issue after a young stroke. One study found this 
problem in just 1 of 71 young stroke patients, which may have been an underestimation, 
as the opinion of the patients’ partners was not investigated.155 Hypersexuality is 
thought to result from disinhibition due to lesions in the frontostriatal circuits, and 
also in the temporal lobe after ischemic stroke.180
Return to work
Return to work after young stroke is an important determinant of life satisfaction,181, 182 
and might even be a necessity for many people to provide for themselves. In addition 
to the personal implications for patients, inability to return to work after stroke imposes 
an economic burden on society as a whole, owing to loss of productive years of 
employment.183 However, only a few studies have addressed this important subject.
Reports to date indicate that 50-80% of stroke patients returned to work after a 
maximum follow-up of 4 years.175, 184-187 However, most young patients with stroke will 
be of vocational age for more than a decade of their remaining life, which stresses the 
need for further studies on the very long-term prognosis with respect to return to 
work. In one study with a follow-up of almost 12  years,71 only 40% of patients had 
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returned to full-time employment by the end of the study period. However, these data 
must be regarded with caution, since the study was retrospective with a relatively 
low response rate.
Screening and treatment
Cognitive impairment, mood disorders, and fatigue seem to be very common in young 
patients with stroke, and functional outcome is poor in a substantial proportion of 
these young adults. If not actively screened for, these consequences often go unnoticed 
by caregivers, possibly leading to frustration in young patients when they are not able 
to return to their pre-stroke activities.188 The first step in treatment of these ‘invisible’ 
psychosocial issues, therefore, is their recognition.
The next step is to start treatment for these symptoms. The current treatment strategies, 
which are suboptimal, consist primarily of occupational therapy189 or medical treatment, 
for example, with antidepressants.190, 191
Directions for future research
Currently, only limited data exist on long-term psychosocial consequences and their 
impact on daily life functioning after stroke in young adults. Future studies should 
focus on the influence of these psychosocial factors on daily life and try to find clinical 
and demographic factors that can predict future psychosocial effects. Large, prospective 
cohort studies are needed for this purpose. These predictors might, in turn, provide 
insight into the pathophysiological mechanisms that underlie these psychosocial 
consequences, although imaging studies, postmortem studies or animal models 
would provide us with more fundamental insights.
In addition, treatment strategies should be developed, and their effects quantified, 
in clinical trials. Individuals who experience a stroke at a younger age have different 
rehabilitation goals from their older counterparts,188 and specific programs need to be 
developed that are adjusted to the specific needs of these young patients.
Conclusions and recommendations
In the past, stroke in individuals under 50 years of age (‘young stroke’) has been 
viewed as a disease with different risk factors and etiology — and usually a better 
prognosis — in comparison with stroke in older patients. After a critical review of the 
available literature, however, this view may be challenged.
Traditional vascular risk factors in young adults with stroke have been somewhat 
neglected in the literature, which seems unjustified given their high prevalence,107 
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especially in young patients between 35 and 50 years of age. This high prevalence 
coincides with a rising incidence of stroke in young adults, suggesting that traditional 
vascular risk factors might contribute more to the etiology of young stroke than was 
previously thought. The presence of these risk factors, however, is not always related 
to causal etiologies such as large-artery atherosclerosis, as assessed with current 
diagnostic tools.
Young patients with stroke are at increased risk of cardiovascular mortality and 
morbidity compared with the general population, sometimes even approaching the 
risks observed in the older stroke population. The patients whose condition is 
classified as atherothrombotic stroke, with highly prevalent traditional risk factors, 
have the highest risk. In these patients, lifelong treatment with secondary prevention 
seems to be a plausible approach. However, further trials are needed to establish 
which patients will benefit from different forms of secondary prevention. Recruitment 
of patients for these trials should be based on etiological subgroups rather than age.
Although many ‘young’ stroke patients are ‘old’ with respect to etiology and prognosis, 
they are ‘young’ when psychosocial consequences come into play, as most patients 
have a life expectancy of decades that includes phases of their lives in which important 
life-changing decisions have to be made. To fulfil these needs, treatment strategies 
tailored to the needs of young patients must be developed.
Stroke in young adults is an acute disease, but its lifelong consequences are 
becoming increasingly recognized. Treatment and guidance, accompanied by a lifelong 
perspective, should be offered to each young stroke survivor in order to attain the 
highest possible quality of post-stroke life.
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Abstract
Background and objective
Up to 14% of all ischemic strokes occur in young adults (≤ 50 years). Post-stroke 
cognitive performance is a decisive determinant of their quality of life. However, virtually 
no studies report on cognition after young stroke, especially not on the long-term. 
This long-term perspective is important since young patients have a long life 
expectancy during which they start forming a family, have an active social life and 
make decisive career moves. We aimed to evaluate the long-term cognitive outcome.
Methods 
All consecutive patients between January 1, 1980 and November 1, 2010 with a first- 
ever young ischemic stroke were recruited for cognitive assessment, using a matched 
stroke-free population as a reference. Composite Z-scores for seven cognitive domains 
were calculated and the ANCOVA model was used (Bonferroni correction). A below 
average performance was defined as >1.0 SD below the age-adjusted mean of the 
controls and cognitive impairment as >1.5SD.
Results
277 patients and 146 matched controls completed cognitive assessment (mean 
follow-up = 11.0 years, SD 8.2; age = 50.9 years, SD 10.3). Long-term cognitive outcome 
after an ischemic stroke was worse in most cognitive domains compared with a non- 
stroke population. Up to 50% of the patients had a below average performance or 
cognitive impairment. Deficits in processing speed, working memory, and attention 
were most common. 
Conclusion
Even eleven years after ischemic stroke in young adults, a substantial proportion of 
patients must cope with permanent cognitive deficits. These results have implications 
for information given to patients and rehabilitation services.
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Introduction
Approximately 10% to 14% of all ischemic strokes occur in young adults (aged 
18-50).8-13, 192 The incidence of stroke in young adults is rising, which is a major concern.14
Their outcome is usually considered fairly good, since these patients usually have a 
good motor recovery,142, 193 and outcome after stroke is usually assessed with rating 
scales that predominantly measure motor performance.194 However, post-stroke 
outcome is also very much dependent on cognitive performance after stroke. 
Surprisingly, there are only a few studies that addressed cognitive outcome on the 
short-term (4-12 months)15, 16 and none on the long-term. Although these short-term 
studies found somewhat lower cognitive performance in ischemic stroke patients 
compared with controls, that may still very well be compatible with the common 
observation of gradual cognitive recovery, that may continue for at least one year or 
longer after stroke.17, 195
Since life expectancy of most of these patients exceeds by far one year,137 patients 
need to be informed about their cognitive prognosis, not only on the short-term, but 
particularly for the coming decades as they are in a period of life in which they start 
forming a family, have an active social life, and make decisive career moves. It is 
exactly this long term perspective that is currently missing. The aim of the present 
study was to investigate the long-term cognitive performance after a first-ever young 
ischemic stroke.
Patients and methods
Study design
This study is part of the “Follow-Up of Transient ischemic attack and stroke patients 
and Unelucidated Risk factor Evaluation” (FUTURE) study, a large cohort study which 
investigates causes and consequences of stroke in young adults.25 The Medical Review 
Ethics Committee region Arnhem-Nijmegen approved the study and the recruitment of 
controls.
The present study comprises all consecutive patients with a first-ever ischemic stroke 
of presumed arterial origin, aged 18-50 years, admitted to Radboud University Medical 
Centre from January 1, 1980, until November 1, 2010. This hospital is a large academic 
center, receiving patients from both the direct environment as well as serving as a 
tertiary referral center. Our hospital is the only academic medical center in our region. 
Patients were identified through a prospective registry of all consecutive young 
ischemic stroke patients that has been kept at the department since the 1970s with a 
standardized collection of baseline, clinical characteristics, and neurological exam. 
Ischemic stroke was defined as focal neurologic deficit persisting more than 24 hours. 
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The diagnosis of ischemic stroke and lesion location were based on medical records 
and radiological findings. 
The diagnostic techniques has been improved during a 30-year period and to minimize 
bias all initial diagnoses were reviewed by a panel of two experts from a pool of four 
(FEdL, EvD, RA, LJD) and in cases of disagreement a consensus meeting was held to 
adjudicate the event.
Primary exclusion criteria for ischemic stroke patients in the FUTURE study were 
cerebral venous sinus thrombosis and retinal infarction. There were additional 
exclusion criteria for cognitive assessment based on the neurological exam, which 
was also a part of the FUTURE study (Figure 1). 
Controls were recruited among patients’ spouses, relatives, or social environment. 
They had to be at least 18 years old without a history of TIA or stroke. The control group 
and patient group were matched for age, sex, and level of education. Controls were all 
living independently, none fulfilled the clinical criteria of dementia. They were recruited 
from the same environment as patients. Written informed consent was obtained from 
all participants.
Cognitive assessment
Neuropsychological tests were administered between November 2009 and end 2011. 
They covered the main cognitive domains and these tests have been previously 
applied in large-scale epidemiological studies of cerebrovascular disease.42, 43 Strict 
instruction protocols were used to assess cognitive performance and researchers 
were trained. The following cognitive domains were examined: Processing speed ( the 
written administration of the Symbol-Digit Modalities Test, Abbreviated Stroop Color 
Word Test, parts I and II), Visuoconstruction (Rey-Osterrieth Complex Figure [ROCF] – 
Copy trial), Working memory (Paper and Pencil Memory Scanning Task [PPMST]), 
Immediate memory (ROCF – Immediate recall and the total number of words 
immediately recalled in the three-trial version of the Rey Auditory Verbal Learning Test 
[RAVLT]), Delayed memory (delayed recall on the ROCF and the RAVLT), Attention 
(Verbal Series Attention Task [VSAT], and Executive functioning (Verbal Fluency and 
Stroop Interference). To account for speed-accuracy trade-off on the Stroop test, 
PPMST, and VSAT, composite scores were calculated [accuracy(%)/reaction time].196 
Stroop Interference was computed by dividing the composite Stroop part III score by 
the mean of the composite scores of parts I and II. To prevent potential bias in scoring 
the ROCF, two researchers independently rated 10% of the complex figures in both 
patients and controls, with high inter-rater reliability using the Spearman’s correlation 
coefficients (Copy: rs=0.90; Immediate recall: rs=0.97; Delayed recall rs=0.95). Detailed 
information on the neuropsychological examination is described extensively 
elsewhere.25
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Other measurements
Age, sex, level of education, depressive symptoms, and fatigue were considered 
possible confounders. Level of education was scored with a Dutch scoring system 
(1=less than primary school; 7=university degree).197 
Depressive symptoms were assessed using the Hospital Anxiety and Depression Scale 
(HADS),55 and fatigue was assessed using the subscale Subjective Fatigue of the 
revised Checklist Individual Strength (CIS-20R).61, 198 
Marital status (married, divorced, widowed, and never married) at follow-up 
was reported. Employment status at follow-up was defined as the number of patients 
who worked/studied at the time of their event and were unemployed, still employed, 
or retired at follow-up assessment. Employment status of controls was defined as 
employed, unemployed, and retired at follow-up assessment. Functional outcome 
during follow-up visit was evaluated using the Barthel Index199 and modified Rankin 
Scale (mRS).194 A good functional outcome was defined as an mRS score of 0-1 and a 
Barthel Index of ≥85.200
Furthermore, assessment of both the etiology (TOAST)7 and severity (National 
Institutes of Health Stroke Scale; NIHSS)201 was performed retrospectively in all cases 
using a validated approach,33, 202 because these scales did not exist at the time when a 
substantial proportion of the patients experienced their qualifying event.
We assessed vascular risk factors (hypertension, diabetes mellitus, dyslipidemia, 
smoking (current/former/never), current alcohol use (>2 units/day)), and vascular 
disease (myocardial infarction and recurrent stroke) on the basis of medical history 
using a standardized, structured questionnaire and/or the use of medication. 
Whenever a myocardial infarction or recurrent stroke was suspected information 
retrieved was verified and adjudicated by physicians. The Body-mass index (BMI) at 
follow-up was calculated as weight (kilograms) divided by height (meters) squared.
Statistical analysis
Baseline characteristics were presented as means (±SD), median (Q1-Q3), or number 
of cases (%). All statistical analyses were performed with SPSS 20.0 software for 
Windows. Baseline characteristics in young ischemic stroke participants and ischemic 
stroke patients who refused cognitive assessment were compared using a Pearson’s 
chi-square test, Mann-Whitney U test, or Student’s t-test when appropriate. To adjust 
for multiple comparisons in all analyses a Bonferroni correction was applied (p-values 
<0.0071 were considered significant, since there were seven pairwise comparisons for 
each analysis)
The mean raw cognitive test scores (±SD) for each test were calculated. The Rey 
Complex Figure – Copy trial showed a left skewed distribution, therefore this variable 
was transformed (e5) to obtain a normal distribution to use in all subsequent analyses.203 For 
the purpose of data reduction, across-domain comparison, and statistical considerations, 
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raw test scores were converted to Z-scores, using the mean and standard deviation of 
the controls. Z-scores of tests assigned to the same cognitive domain were averaged 
and were used in all subsequent analyses as composite Z-score, or domain score. 
If one test of a particular domain was missing, the domain score was occasionally 
based on the remaining tests of that domain (always<5.1%).
An one-way ANCOVA model was used for each cognitive domain with a two-level 
factor adjusting for age, sex, level of education, depressive symptoms, and fatigue 
severity. All p-values reported were two-sided and confidence intervals were calculated 
at the 95% CI. 
Linear regression was used to explore the effect of differences in follow-up duration 
and performance on cognitive domains adjusting for age, sex, level of education, 
depressive symptoms, and fatigue. Results were reported as standardized beta 
coefficients.
Below average performance and cognitive impairment
Due to the long-term follow-up patients differed in age at follow-up cognitive 
assessment. Obviously, age has an influence on cognitive performance apart from 
stroke.204 To account for differences in age, age-adjusted Z-scores for each neuro-
psychological test were calculated using the mean and SD of the controls in three 
different strata of age at follow up: 20-40, 40-60 and 60-80 years. Next, Z-scores of 
cognitive tests assigned to the same cognitive domain were averaged.
The frequency of a below average performance (>1.0SD below age-adjusted mean of 
controls) and cognitive impairment (>1.5SD) was determined.5
A Pearson’s chi-square test (or Fisher’s exact test when an expected cell count was 
less than five) was used to investigate differences between patients and controls in 
the proportion of participants with cognitive impairment 
Lesion location and cognitive outcome
The frequency of cognitive impairment or a below average performance for each 
cognitive domain in patients with supratentorial infarction (left vs. right) and infra-
tentorial infarction was determined. The proportion of patients with cognitive impairments 
were compared with controls using a Pearson’s chi-square test (or Fisher’s exact test 
when an expected cell count was less than five).
Recurrent stroke
All above described analyses were conducted including and excluding patients with a 
recurrent stroke to investigate whether patients with recurrent events influenced the 
results.
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Results
The study population consisted of 277 ischemic stroke participants and 146 controls 
(Figure 1). 
Basic demographic and clinical characteristics of the study population are described 
in Table 1 and neuropsychological test scores are presented in Table 2. 
Mean age of patients was 40.0 years (SD 7.7) at stroke onset; 55.6% was female. 
Mean follow-up of the study population was 11.0 years (SD 8.2), while 48.0% had a 
follow-up of ten years or longer. Participants did not significantly differ on basic 
demographical and clinical characteristics from ischemic stroke patients who refused 
Figure 1 | Flowchart of the study population
*Severe psychiatric disorder (n=1), inability to communicate in Dutch (n=1), blind and deaf 
(n=1), severe fatigue (n=1), severe aphasia (only sounds), bilateral hemianopia (n=1), and severe 
physical disabilities (n=1).
Baseline first-ever ischemic
stroke population
n = 606
Follow-up study population
n = 543
Lost to follow-up: n = 63
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Refused to participate in the FUTURE study: n = 96
Follow-up cognitive
assessment in first-ever
ischemic stroke patients
n = 277
Exclusion cognitive assessment:
1. Severely disabled patients based on the
neurological exam: n = 6*
2. Participated in the FUTURE study, but refused
to visit the research center: n = 42
Deceased: n = 122
Follow-up survivors
n = 325
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to participate or who did participate in the FUTURE-study but did not want to visit 
the research center (Table 1).
Ischemic stroke patients had a worse cognitive performance on six cognitive 
domains after a mean follow-up of 11 years compared with controls (processing 
speed: F(1,406)=35.4, p<0.0001; working memory: F(1,407)=41.7, p<0.0001; immediate 
memory: F(1,412)=14.0, p=0.0002; delayed memory: F(1,408)=17.7, p<0.0001; 
Table 2 | Neuropsychological test scores of patients with a previous young 
stroke and controls
Cognitive domain & test Ischemic stroke Controls
Processing speed, mean (SD)
SDMT 42.6 (13.7) 53.3 (10.2)
Stroop part Ia 4.0 (1.1) 4.7 (0.8)
Stroop part IIa 3.2 (0.9) 3.7 (0.6)
Visuoconstruction, mean (SD)
ROCF copy 30.7 (5.4) 32.4 (2.8)
Memory, mean (SD)
Working memory
PPMST “%”a 2.8 (1.0) 3.6 (0.8)
PPMST “S”a 2.4 (0.8) 3.1 (0.7)
PPMST “MP”a 1.6 (0.5) 2.0 (0.5)
PPMST “DHN”a 1.3 (0.4) 1.6 (0.4)
Immediate memory
RAVLT trial 1-3 18.3 (6.3) 22.1 (6.1)
ROCF immediate recall 16.4 (6.5) 18.3 (5.8)
Delayed memory
RAVLT delayed recall 5.3 (2.8) 6.9 (2.8)
ROCF delayed recall 15.8 (6.3) 18.0 (5.7)
Attention, mean (SD)
VSAT scorea 1.2 (0.5) 1.5 (0.4)
Executive functioning, mean (SD)
Verbal fluency 21.3 (6.8) 24.4 (5.8)
Interferencea 0.51 (0.1) 0.56 (0.1)
SDMT = Symbol-Digit Modalities Test, ROCF = Rey-Osterrieth Complex Figure, PPMST = Paper & Pencil 
Memory Scanning Test, RAVLT = Rey Auditory Verbal Learning Test, VSAT = Verbal Series Attention Test. 
a Speed-accuracy composite score. Higher scores indicate better performance on all measures. 
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attention: F(1,396)=28.6, p<0.0001; executive functioning: F(1,409)=17.2, p<0.0001) 
(Figure 2).
Follow-up duration
In ischemic stroke patients longer follow-up duration was associated with a lower 
immediate memory (β=-0.23, p=0.001), delayed memory (β=-0.30 , p<0.0001), and 
executive functioning score (β=-0.22, p=0.004).
Below average performance and cognitive impairment
Ischemic stroke patients showed a substantial higher proportion of patients with a 
below average performance (>1.0 SD below the mean composite Z-score of controls) or 
cognitive impairment (>1.5 SD) compared with controls (Figure 3A). Up to 50% of all 
ischemic stroke patients had a below average performance or cognitive impairment. 
Cognitive impairments were frequent among patients, affecting up to 34.8%. Deficits in 
processing speed, working memory, and attention were most common.
Figure 2 | Cognitive performance about 11 years after first-ever ischemic stroke in 
young adults compared with controls
Adjusted mean composite Z-score (95% CI) per cognitive domain (adjusted for age, sex, 
education, depressive symptoms, and fatigue). Gray band represents the 95% CI of the adjusted 
mean composite Z-score of controls. Missing values in different domains: 0.7-6.5%. No missing 
values in the control group.
* Denotes a significant difference between ischemic stroke patients and controls. p-value 
<0.0071 was considered significant.
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Figure 3 | The prevalence of long-term cognitive impairment or a below average 
 performance in ischemic stroke patients and controls
The proportion (%) of ischemic stroke patients and controls with a below average performance 
(composite Z-score >1.0SD below the age-adjusted mean of controls) or a cognitive impairment 
(>1.5SD) about 11 years after stroke (3A). The relationship between lesion location and the 
proportion of patients with a below average performance or a cognitive impairment compared 
with controls (3B). IS=Ischemic stroke, Con=Control group, LS=left supratentorial ischemic 
stroke, RS=right supratentorial ischemic stroke, Inf=Infratentorial ischemic stroke.  
*Denotes a significantly higher proportion of patients with cognitive impairment compared with 
controls. P-value <0.0071 was considered significant.
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Lesion location and cognitive outcome
One patient could not be classified as supratentorial or infratentorial infarction 
(infarction in basal ganglia or brainstem). Seven patients with bilateral supratentorial 
infarction were excluded from the analyses since the number of patients was too 
small for further analyses. The results showed that patients with a left supratentorial 
infarction had the worst cognitive outcome, up to 45.5% of patients had cognitive 
impairments on the long-term (Figure 3B). 
Recurrent stroke
After excluding patients with a recurrent stroke (n=30), there was no longer a significant 
negative relation between follow-up duration and executive functioning score in 
ischemic stroke patients. 
Discussion
This study showed that a substantial proportion of young ischemic stroke patients 
after a mean follow-up of eleven years showed a worse cognitive performance on a 
wide range of cognitive domains compared with a matched stroke-free population. 
Patients with a left surpratentorial infarction had the worst cognitive outcome.
Strong elements of our study include a large sample size in a single center, with a high 
response rate.15, 16 We used extensive neuropsychological testing rather than a short 
cognitive screen and we included a representative control group as a reference for 
neuropsychological examination. 
However, some methodological issues need to be addressed. First, the study was not 
community-based, but hospital-based and therefore our sample may not represent 
all young stroke survivors in general. However, we believe that our stroke population 
is representative to the wider Dutch stroke population. Those who survive usually visit 
a university medical center during the course of their disease. Furthermore, the age- 
and sex- standardized prevalence of stroke in our region equals that of the age- and 
sex- standardized prevalence of stroke in the Netherlands.205 We therefore believe that 
our cohort has a good external validity. This is also underlined by the fact that we 
included all consecutive cases admitted to our hospital.
Second, cognitive data of patients who refused to participate obviously was lacking, 
but their baseline characteristics did not differ from participants in the present study, 
making a selection bias unlikely.
Although we investigated a wide range of cognitive domains, agnosia or language 
comprehension15 were not included in our neuropsychological assessment. Based on the 
neurological exam we considered the proportion of patients with these symptoms to be 
small and therefore we believe that this has not largely influenced cognitive performance. 
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We found relatively low MMSE scores in both the patients and the controls, compared 
with others15 and healthy older adults.206 However, all controls lived independently and 
none fulfilled the clinical criteria for dementia. Furthermore, the diagnostic accuracy of 
the MMSE in detecting cognitive impairment is generally poor, especially outside the 
Alzheimer domain.207 Hence, we believe this finding is of little clinical relevance.
Longer follow-up, adjusted for age effects, was associated with a decrease in cognitive 
functioning in ischemic stroke patients. Longer time interval might be associated with 
incident co morbidity that could in turn have negatively affected cognitive performance. 
Another explanation is that these patients are older and that, apart from the stroke, 
neurodegenerative pathology might have emerged that interacts with the cerebro-
vascular disease.208 A better understanding of this interaction is important as 
especially those with the longest follow-up are the oldest patients who might be at risk 
for further cognitive decline, due to this interaction of vascular lesions and neuro-
degenerative pathology. 
Two studies have investigated cognitive performance in 2416 and 4015 young ischemic 
stroke patients 4-12 months after stroke. Malm and colleagues16 examined 24 patients 
with cerebellar infarcts and cognitive domains most affected were mental speed, 
cognitive flexibility, and working memory. We also found that an infratentorial 
infarction was associated with impairments in processing speed and working memory. 
Cao and colleagues15 investigated 40 young ischemic stroke patients and assessed 
other domains and found language comprehension, reasoning and verbal memory to 
be most affected. Processing speed was not assessed in these patients.15 Comparing 
our results with these two studies we found similar deficits in verbal memory, working 
memory and processing speed, but also deficits in executive functioning and attention 
are common on the long-term in ischemic stroke patients. These two domains were 
not addressed in the reported studies.15, 16 
A substantial proportion up to 50% of young ischemic stroke patients had a below 
average cognitive performance or impairment, despite the fact that the median of initial 
stroke severity was relatively mild. This highlights the influence of cerebrovascular 
lesions on cognitive performance, even decades after the stroke. It could also be that 
a severity rating scale, which includes predominantly motor signs (NIHSS), may 
underestimate the effect of stroke on other than motor symptoms. This would justify a 
basic careful neuropsychological examination of stroke patients in the (sub)acute 
phase of the disease.
Interestingly, a focal stroke on the long-term seems to have a widespread impact on 
cognition, affecting multiple cognitive domains. Increasing evidence suggests that 
focal lesions can have a widespread, diffuse impact on brain network organization,164 
which may explain the cognitive impairments attributable to dysfunction of the brain, 
remote from the site of the infarction.209 
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It appears that stroke in young adults seems to have a relatively better cognitive 
prognosis as compared with stroke in the elderly, as we found cognitive deficits in 
20.4-34.8% of our young ischemic stroke patients, whereas 31-77%210 was reported in 
elderly stroke survivors. This difference in cognitive prognosis is perhaps due to a 
better collateral blood supply with an attendant lower volume of the infarction, a more 
pronounced neuronal plasticity and the absence of neurodegenerative pathology in 
younger adults.211
To conclude, in young ischemic stroke patients, with in general a good motor recovery, 
long-term cognitive impairments are common. Given the importance of cognitive 
performance for post-stroke quality of life cognitive functioning should be monitored 
in clinical practice. This may also yield valuable information for treating rehabilitation 
services and return to work. 
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Abstract
Background and objective
Memory impairment after stroke in young adults is poorly understood. In elderly stroke 
survivors memory impairments and the concomitant loss of hippocampal volume are 
usually explained by coexisting neurodegenerative disease (for example amyloid 
pathology) in interaction with stroke. However, neurodegenerative disease, such as 
amyloid pathology, is generally absent at young age. Accumulating evidence suggests 
that infarction itself may cause secondary neurodegeneration in remote areas. Therefore, 
we investigated the relation between long-term memory performance and hippocampal 
volume in young patients with first-ever ischemic stroke. 
Methods
We studied all consecutive first-ever ischemic stroke patients, aged 18-50 years, admitted 
to our academic hospital center between 1980-2010. Episodic memory of 173 patients 
was assessed using the Rey Auditory Verbal Learning Test and the Rey Complex Figure 
and compared with 87 stroke-free controls. Hippocampal volume was determined 
using FSL-FIRST, with manual correction. 
Results 
On average 10 years after stroke, patients had smaller ipsilateral hippocampal volumes 
compared with controls after left-hemispheric stroke (5.4%) and right-hemispheric stroke 
(7.7%), with most apparent memory dysfunctioning after left-hemispheric stroke. A larger 
hemispheric stroke was associated with a smaller ipsilateral hippocampal volume 
(b=-0.003, p<0.0001). Longer follow-up duration was associated with a smaller ipsilateral 
hippocampal volume after left-hemispheric stroke (b=-0.028ml, p=0.002) and right- 
hemispheric stroke (b=-0.015ml, p=0.03).
Conclusion
Our results suggest that infarction is associated with remote injury to the hippocampus, 
which may lower or expedite the threshold for cognitive impairment or even dementia 
later in life.
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Introduction
Episodic memory deficits are common after ischemic stroke with high risk of conversion 
to poststroke dementia over time.6, 212-214 These memory deficits in elderly stroke 
survivors are often explained by coexisting neurodegenerative pathological changes 
(e.g., amyloid pathology) that directly affects hippocampal volume, in interaction with 
the infarction (e.g., post-stroke Wallerian degeneration) as hippocampal strokes are 
rare.213, 215-217
Also, up to 37.1% of young stroke patients (18-50 years) suffer from episodic memory 
impairment or below average memory performance independent of site and severity of 
the infarction, even up to eleven years after stroke.163 However, these memory 
impairments in young stroke patients are poorly understood, as the presence of 
coexisting neurodegenerative pathology observed in elderly stroke survivors (e.g., 
presence of amyloid pathology) is very unlikely to occur at such a young age.218
Infarctions located anywhere in the brain can induce widespread effects causing 
disruption of functional networks of the cortical regions.209, 219 Furthermore, apart 
from these functional changes, atrophy of nonischemic remote brain regions, 
presumably due to neuropathological consequences of ischemic stroke, has been 
observed.220-222
Hippocampal lesion studies have shown that the hippocampus is an important brain 
structure for episodic memory formation, i.e., encoding and long-term consolidation of 
new information.223 These processes can be assessed using the Rey-Auditory Verbal 
Learning Test (RAVLT)224 and the Rey-Osterrieth Complex Figure (ROCF).225
One smaller study of 36 younger patients with medial cerebral artery occlusion found 
a smaller ipsilateral hippocampal volume compared with the contralateral 
hippocampus and concomitant impairment in episodic verbal memory dysfunction, 
up to two years after stroke.221
Memory performance is of utmost importance in young stroke patients as they are in 
a demanding time of life and usually have a life expectancy of decades ahead. 
Therefore, understanding the long-term underlying structural correlates of decline in 
memory functioning after stroke is of key importance and may provide opportunities 
to tailor post-stroke treatment and rehabilitation. However, currently these data are 
lacking. Therefore, we investigated the relation between long-term memory performance 
and hippocampal volume in young patients with first-ever ischemic stroke. We 
hypothesized that infarction in these young adults is associated with long-term 
ipsilateral hippocampal atrophy and longer follow-up duration to be associated with a 
smaller ipsilateral hippocampal volume. We further hypothesized that stroke has a 
generalized effect on the ipsilateral hemisphere, not only restricted to the hippocampus. 
To investigate this, we determined thalamic volume after stroke, because the thalamus, 
apart from the hippocampus, has also been found to be associated with memory 
76
Chapter 5
function226 and previous studies have shown that ipsilateral thalamic volume is 
reduced after medial cerebral artery occlusion.227, 228
Patients and methods
Study design
This study is part of the “Follow-Up of Transient ischemic attack and stroke patients 
and Unelucidated Risk factor Evaluation”-study (FUTURE study), a prospective cohort 
study of prognosis after young stroke or TIA in adults aged 18 through 50 years 
admitted to the Radboud University Medical Centre, the Netherlands, between January 
1, 1980, and November 1, 2010.23, 25, 163 The Medical Review Ethics Committee region 
Arnhem-Nijmegen approved the study and written informed consent was obtained 
from all participants. Patients were identified through a prospective registry of all 
consecutive young stroke/TIA patients that has been kept at the department since the 
1970s with a standardized collection of baseline and clinical characteristics (including 
demographics, stroke subtype, vascular risk factors, and a history of epilepsy). The 
present MRI study comprises all consecutive patients with a first-ever ischemic stroke. 
Ischemic stroke was defined as focal neurologic deficit persisting more than 24 hours. 
Primary exclusion criteria for ischemic stroke in the FUTURE study were previous 
stroke or TIA, cerebral venous sinus thrombosis, and retinal infarction. Additional 
exclusion criteria for the present MRI study were recurrent stroke/TIA and hippocampal 
stroke. 
Participants had the opportunity to undergo an extensive neuropsychological 
examination after long follow-up which was administered between November 2009 
and December 2011. 
Lesion location (left hemisphere, right hemisphere, and infratentorial) was based on 
medical records and radiological findings. The exact lesion location (frontal lobe, 
parietal lobe, temporal lobe, occipital lobe, basal ganglia, thalamus, brainstem, and 
cerebellum) was determined using the T1-weighted images and FLAIR sequence. 
Stroke-free control participants were recruited among the patients’ spouses, relatives, 
or social environment. Controls had to be at least 18 years old without a history of TIA 
or stroke. Controls were all living independently, none fulfilled the clinical criteria of 
dementia. 
Episodic memory
Verbal episodic memory was assessed using the three-trial version of the Rey Auditory 
Verbal Learning Test (RAVLT)224, 229 and visuospatial episodic memory was assessed 
using the Rey-Osterrieth Complex Figure (ROCF).225 The verbal and visual memory 
indices derived from these tests are considered to be associated with hippocampal 
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functioning,209, 230 integrity,231-233 and volume.232, 234-236 The encoding phase of memory 
functioning was assessed using the ‘Immediate verbal recall’ (total number of correctly 
recalled words over the three consecutive learning trials of the RAVLT), and ‘immediate 
visuospatial recall’ (immediate recall score/copy trial score of the ROCF). Storage of 
previously acquired information is reflected by ‘delayed verbal recall’ (number correctly 
reproduced words 30 minutes after Trial 3) and ‘delayed visuospatial recall’ (delayed 
recall score after 30 minutes/copy trial). However, as delayed recall performance might 
be confounded by a retrieval deficit, i.e., the inability to access previously stored 
information, the RAVLT also incorporates ‘delayed verbal recognition’ (number of hits 
and correct rejections on a list of 30 items consisting of 15 target items among 15 
distractor items) that bypasses retrieval and reflects successful storage.224
Other measurements
Age, sex, level of education, depressive symptoms, and fatigue, were considered 
possible confounders for memory performance. Level of education was scored with a 
widely-used Dutch scoring system (1=less than primary school; 7=university degree). 
Depressive symptoms and fatigue were assessed using the depression subscale of 
the Hospital Anxiety and Depression Scale (HADS)55 and the subscale Subjective 
Fatigue of the revised Checklist Individual Strength (CIS-20R).61 Functional outcome 
during follow-up visit was evaluated using the modified Rankin Scale (mRS).237 The 
mRS is a measure for degree of disability or dependence in daily activities of patients 
with stroke (0=no symptoms; 6=death).
Furthermore, assessment of stroke etiology (TOAST)7 and severity (NIHSS: National 
Institutes of Health Stroke Scale)201 was done retrospectively for all cases by 
a validated approach,33, 202 as these scales did not exist at the time when a substantial 
proportion of the patients experienced their qualifying event. The TOAST is a system 
to categorize subtypes of ischemic stroke based on etiology. It includes six categories: 
(1) large-artery atherosclerosis, (2) cardioembolism, (3) small artery occlusion (lacune), 
(4) rare causes, (5) multiple causes, and (6) unknown cause. The NIHSS is a 15-item 
neurologic examination stroke scale used to evaluate the effects of acute cerebral 
infarction on the levels of consciousness, language, neglect, visual-field loss, extra - 
ocular movement, motor strength, ataxia, dysarthria, and sensory loss. 
Neuroimaging data acquisition 
Participants underwent 1.5-T MRI scanning on the Siemens, Magnetom Avanto. The 
scanning protocol included a T1-weighted MPRAGE whole-brain scan (TI /TR/TE 
1000ms/2730ms/2.95ms; flip angle 7°; field of view [FOV] = 256 mm, voxel size 
1.0×1.0×1.0 mm3) and a FLAIR pulse sequence (TI /TR/TE 2200ms/12220ms/85ms; 
interslice gap: 0.6mm ; voxel size 1.2x1.0x3.0mm3).
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Neuroimaging data processing 
Matlab 7 was used to perform all MRI data analyses. We used optimized Voxel-Based 
Morphometry toolbox (VBM8) (http://dbm.neuro.uni-jena.de/vbm.html) within SPM8 
(Wellcome Trust Centre for Neuroimaging, University College London, London, UK; 
http://www.fil.ion.ucl.ac.uk/spm) for each T1-weighted image to determine the relative 
proportion of gray matter, white matter, and CSF per voxel. We used the thorough 
clean up option, turned the final masking and skull-striping with graph-cut off to have 
better segmentation of CSF in case of large cortical infarction. Still, in patients with 
large cortical infarcts the CSF was underestimated and manual correction was needed 
based on visual inspection. FSLview (FMRIB Software Library release 5.0, http://www.
fmrib.ox.ac.uk/fsl) was used to draw a mask using the dura mater as the boundary for 
intracranial space.238 Total brain volume was taken as the sum of total gray and white 
matter. Intracranial volume (ICV) was taken as the sum of total gray and white matter 
and CSF volume. T1-weighted images were used to segment the hippocampus using 
FSL-FIRST.239 Each mask was manually corrected using FSLview.238 One experienced 
investigator, blinded for memory performance scores and baseline characteristics 
(PS), corrected all masks. Anatomical boundaries were determined in the coronal 
section, actual segmentation was performed using a previously published standardized 
protocol in which segmentation correction was performed from posterior to anterior.229 
We used a standard neuroanatomical atlas as a guide.240 The slice before the level in 
which the crura of the fornices appeared in full view was defined as the posterior 
border of the hippocampus. The anterior border of the hippocampus was defined as 
the slice in which the hippocampus was no longer present, and the amygdala fully 
covered the hippocampus. The inferior horn of the lateral ventricle was used as the 
superior border. The inferior border was determined by the white matter. The lateral 
border was defined by the temporal horn of the lateral ventricle and the white matter 
adjacent to the hippocampus. To correct for differences in head size, normalized total 
brain volumes and normalized hippocampal volumes (ml) were calculated with the 
following formula: (average intracranial volume of the total population * (total brain or 
hippocampal volume of the participant/intracranial volume of the participant)).229 
Inter-rater reliability on a random sample of 10% of all cases showed an intra-class 
correlation coefficient for the left hippocampus of 0.81, and for the right hippocampus 
of 0.83. The intra-rater reliability for hippocampal volumes yielded an intra class 
correlation coefficient for the left hippocampus of 0.93 and for the right hippocampus 
0.96.
Lesion volume and lesion probability maps
Cerebral infarctions were defined as hypointense areas on a T1-weighted MPRAGE 
whole-brain scan with corresponding gliotic rim on FLAIR. The T1-weighted image from 
each patient was used to manually trace lesions, with the aid of corresponding slices 
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on the FLAIR image. One experienced investigator (PS) traced all the lesions and was 
blinded for baseline characteristics and outcome measures (hippocampal volume and 
memory performance). Normalized lesion volumes (ml) were calculated with the same 
formula used to normalize hippocampal volume. Next, the T1-weighted images were 
brain-extracted (FSL-BET: Brain Extraction Tool)241 and subsequently, along with the 
lesion mask, registered to the Montreal Neurological Institute (MNI) standard space by 
an affine transformation with 12 degrees of freedom using FSL-FLIRT (FMRIB’s Linear 
Image Registration Tool; Software Library release 5.0, http://www.fmrib.ox.ac.uk/fsl), 
followed by non-linear registration using FNIRT (FMRIB’s Non-linear Image Registration 
Tool).242 Next, for each patient group all lesion masks were merged and averaged, 
which resulted in a lesion probability map for left-hemispheric stroke, right-hemi-
spheric stroke, and infratentorial stroke patients.
Thalamic volume
To determine whether ipsilateral stroke specifically affects the hippocampus we 
additionally investigated thalamic volumes using FSL-FIRST.239 Patients with a thalamic 
stroke were excluded from the analysis. Normalized thalamic volumes were calculated 
with the same formula used to normalize hippocampal volumes.
Statistical analyses
Baseline characteristics were presented as mean (±SD), median (Q1-Q3), or number of 
cases (%) and group differences were tested with a Pearson’s chi-square test, 
Mann-Whitney U test, or Student’s t-test when appropriate. Two-sided p-values<0.05 
were considered statistically significant. We compared lesion volumes between the 
three patient groups (left-hemispheric stroke, right-hemispheric stroke, and 
infratentorial stroke) with ANCOVA (adjusted for age at follow-up, sex, and follow-up 
duration).
The mean memory performance for patients with left-hemispheric stroke, right- 
hemispheric stroke, and infratentorial stroke were compared with controls by means 
of ANCOVA, adjusted for age at follow-up, sex, education, depressive symptoms, and 
fatigue. Aphasia may negatively influence verbal memory performance and therefore 
we examined the effect of excluding aphasic patients from the memory analyses. 
Mean hippocampal volumes were calculated for each of the three lesion locations and 
were compared with controls using an ANCOVA model, adjusted for age at follow-up and 
sex.
We investigated whether ipsilateral hippocampal volume was associated with 
immediate verbal recall, delayed verbal recall, immediate visuospatial recall, and 
delayed visuospatial recall (in Z-scores) after left-hemispheric stroke and right-hemi-
spheric stroke. Linear regression was used for this purpose (b-weights; 95%CI), 
adjusted for age, sex, level of education, follow-up duration, normalized lesion volume, 
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and ipsilateral thalamic volume. The analysis was adjusted for thalamic volume to 
investigate whether ipsilateral hippocampal volume was independently associated 
with memory performance. Patients with thalamic stroke were excluded from this 
analysis.
To investigate whether lesion volume was related to ipsilateral and contralateral 
hippocampal volume after hemispheric stroke linear regression was used (b-weights; 
95%CI), adjusted for age at follow-up, sex, lesion location (left or right), and follow-up 
duration.
The association between follow-up duration and left and right hippocampal volume 
was analyzed by left-hemispheric stroke, right-hemispheric stroke, and infra tentorial 
stroke separately by means of linear regression, corrected for age at follow-up, 
sex, and normalized lesion volume. 
Finally, mean thalamic volumes were calculated for each of the three lesion locations 
and compared with controls using an ANCOVA model, adjusted for age at follow-up 
and sex. Patients with thalamic stroke were excluded. For left and right- hemispheric 
stroke patients separately, we were also interested whether ipsilateral thalamic volume 
was associated with immediate verbal recall, delayed verbal recall, immediate 
visuospatial recall, and delayed visuospatial recall (in Z-scores). The same linear 
regression model as described in the section on hippocampal volume and memory 
functioning was used for this purpose and we subsequently reported whether there was 
an independent association between thalamic volume (b-weights; 95%CI) and 
memory performance.
Results
The study population consisted of 176 ischemic stroke participants and 87 controls. 
No differences were observed in baseline characteristics between participants (n=176) 
and those who refused (n=96) or were lost follow-up (n=63). Basic demographical and 
clinical characteristics of those who did participate in the FUTURE study, but did not 
participate in the present sub study are presented in Table 1.
The mean follow-up duration was 10.1 (SD 7.9) years and the mean age at follow-up 
was 49.7 years (SD 9.7). Eighty seven controls (mean age: 49.0, SD 11.7) with memory 
assessment and T1-weighted whole-brain image were available. The number of 
patients with bilateral infarction (n=3) was too small for subsequent analyses, 
therefore they were excluded and 173 patients remained for subsequent analyses. 
Table I shows the exact lesion location of patients. Left-hemispheric stroke patients 
and right-hemispheric stroke patients showed the highest lesion probability in the 
Medial Cerebral Artery (MCA) territory (Figure 1). Infratentorial stroke patients had the 
highest lesion probability in right cerebellum and pons (Figure 1). 
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Strokes in the right hemisphere were on average larger than strokes in the left 
hemisphere (F(1,128)=8.03, p=0.005) and than infratentorial strokes (F(1,95)=14.09, 
p=0.0003) (Table 1 and Figure 1). Left-hemispheric stroke patients had larger strokes 
compared with infratentorial stroke patients (F(1,108)=3.93, p=0.049). Patients with a 
right-hemispheric stroke had a more severe stroke (higher NIHSS score at stroke 
onset) compared with left-hemispheric stroke patients (Mann-Whitney U test, 
p=0.002), but not compared with infratentorial stroke patients (p=0.7) (Table 1). 
Infratentorial stroke patients had a more severe stroke compared with left-hemispher-
ic stroke patients (p=0.009).
Figure 1 | Lesion probability maps in patients with left-hemispheric stroke
The color overlay created on top of the Montreal Neurologic Institute (MNI) standard brain 
template shows the probability of each voxel containing a lesion in each patient group. The color 
bar denotes the probability range. 
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Chapter 5
Memory performance
Table 2 shows the mean memory performance of patients (expressed in Z-scores) 
compared with controls. Left-hemispheric stroke patients performed significantly 
worse on immediate verbal recall (unadjusted mean Z-score:-0.67, 95% CI: -0.88 to 
-0.46) and delayed verbal recall (mean:-0.56, 95% CI: -0.80 to -0.32), delayed 
visuospatial recall (mean=-0.49, 95% CI: -0.78 to -0.19), and delayed verbal recognition 
(mean:-0.73, 95% CI: -1.02 to -0.45) compared with controls (mean Z-score for every 
measure=0.00, 95% CI: -0.21to 0.21) (Table 2). Right-hemispheric stroke patients only 
performed significantly worse than controls on delayed verbal recognition (mean 
Z-score=-0.54, 95% CI: -0.82 to -0.27). Infratentorial stroke patients performed 
significantly worse on immediate verbal recall (mean=-0.44, 95% CI: -0.74 to -0.15) 
and delayed verbal recognition (mean=-0.63, 95% CI: -1.01 to -0.25) compared with 
controls.
Exclusion of patients with aphasia (n=19) did not affect our results, except for a change 
into a trend towards significance for the delayed visuospatial recall (p=0.058) in 
left-hemispheric stroke patients. 
Table 2 | 10-year follow-up of mean memory performance (Z-scores) for 
 patients compared with controls
Hemispheric stroke Infratentorial 
strokeLeft Right
No. 73 60 40
Verbal memory (RAVLT), mean (SD)
Immediate verbal recall -0.70 (0.9)*** -0.25 (0.9) -0.44 (0.9)*
Delayed verbal recall -0.57 (1.0)** -0.28 (0.9) -0.46 (0.9)
Delayed verbal recognition 
(hits + correct negatives) -0.73 (1.2)***  -0.53 (1.1)** -0.60 (1.2)*
Visuospatial memory (ROCF), mean (SD)
Immediate visuospatial recall -0.42 (1.1) 0.13 (1.1) 0.18 (1.1)
Delayed visuospatial recall    -0.51 (1.2)* 0.13 (1.2) 0.00 (1.1)
RAVLT= Rey Auditory Verbal Learning Test, ROCF= Rey-Osterrieth Complex Figure. Missing data in 
patients: no ROCF: 1.7%, no RAVLT: 1.2%. Controls (n=87) are not displayed since their mean Z-score is 
zero (SD=1) for each measure. A star denotes a significant worse performance for patients compared 
with controls after adjustments for age at follow-up, sex, education, depressive symptoms, and fatigue.
*P <0.05, **P <0.01, ***P <0.001.
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Hippocampal volume after stroke
After a mean follow-up duration of 10 years patients with left-hemispheric stroke 
showed a smaller left hippocampal volume (2.98ml, SD 0.4) compared with controls 
(3.15ml, SD 0.3)(F(1,156)=8.28, p=0.005), which was an unadjusted mean difference of 
5.4% (adjustment for age and sex did not affect this difference) (Figure 2). Right-hemi-
spheric stroke was associated with smaller right hippocampal volume (3.11ml, SD 0.4) 
compared with controls (3.36ml, SD 0.4)(F(1,143)=16.79, p<0.0001), which was a 
difference of 7.4% (after adjustment for age and sex: 7.7%)(Fig. 2). The mean contra- 
lateral hippocampal volume of both left and right-hemispheric stroke patients did not 
significantly differ from controls (Figure 2). There were no differences between mean 
hippocampal volume of patients with infratentorial stroke and controls (Figure 2).
After adjusting for age, sex, level of education, follow-up duration, normalized lesion 
volume, and left thalamic volume, there was a significant positive association between 
left hippocampal volume and immediate visuospatial recall (b=0.90, 95% 
CI= 0.20 to 1.60, t=2.58, p=0.012) and delayed visuospatial recall (b=1.01, 95%CI= 
0.27 to 1.75, t=2.74, p=0.008) in left-hemispheric stroke patients. No association was 
observed between left hippocampal volume and verbal memory performance after 
left-hemispheric stroke. In right-hemispheric stroke patients no significant associations 
between right hippocampal volume and memory performance were observed. 
Relationship between lesion volume and hippocampal volume
Even after adjustment for age at follow-up, sex, lesion location (left/right), and follow- 
up duration, a larger hemispheric stroke was significantly associated with a smaller 
ipsilateral hippocampal volume (b=-0.003, 95%CI= -0.005 to -0.002 per ml increase 
Figure 2 | Unadjusted mean hippocampal volume (±SEM) 10 years after ischemic 
stroke in young adults compared with stroke-free controls
Significant differences are shown after adjusting for age at follow-up and sex. 
*P <0.05, **P <0.01, ***P <0.001 .
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in lesion volume, t=-4.46, p<0.0001), not contralateral hippocampal volume (b=-0.001, 
95%CI= -0.002 to 0.000, t=-1.36, p=0.18).
Relationship between follow-up duration and hippocampal volume
After controlling for age, sex, and normalized lesion volume, in patients with left- 
hemispheric stroke there was a negative association between follow-up duration and 
left hippocampal volume (b= -0.028 ml, 95% CI=-0.04 to -0.01, t=-3.25, p=0.002). 
After each decade the left hippocampus is estimated to be 0.28 ml smaller. 
In right-hemispheric stroke patients longer follow-up duration was associated with a 
smaller right hippocampal volume (b= -0.015 ml, 95% CI=-0.03 to -0.003, t=-2.54, 
p=0.03). This is an estimated reduction of 0.15 ml after a decade. We did not observe 
a relationship between duration of follow-up and contralateral hippocampal volume 
after hemispheric stroke. No associations were observed after infratentorial stroke.
Thalamic volume after stroke
To investigate whether the results were specific to the hippocampus, thalamic volumes 
after stroke were also examined. In left-hemispheric stroke patients a significantly 
smaller mean left thalamic volume (7.00ml, SD 0.9) was found compared with controls 
(7.60ml, SD 0.6)(F(1,148)=24.66, p<0.0001). Right-hemispheric stroke patients had a 
smaller mean right thalamic volume (6.38ml, SD 1.1) compared with controls (7.39ml, 
SD 0.6)(F(1,127)=49.5, p<0.0001). Hemispheric stroke was not associated with smaller 
contralateral thalamic volume compared with controls. Patients with infratentorial 
stroke did not have significantly smaller thalamic volumes compared with controls. 
After adjustment for age, sex, level of education, follow-up duration, ipsilateral 
hippocampal volume, and normalized lesion volume, no independent association 
between ipsilateral thalamic volume and memory performance was found in hemi - 
spheric stroke patients (all p-values>0.05).
Discussion
We showed that on average 10 years following ischemic stroke in adults 18 through 
50 years, hemispheric stroke outside the medial-temporal lobe is associated with a 
smaller ipsilateral hippocampal volume compared with a stroke-free population, 
accompanied by a worse memory performance. 
We showed that patients with a left-hemispheric stroke after a mean follow-up of 10 
years had a worse memory performance on almost all memory measures with an 
attendant smaller ipsilateral hippocampal volume compared with controls. Although the 
memory performance was only very mildly affected in right-hemispheric stroke patients 
compared with controls, we observed a smaller ipsilateral hippocampal volume. 
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Possibly, aphasia limits the proper assessment of verbal memory performance in 
left-hemispheric stroke patients. However, these patients also had a worse visual 
memory performance and the exclusion of patients with aphasia did not significantly 
alter our findings making this a very unlikely explanation. Other studies also found that 
left hippocampal atrophy is more evidently related to poorer memory function than 
right hippocampal atrophy.235, 243-245 This finding is in line with hippocampal lesion 
data.246, 247 These previous results and our present findings suggest that volumetric 
changes in the left hippocampus may be more important to memory performance than 
volumetric changes in the right hippocampus.
In left-hemispheric stroke patients, our results suggest poorer encoding ability as well 
as a decay of acquired visuospatial information over time, both of which have been 
found to correlate with hippocampal volume and functioning.230, 233, 235
Somewhat surprisingly, the regression analyses yielded no association between 
verbal memory and ipsilateral hippocampal volume, whereas this relationship has 
been found in patients with Alzheimer’s disease.248 In patients with Alzheimer’s 
disease larger reductions in hippocampal volume have been observed (left: 30% and 
right: 35%) compared to our young stroke patients (left: 5.4% and right: 7.7%).249 
Possibly, once volume loss exceeds a certain volume, as for example in Alzheimer’s 
disease, the relation between hippocampal volume and verbal episodic memory may 
become more evident.249, 250
A previous study by Xie et al. (2011)221 investigated 36 relatively young patients up to 
two years after middle cerebral artery occlusion. However, life expectancy of most of 
these young patients exceeds by far two years. Our findings therefore extend those of 
Xie et al. (2011) as we found a relation between hippocampal volume and hemispheric 
stroke, but not infratentorial stroke, with a much longer follow-up of 10 years. Data on 
lesion side (left/right) was lacking in the study of Xie et al. (2011), which is important 
since the asymmetry between left and right hippocampal volume, with larger right 
than left volumes, is established in healthy adults.251 Therefore, we compared volumes 
of patients with volumes of controls within each hemisphere. 
Furthermore, another important finding of our study is the inverse relation between 
follow-up duration in years and ipsilateral hippocampal volume, reflecting decreasing 
hippocampal volume from the early months after stroke up to 30 years after stroke. 
This relation persisted even after adjusting for age. This might explain the negative 
association between follow-up duration and memory performance previously 
observed in these young adults.163
Finally, our results suggest that hemispheric stroke has a generalized effect on 
ipsilateral brain structures remote from the infarction, such as a smaller ipsilateral 
hippocampus and thalamus. However, after adjusting for age, sex, education, follow-up 
duration, normalized lesion volume, and ipsilateral hippocampal volume no independent 
relation was found between thalamic volume and memory performance. Ipsilateral 
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hippocampal volume was still associated with visual memory function in left-hemi-
spheric stroke patients after excluding patients with thalamic stroke and adjusting for 
left thalamic volume in the regression analysis, suggesting an independent association 
between ipsilateral hippocampal volume and memory performance.
Underlying mechanism of smaller ipsilateral hippocampal volume
Rodent studies showed loss of pyramidal cells in the CA1 area of the hippocampus 
after ischemia in other areas of the brain,252 possibly caused by spreading depression 
(SD), causing secondary neuronal damage and infarct expansion. SD is associated 
with failure of brain ion homeostasis, efflux of excitatory amino acids from neurons, 
resulting in increased energy metabolism and changes in cerebral blood flow.253 
Support for SD as underlying mechanism of hippocampal damage after infarction 
comes from the finding that inhibition of SD propagation by blocking intercellular 
communication via gap junction channels after ischemic stroke in rodents, results in 
less hippocampal damage and fewer deficits in memory.221 
The observation of a smaller ipsilateral hippocampus dependent on follow-up duration 
after stroke may induce a vulnerability of the hippocampus in the affected hemisphere 
to the effect of ageing, possibly leading to accelerated cognitive decline at an already 
earlier age. When these patients finally come to an age when neurodegenerative 
features come into play, their remaining hippocampal volume may already be lower or 
expedite the threshold for cognitive impairment or even dementia, compared with 
persons without a stroke at young age. This notion is in agreement with the finding 
that patients who develop Alzheimer’s disease, loss of hippocampal volume seems to 
be present years before the clinical diagnosis.234
Strengths and limitations 
The strengths of our study include its large sample size and the long follow-up. This 
single center study allowed us to collect baseline and follow-up information according 
to identical procedures in all patients, with high inter-rater and intra-rater agreement 
for hippocampal volumes. We used strict protocols and researchers were trained, in 
order to reduce the risk of information bias. 
Some limitations of our study need to be addressed. Although the FUTURE study has 
a prospective design, the current analysis is cross-sectional and we therefore can only 
report on smaller hippocampal volume after stroke. While this may be due to 
post-stroke hippocampal atrophy, a longitudinal design is required to further support 
causality. However, our data clearly demonstrate a relation between the stroke and 
future loss of ipsilateral hippocampal volume, since we did not observe smaller 
contralateral hippocampal volumes and longer follow-up duration was associated 
with smaller ipsilateral hippocampal volume. Additional support comes from our 
finding that a larger hemispheric stroke was associated with smaller ipsilateral 
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hippocampal volume. In contrast with one smaller study (n=36),221 we did observe an 
inverse relationship between lesion volume and ipsilateral hippocampal volume. 
Possibly, in the previous study low statistical power due to a small sample size resulted 
in no association.221 Thus, our findings suggest that it is highly unlikely that these 
patients already had smaller ipsilateral hippocampal volumes before stroke onset.
Second, selection bias might have occurred, since patients who refused or were not 
eligible for MRI scanning had a poorer outcome compared with participants. However, 
bias would only have occurred when the relation between the stroke and hippocampal 
volume would be selectively different in non-participants, which does not seem likely. 
However, non-participants might have had more vascular risk factors, which may 
accelerate decline of hippocampal volume. 
Third, MRI quantification (with manual correction of hippocampal volume and ICV in 
case of large cortical infarcts) could not have been done blindly for lesion location and 
size. This might have biased the results. However, automated analyses on thalamic 
volume showed the same results as compared with manually corrected hippocampal 
volume, suggesting no bias due to unblinded reading.
Conclusions and clinical implications
To conclude, the greater (probable lifelong) memory impairment after stroke may be 
explained by a smaller ipsilateral hippocampus. At present the mean memory 
performance of our patients was not within the “impaired” range (i.e., less than 1.5 
standard deviations below the mean of the controls). Given their young age, these 
patients are expected to live on for several decades and the reduced ipsilateral 
hippocampal volume accompanied by a worse memory score may point towards a 
lower neural reserve in these patients, making them at risk for further cognitive 
decline, especially when neurodegenerative disease comes into play. Also, in these 
young patients even small decrements in memory function may affect vocational and 
academic achievements, which makes our findings highly relevant.
The stronger association between left-hemispheric stroke, a smaller left hippo campal 
volume, and worse memory performance has clinical implications, since it seems that 
especially small baseline left hippocampal volume is associated with higher risk of 
conversion into dementia.254 These patients with memory decline and smaller 
hippocampal volumes therefore might be especially at risk for further cognitive 
decline. It is important to inform patients on these long-term consequences and 
provide realistic outlooks given the underlying structural changes. Future studies are 
needed that prospectively investigate the underlying structural changes of cognitive 
decline to support causality.
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Abstract
Background and objective
Memory impairment after stroke is poorly understood as stroke rarely occurs in the 
hippocampus. Previous studies have observed smaller ipsilateral hippocampal 
volumes after stroke compared with controls. Possibly, these findings on macroscopic 
level are not the first occurrence of structural damage and are preceded by microscopic 
changes that may already be associated with a worse memory function. We therefore 
examined the relationship between hippocampal integrity, volume, and memory 
performance long after first-ever ischemic stroke in young adults.
Methods
We included all consecutive first-ever ischemic stroke patients, without hippocampal 
strokes or recurrent stroke/TIA, aged 18-50 years, admitted to our academic hospital 
between 1980 and 2010. One hundred and forty-six patients underwent T1 MPRAGE, 
DTI scanning and completed the Rey Auditory Verbal Learning Test and were compared 
with 84 stroke-free controls. After manual correction of hippocampal automatic 
segmentation, we calculated mean hippocampal fractional anisotropy (FA) and 
diffusivity (MD).
Results
On average 10 years after ischemic stroke, lesion volume was associated with lower 
ipsilateral hippocampal integrity (p<0.05), independent of hippocampal volume. In 
patients with a normal ipsilateral hippocampal volume (volume is less than or equal to 
1.5 SD below the mean volume of controls) significant differences in ipsilateral hippo- 
campal MD were observed (p<0.0001). However, patients with a normal hippocampal 
volume and high hippocampal MD did not show a worse memory performance 
compared with patients with a normal volume and low hippocampal MD (p>0.05).
Conclusion
Patients with average ipsilateral hippocampal volume could already have lower 
ipsilateral hippocampal integrity, but at present with no attendant worse memory 
performance compared with patients with high hippocampal integrity. Longitudinal 
studies are needed to investigate whether a low hippocampal integrity after stroke 
might lead to exacerbated memory decline with increasing age. 
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Introduction 
Although episodic memory dysfunction frequently occurs after ischemic stroke at 
young age (18 through 50 years), it’s underlying mechanism is poorly understood. 
That is, stroke typically does not affect brain structures that are crucial for memory 
formation and retrieval, such as the hippocampus.209 However, recent studies started 
to unravel potential underlying mechanisms by demonstrating smaller ipsilateral hippo- 
campal volumes in patients who experienced an ischemic stroke outside the medial 
temporal lobe at young age, with an accompanying worse memory performance.255
Most likely, these findings on the macroscopic level are not the first manifestation of 
structural damage of the hippocampus after ischemic stroke as they are presumably 
preceded by microstructural changes with already (subtle) cognitive correlates. 
Diffusion Tensor Imaging (DTI) is able to detect these early manifestations of damage 
on the microstructural level.233 Therefore, in young stroke patients these microstruc-
tural changes may explain lower verbal memory performance, even before structural 
changes on conventional MRI appear. However, to the best of our knowledge, this has 
never been investigated in patients with stroke at young age, whereas understanding 
of the pathophysiology of post-stroke memory dysfunction is of particular importance 
in young patients, since they are in a period of life in which they start forming a family, 
have an active social life, and make decisive career moves, requiring optimal cognitive 
function. 
Therefore, we investigated long-term hippocampal integrity in patients with first-ever 
young ischemic stroke. This study is embedded within the “Follow-Up of Transient 
ischemic attack and stroke patients and Unelucidated Risk factor Evaluation”-study 
(FUTURE study) that addresses risk factors and prognosis after stroke in young adults. 
Patients and methods
Study design
This study is part of the FUTURE study, a prospective cohort study of prognosis after 
transient ischemic attack (TIA), ischemic stroke, or hemorrhagic stroke in adults aged 
18 through 50 years admitted to the Radboud university medical centre, the Netherlands, 
between January 1, 1980, and November 1, 2010.24, 25, 163 The Medical Review Ethics 
Committee region Arnhem-Nijmegen approved the study and written informed consent 
was obtained from all participants.
Patients were identified through a prospective registry of all consecutive young stroke/TIA 
patients that has been kept at the department since the 1970s with a standardized 
collection of baseline and clinical characteristics (including demographics, stroke subtype, 
vascular risk factors, and a history of epilepsy). Ischemic stroke was defined as focal 
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neurologic deficit persisting more than 24 hours. Lesion location (left hemisphere, 
right hemisphere, and infratentorial) was based on medical records and radiological 
findings. Lesion location was further specified into frontal lobe, parietal lobe, temporal 
lobe, occipital lobe, basal ganglia, thalamus, brainstem, and cerebellum based on the 
T1-weighted images and FLAIR sequence. Patients had the opportunity to undergo an 
extensive neuropsychological examination after long follow-up which was administered 
between November 2009 and December 2011.163 
The present substudy comprises all consecutive patients with a first-ever ischemic 
stroke. Primary exclusion criteria for ischemic stroke in the FUTURE study were 
previous stroke or TIA, cerebral venous sinus thrombosis, and retinal infarction.25 
Additional exclusion criterion for the present substudy were recurrent stroke/TIA and 
hippocampal stroke. 
Stroke-free control participants were recruited among the patients’ spouses, relatives, 
or social environment. Inclusion criteria were: 18 years or older without a history of TIA 
or stroke. The control group and patient group were matched for age, sex, and level of 
education. Controls were all living independently, none fulfilling the clinical criteria of 
dementia. 
Episodic memory
Episodic memory performance was evaluated with the Rey Auditory Verbal Learning 
Test [RAVLT],229 a widely used word-list learning test tapping verbal memory function. 
The RAVLT consists of three consecutive learning trails, followed by a delayed free 
recall test as well as a delayed recognition test. In the present study we used the 
immediate verbal recall score (total number of correctly recalled words over the three 
consecutive learning trials) and the delayed verbal recall score since these measures 
are most sensitive to hippocampal (dys)function and previous studies found a clear 
association with hippocampal integrity.232, 234, 256-258 Immediate verbal recall reflects the 
encoding phase of memory functioning. Delayed verbal recall after the learning trials 
of the RAVLT reflects storage and retrieval success of previously acquired information.224 
Other measurements
Level of education was scored with a widely-used Dutch scoring system (1=less than 
primary school; 7=university degree). Functional outcome during follow-up visit was 
evaluated using the modified Rankin Scale (mRS).237 Furthermore, assessment of 
stroke etiology (TOAST)7 and severity (National Institutes of Health Stroke Scale, 
NIHSS)201 was done retrospectively for all cases by a validated approach,33, 202 as these 
scales did not exist at the time when a substantial proportion of the patients 
experienced their qualifying event. The etiology of stroke using TOAST was classified 
as atherothrombotic stroke, cardioembolic stroke, lacunar stroke, rare causes 
(vasculitis, moyamoya, migraine, coagulopathy, systemic disease, genetic, toxic, 
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post-surgery, traumatic, pregnancy related), multiple causes, or unknown cause. 
Depressive symptoms and fatigue were assessed using the depression subscale of 
the Hospital Anxiety and Depression Scale (HADS)55 and the subscale Subjective 
Fatigue of the revised Checklist Individual Strength (CIS-20R).61
We assessed vascular risk factors at follow-up (hypertension, diabetes mellitus, 
dyslipidemia, smoking (current/former/never), current alcohol use (>2 units/day)) on 
the basis of medical history using a standardized, structured questionnaire and/or the 
use of medication. The Body-mass index (BMI) at follow-up was calculated as weight 
(kilograms) divided by height (meters) squared.
Neuroimaging data acquisition 
Participants underwent a 1.5-T MRI scanning on the Siemens, Magnetom Avanto. 
A T1-weighted whole-brain scan was collected (magnetization-prepared rapid 
acquisition with gradient echo [MPRAGE], TI 1000 ms, repetition time [TR] 2730 ms, 
echo time [TE] 2.95 ms, flip angle 7°, field of view [FOV] = 256 mm, voxel size 1.0×1.0×1.0 
mm3) as well as a set of whole-brain diffusion-weighted images (TR 9100 ms, TE 98 
ms, diffusion directions 61, with non co-linear orientation of the diffusion-weighting 
gradient and b-value 1000 s/mm2. Seven unweighted images, FOV = 220 mm, voxel 
size 2.2×2.2×2.2 mm3) and a FLAIR pulse sequence (TI /TR/TE 2200ms/12220ms/85ms; 
interslice gap: 0.6mm; voxel size 1.2x1.0x3.0mm3).
Neuroimaging data processing 
Hippocampal and intracranial volumetry
Neuroimaging data analyses are extensively described elsewhere.255 In short, 
neuroimaging data were analyzed using Matlab 7. Voxel-Based Morphometry toolbox 
(VBM8) within SPM8 was used for each T1-weighted image to determine the volume of 
gray matter, white matter, and CSF to calculate the intracranial volume (ICV).
Hippocampal volumes were determined by automatic segmentation (FSL-FIRST: FMRIB 
Software Library release 5.0, http://www.fmrib.ox.ac.uk/fsl) with manual correction 
using FSLview by one experienced investigator (PS) who was blinded for baseline 
characteristics and memory performance. The anatomical boundaries were determined 
using a previously published standardized protocol in which segmentation correction 
was performed from posterior to anterior.229, 259 Normalized brain volume and 
hippocampal volume (ml) were calculated with the following formula: (average 
intracranial volume of the total population * (brain or hippocampal volume of the 
participant/intracranial volume of the participant)).260 Inter-rater reliability on 10% of 
all cases showed an intra-class correlation coefficient for the left hippocampus of 0.81, 
and for the right hippocampus of 0.83. The intra-rater reliability for hippocampal 
volumes yielded an intra class correlation coefficient for the left hippocampus of 0.93 
and for the right hippocampus 0.96.
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Thalamus
To determine whether the results are specific for the hippocampus or not, we 
additionally investigated thalamic integrity. Lesion studies have shown that, apart 
from the hippocampus, thalamic lesions have also been found to be associated with 
memory dysfunction226 and previous studies have shown that ipsilateral thalamic 
volume is reduced after ischemic stroke.227, 228, 255 Thalamic volume was determined 
using FSL-FIRST.239 Patients with a thalamic stroke were excluded from the analysis. 
Normalized thalamic volumes were calculated with the same formula used to normalize 
hippocampal volumes.
DTI analysis
First, diffusion data were preprocessed to detect and correct head and cardiac motion 
artifacts, using an in-house developed iteratively re-weighted-least-squares algorithm 
named ‘PATCH’.261 Eddy current corrections and motion artifacts from affine 
misalignment are performed simultaneously by minimization of the residual diffusion 
tensor errors. Using DTIFit within the Functional MRI of the Brain Diffusion Toolbox, we 
created FA en MD images. Next, the mean unweighted image (b=0) was used to 
coregister to the anatomical T1 image using SPM8 with default settings, which were 
then applied to the FA en MD images. All images were visually inspected for severe 
motion artefacts and co-registration errors. To reduce partial volume effects for 
hippocampal and thalamic MD and FA, we eroded the hippocampus and thalamic 
volumes by one voxel in all directions.232 All images were checked for not including 
peri-hippocampal CSF. The mean FA and MD were calculated for the right and left 
hippocampus and thalamus. 
Ischemic stroke volume and lesion probability maps
Ischemic lesions were defined as hypointense areas on a T1-weighted MPRAGE 
whole-brain scan with corresponding gliotic rim on FLAIR. The T1-weighted image from 
each patient was used to manually trace lesions, with the aid of corresponding slices on 
the FLAIR image. One experienced investigator traced all the lesions and was blinded for 
baseline characteristics and outcome measures. Normalized lesion volumes (ml) were 
calculated with the same formula used to normalize hippocampal volume. Next, 
the T1-weighted images were brain-extracted (FSL-BET: Brain Extraction Tool)241 and 
subsequently, along with the lesion mask, registered to the Montreal Neurological 
Institute (MNI) standard space by an affine transformation with 12 degrees of freedom 
using FSL-FLIRT (FMRIB’s Linear Image Registration Tool; Software Library release 5.0, 
http://www.fmrib.ox.ac.uk/fsl), followed by non-linear registration using FNIRT 
(FMRIB’s Non-linear Image Registration Tool). Next, for each patient group all lesion 
masks were merged and averaged, which resulted in a lesion probability map for 
left-hemispheric stroke, right-hemispheric stroke, and infratentorial stroke patients.
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Statistical analyses
Baseline characteristics were presented as means (±SD), median (Q1-Q3), or number 
of cases (%). To investigate whether participants in the present DTI study differed from 
non-participants on basic demographical and clinical characteristics we used a t-test 
in case of normal distributed data (age at event and follow-up), a Mann-Whitney U test 
in case of ordinal data (NIHSS at admission), and Pearson’s chi-square test in case of 
categorical data (sex, TOAST, lesion location). For the participants, group differences 
between the three groups of patients (left/right/infratentorial stroke) on basic demo- 
graphical and clinical characteristics were investigated using a t-test, Kruskal-Wallis 
test (three groups), or Pearson’s chi-square test when appropriate. Since the explanatory 
nature of this study, two-tailed p-values <0.05 were considered significant.
We investigated whether different lesion locations (left hemisphere/right hemisphere/ 
infratentorial) were associated with differences in left and right hippocampal integrity 
compared with a non-stroke population. We therefore calculated mean FA and MD for 
the left and right hippocampus separately, stratified by stroke location (left hemisphere/
right hemisphere/infratentorial) and were compared with controls by means of ANCOVA, 
adjusted for age at follow-up and sex. 
We investigated whether lesion volume was associated with lower ipsilateral hippo- 
campal integrity in hemispheric stroke, independent from hippocampal volume. Linear 
regression was used for this purpose adjusting for age, sex, follow-up duration, lesion 
location (left/right), and ipsilateral hippocampal volume. To investigate the relation 
between ipsilateral hippocampal volume and ipsilateral hippocampal integrity, the 
same linear regression model was used as to investigate the relation between lesion 
volume and hippocampal integrity and we subsequently reported whether there was 
an independent association between ipsilateral hippocampal volume and ipsilateral 
hippocampal integrity. 
Finally, we investigated whether there were patients with normal ipsilateral hippo - 
campal volume and lower ipsilateral hippocampal integrity and possibly already 
an attendant worse memory performance compared with patients with normal volume 
and high hippocampal integrity. We used controls as a reference for normal 
hippocampal volume. To account for the effects of aging on hippocampal volume262 
we divided the control group into two equal groups based on the median age of the 
control group. Next, we used the mean hippocampal volume and SD of these two 
age groups to calculate an age-adjusted Z-score of hippocampal volume for each 
participant. Hippocampal atrophy was defined as more than 1.5 below the mean 
volume of controls.263, 264 Normal hippocampal volume was defined as less than or 
equal to 1.5 SD below mean volume of controls. Next, we excluded patients with 
thalamic stroke from the analysis to investigate the independent effect of the 
hippocampus. For left and right-hemispheric stroke patients separately, patients with 
normal ipsilateral hippocampal volume were split into two equal groups based on the 
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median of ipsilateral hippocampal MD: low ipsilateral hippocampal MD (lowest 50%) 
and high ipsilateral hippocampal MD (highest 50%). We investigated whether these 
two patient groups with normal volume and low versus high hippocampal MD 
significantly differed in hippocampal MD, using an ANCOVA model, adjusted for age, 
sex, follow-up duration, and ipsilateral hippocampal volume. Next, we investigated 
whether hippocampal volume significantly differed between these patients with high 
or low hippocampal MD, using an ANCOVA model, adjusted for age, sex, and follow-up 
duration. Last, we investigated in patients with normal volume whether there was a 
difference in memory performance between patients with low hippocampal MD and 
high hippocampal MD. In this way, we investigated the additional effect of higher 
hippocampal MD on memory performance in stroke patients. An ANCOVA model 
was used for this purpose adjusted for age, sex, education, follow-up duration, and 
ipsilateral hippocampal volume.
The described analyses on memory performance were also performed for patients with 
normal thalamic volume and low or high ipsilateral thalamic integrity (thalamic stroke 
excluded), to investigate whether present results were specific for the hippocampus. 
Results
T1-weighted whole-brain imaging, DTI-scanning (no artefacts), and memory performance 
was available from 146 ischemic stroke patients and 84 stroke-free controls. Baseline 
characteristics between participants and those who refused or were lost to follow-up 
were not significantly different. Those who participated in the FUTURE study, but did 
not participate in the present study had lower education (p=0.03) and a higher mRS 
at follow-up (p=0.0001) compared with participants who did participate in the 
present DTI study. 
Table 1 shows the baseline characteristics of the study population and group 
comparisons between the three groups of patients. Mean follow-up duration was 10.4 
years (SD 8.0) and mean age at follow-up was 50.0 years (SD 9.8). Mean age of controls 
was 48.9 years (SD 11.9). Infratentorial stroke patients had a significant higher 
proportion of men compared with left-hemispheric stroke patients (p=0.002) and 
right-hemispheric stroke patients (p=0.003) (Table 1). Left-hemispheric stroke patients 
reported more depressive symptoms compared with infratentorial stroke patients 
(p=0.02). Based on the NIHSS at admission, right-hemispheric stroke patients had a 
more severe stroke compared with left-hemispheric stroke patients (p=0.008). Infra-
tentorial stroke patients had a more severe stroke compared with left-hemispheric stroke 
patients (p=0.03), but did not differ in stroke severity compared with right-hemispheric 
stroke patients (p=0.6). 
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Right-hemispheric stroke patients had a significant higher mean lesion volume 
compared with left-hemispheric stroke patients (p=0.01) and infratentorial stroke 
patients (p=0.0004). Whereas, left-hemispheric stroke patients had a significant 
higher mean lesion volume compared with infratentorial stroke patients (p=0.02). 
Left-hemispheric stroke patients and right-hemispheric stroke patients showed the 
highest lesion probability in the Medial Cerebral Artery (MCA) territory (Figure 1). 
Infratentorial stroke patients had the highest lesion probability in right cerebellum and 
pons (Figure 1). 
We observed higher mean right hippocampal MD in right-hemispheric stroke patients 
compared with controls (p=0.007), with a trend towards significance for higher left 
hippocampal MD in left-hemispheric stroke patients compared with controls (p=0.059) 
(Figure 2). Right-hemispheric stroke patients showed lower mean right hippocampal 
FA compared with controls (p=0.007). There were no differences in mean left and right 
hippocampal MD or FA between patients with infratentorial stroke and controls (Figure 
2). We did not observe a relationship between ipsilateral hippocampal volume and 
ipsilateral hippocampal FA or MD in hemispheric stroke patients after adjusting for 
age, sex, follow-up duration, lesion location (left/right), and normalized lesion volume 
(p>0.05). 
Relationship between lesion volume and ipsilateral hippocampal integrity
After adjusting for age, sex, follow-up duration, lesion location (left/right), and 
ipsilateral hippocampal volume, larger hemispheric stroke volumes were associated 
with lower values of ipsilateral hippocampal FA (β=-0.38, p=0.0002) and higher values 
of ipsilateral hippocampal MD (β=0.26, p=0.01).
Patients with normal ipsilateral hippocampal volume and high versus low 
ipsilateral hippocampal MD
In left-hemispheric stroke patients with normal left hippocampal volume (less than or 
equal to 1.5 SD below the mean volume of controls) and significantly higher values of 
left hippocampal MD (F(1,36)=38.28, p<0.0001), we did not observe a worse immediate 
verbal recall score (F(1,34)=0.05, p=0.8) or a worse delayed verbal recall score 
(F(1,33)=0.35, p=0.6) compared with patients with normal volume and lower 
hippocampal MD (Table 2). These two groups did not significantly differ in mean left 
hippocampal volume (p=0.6) (Table 2).
Right-hemispheric stroke patients with normal right hippocampal volume and 
significantly higher values of right hippocampal MD (F(1,25)=27.07, p<0.0001) did not 
show a worse immediate verbal recall score (F(1,24)=0.27, p=0.6) or a worse delayed 
verbal recall score (F(1,24)=0.56, p=0.5) compared with patients with normal volume 
and lower hippocampal MD values (Table 2). These two groups did not significantly 
differ in mean right hippocampal volume (p=0.4). 
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Chapter 6
Thalamic integrity after ischemic stroke in young adults
We used the thalamus as a control region to investigate whether the results were 
specific for hippocampal integrity or also apply to other ipsilateral structures. 
After adjusting for age and sex, we observed a significant higher mean left thalamic MD 
after left-hemispheric stroke (0.087x10-2 mm2/s, SD 0.06x10-3) compared with controls 
(0.083x10-2 mm2/s, SD 0.05x10-3) (F(1,133)=20.2, p<0.0001). We observed a higher 
mean right thalamic MD after right-hemispheric stroke (0.088x10-2 mm2/s, SD 
0.06x10-3) compared with controls (0.084x10-2 mm2/s, SD 0.05x10-3) (F(1,119)=22.7, 
p<0.0001). No significant differences between hemispheric stroke patients and 
Figure 1 | Lesion probability maps in patients with left-hemispheric stroke,  
right-hemispheric stroke, and infratentorial stroke
The color overlay created on top of the Montreal Neurologic Institute (MNI) standard brain 
template shows the probability of each voxel containing a lesion in each patient group. The color 
bar denotes the probability range. 
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6controls were found for the contralateral hippocampal FA and MD. Infratentorial stroke 
patients did not differ from controls in mean left and right thalamic MD or FA (p>0.05). 
In left-hemispheric stroke patients with normal left thalamic volume and significantly 
higher left thalamic MD (F(1,30)=41.69, p<0.0001) no difference in mean immediate 
recall score (p=0.2) and delayed recall score (p=0.6) was observed compared with 
patients with normal left thalamic volume and lower thalamic MD. These two groups 
did not significantly differ in mean left thalamic volume (p=0.3). 
In right-hemispheric stroke patients with normal right thalamic volume and significantly 
higher right thalamic MD (F(1,15)=14.87, p=0.002) no difference was observed in mean 
immediate recall score (p=0.4) and delayed recall score (p=0.8) compared with 
patients with normal thalamic volume and lower right hippocampal MD. No difference 
between these two groups in mean right hippocampal volume was observed (p=0.2). 
Figure 2 | Unadjusted mean fractional anisotropy (FA) and mean diffusivity (MD)  
in the left and right hippocampus about 10 years after ischemic stroke in young 
adults compared with controls 
P-values are adjusted for age at follow-up and sex. 
0.14
0.15
0.16
0.17
0.18
0.19
Left hippocampus Right hippocampus
M
ea
n 
FA
Le-hemispheric stroke
Right-hemispheric stroke
Infratentorial stroke
Controls
p=0.008 
0.085
0.090
0.095
0.100
Left hippocampus Right hippocampus
M
ea
n 
M
D
p=0.059 
x10-2mm2/s  
  p=0.007 
104
Chapter 6
Ta
bl
e 
2 
| C
om
pa
ri
so
ns
 b
et
w
ee
n 
he
m
is
ph
er
ic
 s
tr
ok
e 
pa
ti
en
ts
 w
it
h 
no
rm
al
 ip
si
la
te
ra
l h
ip
po
ca
m
pa
l v
ol
um
e 
an
d 
hi
gh
 v
er
su
s 
lo
w
 
ip
si
la
te
ra
l h
ip
po
ca
m
pa
l M
D
Le
ft
-h
em
is
ph
er
ic
 s
tr
ok
e 
pa
ti
en
ts
  
w
it
h 
no
rm
al
 le
ft
 h
ip
po
ca
m
pa
l v
ol
um
e
R
ig
ht
-h
em
is
ph
er
ic
 s
tr
ok
e 
pa
ti
en
ts
  
w
it
h 
no
rm
al
 ri
gh
t h
ip
po
ca
m
pa
l v
ol
um
e
Lo
w
  
hi
pp
oc
am
pa
l M
D
H
ig
h 
 
hi
pp
oc
am
pa
l M
D
p-
va
lu
ea
Lo
w
  
hi
pp
oc
am
pa
l  
M
D
H
ig
h 
 
hi
pp
oc
am
pa
l M
D
p-
va
lu
eb
N
o.
21
20
15
16
Ip
si
la
te
ra
l h
ip
po
ca
m
pa
l M
D 
(m
m
2/
se
c)
8.
9x
10
-4
 (0
.1 
x1
0-
4 )
9.
9x
10
-4
 (0
.1 
x1
0-
4 )
<0
.0
00
1
9.
1x
10
-4
(0
.1 
x1
0-
4 )
9.
9x
10
-4
 (0
.1 
x1
0-
4 )
<0
.0
00
1
Ip
si
la
te
ra
l h
ip
po
ca
m
pa
l v
ol
um
e 
(m
l)
3.
2 
(0
.1)
3.
1 
(0
.1)
0.
6
3.
2 
(0
.1)
3.
3 
(0
.1)
0.
4
Im
m
ed
ia
te
 v
er
ba
l r
ec
al
l (
Z-
sc
or
e)
-0
.6
 (0
.2
)
-0
.6
 (0
.2
)
0.
8
-0
.3
 (0
.2
)
-0
.1 
(0
.2
)
0.
6
De
la
ye
d 
ve
rb
al
 re
ca
ll 
(Z
-s
co
re
)
-0
.4
 (0
.2
)
-0
.6
 (0
.2
)
0.
6
-0
.1 
(0
.3
)
-0
.4
 (0
.3
)
0.
5
D
at
a 
ar
e 
pr
es
en
te
d 
as
 n
um
be
r 
or
 a
dj
us
te
d 
m
ea
n 
(±
SE
M
). 
a 
Co
m
pa
ris
on
 b
et
w
ee
n 
le
ft-
he
m
is
ph
er
ic
 s
tr
ok
e 
pa
tie
nt
s 
w
ith
 lo
w
 le
ft 
hi
pp
oc
am
pa
l M
D 
ve
rs
us
 h
ig
h 
le
ft 
hi
pp
oc
am
pa
l M
D.
 b  
Co
m
pa
ris
on
 b
et
w
ee
n 
rig
ht
-h
em
is
ph
er
ic
 s
tr
ok
e 
pa
tie
nt
s 
w
ith
 lo
w
 ri
gh
t h
ip
po
ca
m
pa
l M
D 
ve
rs
us
 h
ig
h 
rig
ht
 h
ip
po
ca
m
pa
l M
D.
 F
or
 th
e 
an
al
ys
es
 o
n 
hi
pp
oc
am
pa
l v
ol
um
e 
w
e 
ad
ju
st
ed
 f
or
 a
ge
, s
ex
, a
nd
 f
ol
lo
w
-u
p 
du
ra
tio
n.
 F
or
 t
he
 a
na
ly
se
s 
on
 ip
si
la
te
ra
l h
ip
po
ca
m
pa
l M
D 
w
e 
ad
di
tio
na
lly
 a
dj
us
te
d 
fo
r 
ip
si
la
te
ra
l 
hi
pp
oc
am
pa
l v
ol
um
e.
 F
or
 th
e 
an
al
ys
es
 o
n 
im
m
ed
ia
te
 a
nd
 d
el
ay
ed
 v
er
ba
l r
ec
al
l w
e 
ad
ju
st
ed
 fo
r a
ge
, s
ex
, e
du
ca
tio
n,
 fo
llo
w
-u
p 
du
ra
tio
n,
 a
nd
 ip
si
la
te
ra
l h
ip
po
ca
m
pa
l 
vo
lu
m
e.
 M
D 
= 
M
ea
n 
D
iff
us
iv
ity
.
105
Hippocampal integrity after stroke
6
Discussion
We showed that after a mean follow-up of ten years, a first-ever hemispheric stroke at 
young age (18 through 50 years) is associated with a lower ipsilateral hippocampal 
integrity compared with a non-stroke population. Larger lesion volume was associated 
with a lower ipsilateral hippocampal integrity independent of ipsilateral hippocampal 
volume. In a subset of hemispheric stroke patients with normal ipsilateral hippocampal 
volume and a significantly higher mean ipsilateral hippocampal MD no worse memory 
performance was found compared with patients normal hippocampal volume and 
lower hippocampal MD.
The strengths of our study include its large sample size and the long follow-up. 
We collected baseline and follow-up information according to identical procedures in 
all patients with high inter-rater and intra-rater agreement for hippocampal volumes. 
We used strict protocols for memory assessment and researchers were trained, in 
order to reduce the risk of information bias. 
Some methodological issues of our study need to be considered.255 Although the 
FUTURE study has a prospective design, the current analysis is cross-sectional and 
we therefore can only report on lower hippocampal integrity after stroke compared 
with a non-stroke population. While this may be due to post-stroke microstructural 
degradation of the hippocampus, a longitudinal design is required to further support 
causality. However, our data demonstrate a relation between the stroke and a reduced 
ipsilateral hippocampal integrity, since we did not observe a lower microstructural 
integrity of the contralateral hippocampus. Furthermore, larger hemispheric stroke 
volume was associated with lower ipsilateral hippocampal integrity independent of 
ipsilateral hippocampal volume. Therefore, it is highly unlikely that these patients 
already had a lower microstructural integrity of the ipsilateral hippocampus before 
stroke onset. 
Also, selection bias might have occurred, since patients who participated in the 
FUTURE study, but could not participate in de present DTI study had a poorer outcome 
compared with participants. However, selection would only have occurred when the 
relation between the stroke and microstructural integrity of the hippocampus would 
be selectively different in non-participants and this does seem unlikely.255
The observed associations in the present study do not apply to all measures of 
microstructural integrity. The value of FA reflects the directionality of molecular 
displacement by diffusion and is influenced by crossing fibers.265 These crossing fibers 
are present in the hippocampus266 and thalamus267 and influence the FA. Due to the 
intrahippocampal and thalamic fiber incoherence, low FA may not necessarily reflect 
underlying lower structural integrity.268 Thus, crossing fibers in the hippocampus and 
thalamus might be an explanation for a lack of finding with FA but not with MD. MD 
reflects the magnitude of water diffusion which is less influenced by direction of fibers 
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and therefore MD remains relatively constant and is more reliable for assessing micro-
structural integrity of brain structures with crossing fibers.233, 268, 269
Another limitation of our study was that the DTI voxel size at MRI acquisition was 
relatively large. This could have caused cerebrospinal fluid partial volume effects in 
the hippocampal and thalamic region of interest.268 This is especially the case in 
patients with hippocampal or thalamic atrophy, which could induce higher MD values. 
We used eroded hippocampal and thalamic masks for our analyses and therefore it 
seems unlikely that partial volume effects had an influence on our results. 
A limitation of the current approach is the cut-off of Z≤-1.5SD as “normal hippocampal 
volume”263, 264 since older subjects with smaller volumes might still have normal 
volumes for their age.262 However, we have tried to reduce this effect by dividing the 
controls into two equal groups based on the median age of the control group and 
subsequently determined “normal volume” per age category. 
Our data clearly demonstrate a relationship between hemispheric stroke volume and 
remote effects on the microscopic level in the ipsilateral hippocampus. This relationship 
has also been found on macroscopic level of the ipsilateral hippocampus.221, 255 However, 
the results on lower ipsilateral hippocampal integrity in left-hemispheric stroke 
patients were somewhat less convincing, showing a trend towards significance. This 
might be explained by our finding on the association between larger stroke volume 
and remote lower ipsilateral hippocampal integrity. As we observed larger stroke 
volumes in right-hemispheric stroke patients it might be that this resulted in larger 
reductions of ipsilateral hippocampal integrity in right-hemispheric stroke patients 
compared with left-hemispheric stroke patients. Interestingly, we did observe lower 
left thalamic integrity in left-hemispheric stroke patients compared with controls. 
Although thalamic stroke was excluded, this difference might be due to the location of 
the thalamus as it lies closer to the most common stroke location in our stroke cohort 
(MCA territory) compared with the hippocampus and therefore possibly disconnection 
due to stroke is more likely. Thus, our finding highlights that stroke volume is an 
important risk factor for remote effects on the ipsilateral hippocampus. A possible 
explanation for these remote effects may be the occurrence of spreading depression 
(SD).221 SD is the pervasive failure of brain ion homeostasis that transiently interrupts 
function of intact brain regions, which causes secondary neuronal damage and infarct 
expansion.221 Another possibility could be disconnection of the hippocampus due to 
stroke in the connecting fiber tracts.219 
Another important finding of our study is that patients with preserved hippocampal volume 
and low hippocampal integrity at present do not show a worse memory performance 
compared with patients with normal volume and higher hippocampal integrity. Thus, 
the addition of low ipsilateral hippocampal integrity in stroke patients with normal 
hippocampal volume is not associated with a worse memory performance. Other 
studies in a non-demented elderly did observe an association between lower 
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hippocampal integrity and verbal memory performance, independent of hippocampal 
volume.232, 233 In healthy elderly individuals a low hippocampal integrity before volume 
loss might reflect an early marker of underlying neurodegenerative disease, such as 
Alzheimer’s Disease.232, 233 However, in young stroke patients the co-occurrence of 
Alzheimer pathology is very unlikely given their young age (about 10%).19, 20 Possibly, 
the variance in hippocampal MD values found in our young stroke population is smaller 
due to a different underlying mechanism and therefore no difference in memory 
performance was found. The course and extent of hippocampal damage might differ 
due to different underlying mechanisms and needs further investigation. Nevertheless, 
our results put forward the idea of a lower reserve in patients with a normal hippo - 
campal volume on conventional MRI, but with lower microstructural integrity. They still 
might be at risk to develop MCI/dementia earlier, compared with a non-stroke population, 
especially when these patients come to an age where aging-related neuro degenerative 
pathology (amyloid pathology) occurs. Future longitudinal research should further 
investigate whether these young patients with higher hippocampal MD eventually 
develop MCI/dementia earlier compared with a non-stroke population.270
Finally, our results suggest that hemispheric stroke has a generalized effect on 
ipsilateral brain structures remote from the infarction, such as a lower ipsilateral 
hippocampal and thalamic integrity. This is further confirmed by previous studies on 
hippocampal and thalamic volume after ischemic stroke.221, 227, 228, 255 Lower micro-
structural integrity in remote structures has also been found in subjects with cerebral 
small vessel disease.271-273 Thus, these results in subjects with cerebral small vessel 
disease and stroke patients provide evidence that beyond the area of infarction, 
remote effects of subcortical damage occur. 
In conclusion, our data suggest that vascular lesions are associated with remote lower 
ipsilateral hippocampal integrity. At present, patients with normal volume and lower 
hippocampal integrity do not show a worse memory performance compared with 
patients with normal volume and higher hippocampal integrity. Possibly, a history of 
stroke, combined with brain changes associated with normal ageing, might eventually 
lead to exacerbated memory decline. Our findings add to the increasing awareness of 
stroke not only being an acute disease with immediate consequences, but also results 
in lifelong consequences.

Schaapsmeerders P, Tuladhar AM, Arntz RM, Franssen S, Maaijwee NA, Rutten-Jacobs LC, 
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Abstract
Background and objective:
Post-stroke cognitive impairment occurs  frequently  in young patients with  ischemic 
stroke (18 through 50 years of age). Accumulating data suggest that stroke is associated 
with lower white matter integrity remote from the stroke impact area, which might 
explain why some patients have good long-term cognitive outcome and others do not. 
Given the life expectancy of decades in young patients we therefore investigated 
remote white matter in relation to long-term cognitive function.
Methods
We included all consecutive first-ever ischemic stroke patients, left/right hemisphere, 
without recurrent stroke or TIA during follow-up, aged 18 through 50 years, admitted 
to our university medical center between 1980 and 2010. One hundred and seventeen 
patients underwent MRI scanning including a T1-weighted scan, a diffusion tensor 
imaging scan, and completed a neuropsychological assessment. Patients were 
compared to a matched stroke-free control group (age, sex, and education matched). 
Cognitive impairment was defined as >1.5SD below the mean cognitive index score of 
controls and no cognitive impairment as ≤1SD. Tract-Based-Spatial Statistics was 
used to assess the white matter integrity (FA and MD).
Results
About 11 years after ischemic stroke lower remote white matter integrity was associated 
with a worse long-term cognitive performance. A lower remote white matter integrity, 
even in the contralateral hemisphere, was observed in cognitively impaired patients 
(n=25) compared with cognitively unimpaired patients (n=71).
Conclusion 
These findings indicate that although stroke has an acute onset, it might have long 
lasting effects on remote white matter integrity and thereby increases the risk of 
long-term cognitive impairment.
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Introduction
Cognitive impairments are common after stroke in young adults (18 through 50 years 
of age).15, 163, 274 Stroke severity at admission,275 stroke volume, and stroke location4 are 
related to post-stroke cognitive impairment. These factors however do not fully explain 
why some patients show good cognitive outcome after stroke and others do not.2 
Accumulating data suggest that, apart from temporary remote neurophysiological 
changes after stroke (i.e., diaschisis),276 a focal (ischemic) lesion could potentially 
affect long-term remote structural integrity (e.g., of the hippocampus and thalamus) in 
the ipsilateral hemisphere after stroke,163, 221, 227, 277, 278 which has been associated with a 
worse post-stroke memory performance.221, 255 Besides remote structural changes in 
the ipsilateral hemisphere, a few small neuroimaging studies (6 to 16 patients) in older 
stroke patients (60 years and over) found loss of white matter integrity as remote as 
the contralesional hemisphere279 and this was associated with motor impairment up to 
six months after stroke280, 281 and poorer cognitive recovery three months after right 
middle cerebral artery stroke.282 It is unknown whether lower microstructural integrity 
in areas remote from the initial stroke, including as remote as the contralateral 
hemisphere, is related to long-term (i.e., years) cognitive dysfunction after stroke. 
In addition, the presence of pre-existing (subclinical) cerebral small vessel disease, 
such as diffuse white-matter hyperintensities or subclinical infarcts may also contribute 
to the post-stroke spectrum of cognitive impairment,2 however, this has never been 
investigated in young stroke patients. A better understanding of the etiology of post- 
stroke cognitive impairment and its possible recovery is especially important in young 
stroke survivors, as they are in a demanding phase of their lives with respect to 
educational, vocational, and family-related functioning. 
We hypothesized that patients with cognitive impairment years after their index stroke 
show a lower white matter structural integrity remote from the initial stroke and more 
co-existing cerebrovascular disease compared with cognitively unimpaired patients. 
Conversely, patients with a higher structural integrity in remote brain structures were 
expected to have an average post-stroke cognitive performance compared with 
stroke-free controls.
Patients and methods
Study design
This study is part of the FUTURE study, a prospective cohort study of prognosis after 
transient ischemic attack (TIA), ischemic stroke, or hemorrhagic stroke in adults aged 18 
through 50 years admitted to the Radboud university medical centre, the Netherlands, 
between January 1, 1980, and November 1, 2010.25, 163 The Medical Review Ethics 
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Committee region Arnhem-Nijmegen approved the study and written informed consent 
was obtained from all participants.
Patients were identified through a prospective registry of all consecutive young stroke/ TIA 
patients that has been kept at the department since the 1970s with a standardized collection 
of baseline and clinical characteristics. Ischemic stroke was defined as focal neurologic 
deficit persisting more than 24 hours. Patients had the opportunity to undergo an 
extensive neuropsychological examination together with subsequent MRI scanning 
during the follow-up between November 2009 and December 2011.163 
The present study comprises all consecutive patients with a first-ever ischemic stroke 
in one of the hemispheres. Exclusion criteria in the present study were a previous 
stroke or TIA, cerebral venous sinus thrombosis, retinal infarction,25 recurrent stroke/
TIA during the follow-up period, and severe aphasia. Lesion location was based on 
neuroimaging findings at follow-up, which was related to the stroke location at the 
time of the event described in medical records and radiological findings.
Controls were recruited among the patients’ spouses, relatives, or social environment. 
Inclusion criteria were 18 years or older, without a history of stroke or TIA. The control 
group and patient group were matched for age (p=0.5) , sex (p=0.6), and education 
(p=0.1). Controls were used to define cognitive impairment and no impairment in 
stroke patients. Controls were all living independently, none fulfilling the clinical 
criteria of dementia. 
Cognitive performance
The neuropsychological tests used in the FUTURE study covered the main cognitive 
domains and detailed information on these cognitive tests has been described 
extensively elsewhere.25, 163 A z-score per test was calculated for each participant 
based on the mean and the SD of the controls (n=84). Next, averaging z-scores of 
cognitive tests that mainly reflected the same cognitive domain resulted in a composite 
z-score per cognitive domain. The seven cognitive domains were: processing speed 
(Symbol-Digit Modalities Test, Abbreviated Stroop Color Word Test parts I and II), vi-
suoconstruction (Rey-Osterrieth Complex Figure-copy trial, ROCF), working memory 
(Paper and Pencil Memory Scanning Test, PPMST), immediate memory (ROCF-
immediate recall and the total number of words immediately recalled in the 3-trial 
version of the Rey Auditory Verbal Learning Test, RAVLT), delayed memory (delayed 
recall of the ROCF and the RAVLT), attention (Verbal Series Attention Test, VSAT), and 
executive functioning (Verbal fluency and Stroop interference). 
The cognitive index score is a composite score defined as the average of the seven 
cognitive domains. Cognitive impairment was defined as a cognitive index score > 1.5 
SD below the mean of controls, which has often been used as a cut-off for vascular 
cognitive impairment in stroke patients.5 No cognitive impairment was defined as a 
cognitive index score less than or equal to 1 SD below the mean of controls.163, 283 
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Other measurements
Level of education was classified with a widely-used Dutch scoring system (1=less 
than primary school; 7=university degree).284 Functional outcome during follow-up 
visit was evaluated using the modified Rankin Scale (mRS).237 Assessment of stroke 
etiology (TOAST)7 and severity (National Institutes of Health Stroke Scale, NIHSS) was 
done retrospectively for all cases by a validated approach,33, 202 as these scales did not 
exist at the time when a substantial proportion of the patients experienced their 
qualifying event. Depressive symptoms were assessed using the depression subscale 
of the Hospital Anxiety and Depression Scale55 and fatigue by the subscale Subjective 
Fatigue of the revised Checklist Individual Strength (CIS-20R).61
Neuroimaging data acquisition 
Participants underwent a 1.5-T MRI scanning on the Siemens, Magnetom Avanto. A 
T1-weighted whole-brain MPRAGE scan was collected, TI 1000 ms, repetition time [TR] 
2730 ms, echo time [TE] 2.95ms, flip angle 7°, field of view [FOV] = 256mm, voxel size 
1.0×1.0×1.0mm3) as well as a set of whole-brain diffusion-weighted images (TR 
9100ms, TE 98ms, diffusion directions 61, with non-collinear orientation of the diffu-
sion-weighting gradient and a b-value of 1000 s/mm2. Seven unweighted images, FOV 
= 220mm, voxel size 2.2×2.2×2.2mm3), a FLAIR pulse sequence (TI /TR/TE 
2200ms/12220ms/85ms; interslice gap: 0.6mm; voxel size 1.2×1.0×3.0mm3), and a 
gradient echo susceptibility weighted imaging (SWI) sequence (TR/TE 49/40ms; voxel 
size 0.8×0.7×1.0mm³).25
Neuroimaging data processing 
Ischemic stroke volume and lesion probability map
Ischemic stroke was defined as a hypointense area on a T1-weighted MPRAGE 
whole-brain scan with corresponding gliotic rim on the FLAIR image. One experienced 
investigator, blinded for baseline characteristics and outcome measures traced all 
ischemic strokes manually using a T1-weighted image (in the coronal plane). Stroke 
volumes (ml) were normalized using the following formula: average intracranial 
volume of the total population × (stroke volume of the participant/intracranial volume 
of the participant).260 Intracranial volume was calculated as the sum of gray matter, 
white matter, and CSF using VBM8.255 Next, brain-extracted images238 were registered, 
along with the lesion mask, to the Montreal Neurological Institute (MNI) standard 
space by an affine transformation (12 degrees of freedom) using FSL-FLIRT,238 followed 
by non-linear registration using FNIRT.238 Next, all stroke masks were merged and 
averaged, which resulted in a lesion probability map.
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Diffusion tensor imaging (DTI) preprocessing
The raw DTI data were denoised using a local PCA filter, which reduces random noise 
by locally shrinking less significant Principal Components using an overcomplete 
approach.285 Next, misalignments from eddy-currents and subject motion were 
corrected by a mutual information-based co-registration technique (SPM; affine 
transformation). An average b0-image mask was constructed and was used to mask 
the results. Magnetic susceptibility induced EPI distortions in the diffusion tensor 
images were unwarped along the phase-encode direction by mapping the mean 
unweighted image onto the T1 reference image.286 The diffusion tensors and their 
indices (fractional anisotropy; FA, and mean diffusivity; MD) were robustly estimated 
using the in-house developed iteratively re-weighted-least-squares algorithm named 
‘PATCH’.261
Tract-Based Spatial Statistics (TBSS) 
In short, TBSS projects all FA and MD images onto a mean FA tract skeleton, before 
applying voxelwise cross-subject statistics.287 The TBSS non-linear registration of a 
large (cortical) stroke failed in some cases and therefore, a FNIRT configuration file 
optimized for FA data was used238 where the stroke lesions were masked out. The FA 
skeleton was thresholded at 0.3 to include the major white matter tracts and exclude 
brain parts with low inter-subject reliability. For all TBSS analyses the FA and MD white 
matter skeleton were first symmetrized for all subjects287 and flipped (right to left) for 
right-hemispheric stroke patients. 
Vascular risk factors and treatment at follow-up assessment
Blood pressure readings in the left and right arm were performed three times in supine 
position. Next, the mean blood pressure was calculated for the left and right arm 
separately. The highest mean blood pressure was used to identify hypertension. 
Hypertension was defined as a systolic blood pressure ≥135 mmHg, or a diastolic 
blood pressure of ≥85 mmHg, or the use of antihypertensive medication. Diabetes 
mellitus was defined as random blood glucose level >11.1 mmol/L, or two consecutive 
fasting venous plasma glucose levels ≥7.0 mmol/L,288 or the use of antidiabetics (oral 
or insulin). Dyslipidemia was defined as total cholesterol ≥5.0 mmol/L or LDL ≥2.5 mmol/L, 
or triglycerides ≥2.0 mmol/L,24 or the use of statins. Information on smoking was 
collected by a structured questionnaire. Current smoking was defined as smoking ≥1 
cigarette per day in the year prior to follow-up. The Body Mass Index (BMI) was 
calculated as the weight in kilograms divided by the square of the height in meters.
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Cerebral small vessel disease
White Matter Hyperintensities (WMH) of presumed vascular origin were defined as 
hyperintense signal on FLAIR, without cavitation.18 We used an in-house developed 
validated semi-automatic approach to define WMH. All scans were inspected for 
segmentation errors and gliosis surrounding lacunes or surrounding the ischemic 
stroke were excluded. WMH-volumes were normalized to intracranial volume.260 
Microbleeds were defined as small areas of signal void with associated blooming seen 
on SWI with a diameter of less than 10 mm in diameter, excluding signal voids in the 
area of the ischemic stroke.18, 289 Lacunes of presumed vascular origin were defined as 
round or ovoid, subcortical, fluid-filled cavities in the territory of one perforating 
arteriole on the FLAIR image with a diameter of 3mm to about 15mm.18 One experienced 
researcher analyzed all MRI data and was blinded for baseline characteristics and 
outcome measures. Interrater and intrarater reliability for the presence of microbleeds 
yielded a kappa of 1.0 and 0.92 respectively. In a random sample of 10% the interrater 
reliability for the presence of lacunes yielded a kappa of 0.76 and intrarater reliability 
a kappa of 0.80.
Statistical analyses
Group differences in baseline characteristics between those who participated and 
those who did participate in the FUTURE study, but not in the present DTI study were 
tested with a Mann-Whitney U test, ANOVA, or Pearson’s chi-square test, when 
appropriate. Two-tailed p-values<0.05 were considered statistically significant.
Normalized WMH-volume and normalized stroke volume showed a right skewed 
distribution and therefore a base-10 logarithm transformation was used. As the 
WMH-volume data contained zero’s, a constant number of 0.001 was added to all data 
points before log transformation.
For each TBSS analysis 5000 permutations were used and significant associations 
were determined using the threshold-free cluster-enhancement with a threshold of 
p<0.05 corrected for multiple comparisons.287, 290, 291 All TBSS analyses were adjusted 
for age, sex, follow-up duration, education, lesion location (left/right hemisphere), 
normalized WMH-volume, depressive symptoms, and fatigue unless otherwise stated. 
In case of missing values for these covariates (always <1.7%) the mean of the whole 
group was taken.
First, voxel-wise statistical analysis using TBSS was carried out to investigate the 
relationship between remote white matter integrity (FA and MD of the ipsilateral and 
contralateral hemisphere) in stroke patients (n=117) and the cognitive index score, 
additionally adjusted for normalized stroke volume. Subsequently, this TBSS analysis 
was repeated for the performance on each of the seven cognitive domains. In addition, 
to investigate the strength of the association between white matter integrity in the 
contralateral hemisphere (skeletal DTI parameters FA and MD) and the cognitive index 
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score a linear regression model was used with the cognitive index score as dependent 
variable and the mean FA/MD as independent variable, adjusted for age, sex, education, 
follow-up duration, depressive symptoms, fatigue, lesion location, normalized lesion 
volume, and normalized WMH-volume.
Next, we investigated whether low remote white matter integrity increased the risk of 
long-term cognitive impairment and whether a higher remote white matter integrity 
was associated with no post-stroke cognitive impairment. Therefore, FA and MD white 
matter of the ipsilateral and contralateral hemisphere of patients with cognitive 
impairment were compared with cognitively unimpaired patients, additionally adjusted 
for normalized stroke volume. 
Finally, we expected stroke volume and pre-existing cerebral small vessel disease to 
be associated with remote lower white matter integrity and consequently account for 
post-stroke cognitive performance itself. Therefore, the relation between stroke 
volume and ipsilateral and contralateral FA and MD of the white matter was assessed, 
adjusting for age, sex, follow-up duration, lesion location (left/right), WMH-volume, 
depressive symptoms, and fatigue. The prevalence of microbleeds, lacunes, vascular 
risk factors, and treatment were compared between cognitively impaired and 
unimpaired patients using a Chi-square test. Log-transformed WMH-volume and 
stroke volume were compared between these two groups with AN(C)OVA, adjusted for 
age in case of WMH-volume.
Results
T1-weighted whole-brain imaging, DTI, and FLAIR, SWI, and overall cognitive performance 
was available from 117 ischemic stroke patients and 84 stroke-free controls (Figure 1). 
Of the 195 patients with first-ever ischemic stroke in one hemisphere and no recurrent 
stroke/TIA who participated in the FUTURE study, 117 were included in the present 
study (Figure 1). Non-participants had a higher mRS at follow-up, a higher NIHSS score 
at admission, were significantly older at the qualifying event, and less often had an 
unknown cause according to the TOAST criteria compared with participants (Table 1).
Mean follow-up duration of the stroke population was 10.7 years (SD 8.1), mean age at 
follow-up was 49.8 years (SD 9.4), and the most frequent lesion location was in the 
middle cerebral artery (MCA) territory (Table 2 and Figure 2). 
About 11 years after stroke the FA of the white matter both in the ipsilateral and 
contralateral hemisphere was positively related with the cognitive index score, 
whereas white matter MD of the ipsilateral and contralateral hemisphere was negatively 
associated with the cognitive index score (n=117) (Figure 2). These associations were 
independent of WMH-volume, stroke volume, and other confounding variables. 
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Figure 1 | Flowchart op the study population 
First-ever ischemic stroke in one
hemisphere and no recurrent
stroke/TIA who participated in
the FUTURE study
n = 195
  
FO
LL
O
W
-U
P
Follow-up cognitive assessment
n = 164
  Participated in the FUTURE study, but refused to
visit the research center: n = 28  
Follow-up
cognitive assessment and DTI
n = 117
No DTI scan: n = 43
Exclusion due to motion artefact in DTI: n = 3
Spatial normalization procedure failed: n = 1
B
A
SE
LI
N
E
  
Recurrent stroke/TIA: n = 58
Location of stroke not restricted
to one hemisphere: n = 72
No cognitive assessment available: n = 3
Baseline first-ever ischemic
stroke population
n = 606
Follow-up study population
n = 543
Lost to follow-up: n = 63
Refused to participate in the FUTURE study: n = 96
Deceased: n = 122
Follow-up survivors
n = 325
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Subsequent analyses showed that a lower remote white matter integrity was associated 
with a lower performance on the domains of processing speed, attention, working 
memory, and executive functioning (Figure 3). 
A higher mean FA value of the white matter skeleton in the contralateral hemisphere 
was related to a higher cognitive index score (β=0.24, p=0.008). A higher mean MD 
value of the white matter in the contralateral hemisphere was related to a worse 
cognitive index score (β=-0.18, p=0.03).
Table 1 | Demographic and clinical characteristics between participants and 
 patients who did not participate in the present sub study
Characteristics Participants Non-
participants
p-value
No. 117 78
Age at event, mean (SD), y 39.0 (8.2) 41.5 (7.2) 0.03
Follow-up duration, mean (SD), y 10.7 (8.1) 10.2 (9.3) 0.70
Age at follow-up, mean (SD), y 49.8 (9.4) 51.8 (10.4) 0.16
Men, No. (%) 47 (40.2) 23 (29.5) 0.13
Education, median (Q1-Q3) 5 (4-6) 5 (4-5) 0.08
NIHSS at stroke onset, median (Q1-Q3) 4 (2-8) 6 (2-12) 0.02
mRS at follow-up, median (Q1-Q3) 1 (0-2) 2 (1-3) <0.0001
Lesion location 0.56
Left hemisphere, No. (%) 62 (53.0) 38 (48.7)
Right hemisphere, No. (%) 55 (47.0) 40 (51.3)
TOAST
Atherothrombotic stroke, No. (%) 24 (20.5) 24 (30.8) 0.10
Cardioembolic stroke, No. (%) 9 (7.7) 11 (14.1) 0.15
Lacunar stroke, No. (%) 14 (12.0) 11 (14.1) 0.66
Rare causes, No. (%) 23 (19.6) 17 (21.8) 0.72
Multiple causes, No. (%) 1 (0.9) 3 (3.8) 0.15
Unknown cause, No. (%) 46 (39.3) 12 (15.4) 0.0003
NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; TOAST, Trial of Org 10172 
in Acute Stroke Treatment. Missing data in participants: education=1.7%, NIHSS at admission=0.9%. 
Missing data in non-participants: education=2.6%.
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Table 2 | Demographic and clinical characteristics of ischemic stroke patients  
and controls
 Characteristics Ischemic stroke  
patients
Controls
No. 117 84
Age at event, mean (SD), y 39.0 (8.2)
Year of stroke event, No. (%)
1980-1989 18 (15.4)
1990-1999 34 (29.1)
2000-2010 65 (55.6)
Follow-up duration, mean (SD), y 10.7 (8.1)
Age at follow-up, mean (SD), y 49.8 (9.4) 48.9 (11.9)
Men, No. (%) 47 (40.2) 38 (45.2)
Education, median (Q1-Q3) 5 (4-6) 5 (5-6)
NIHSS at stroke onset, median (Q1-Q3) 4 (2-8)
Normalized stroke volume, median (Q1-Q3), ml 5.5 (0.2-32.8)
Normalized WMH-volume, median (Q1-Q3), ml 1.4 (0.7-3.3) 0.4 (0.03-1.04)
mRS at follow-up, median (Q1-Q3) 1 (0-2) 0 (0-0)
HADS - depressive symptoms, mean (SD) 3.7 (3.6) 2.5 (2.8)
CIS-20R - subjective fatigue, mean (SD) 29.1 (13.4) 23.0 (12.7)
Lesion location
Left hemisphere, No. (%) 62 (53.0)
Right hemisphere, No. (%) 55 (47.0)
TOAST
Atherothrombotic stroke, No. (%) 24 (20.5)
Cardioembolic stroke, No. (%) 9 (7.7)
Lacunar stroke, No. (%) 14 (12.0)
Rare causes, No. (%) 23 (19.7)
Multiple causes, No. (%) 1 (0.9)
Unknown cause, No. (%) 46 (39.3)
Data are expressed as mean (SD), number (%), or median (Q1- Q3). NIHSS, National Institutes of Health 
Stroke Scale; mRS, modified Rankin Scale; HADS, Hospital Anxiety and Depression Scale; CIS-20R, 
Checklist Individual Strength; TOAST, Trial of Org 10172 in Acute Stroke Treatment. Missing data in 
patients: education = 1.7%, NIHSS at admission = 0.9%, HADS-depressive symptoms = 1.7%, CIS-20R = 
1.7%. No missing data in controls.
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Figure 2 | The relation between the cognitive index score en white matter integrity 
Voxel-wise analysis of the FA, positively related with the cognitive index score, and MD 
negatively related with the cognitive index score in the  population with stroke (n=117). 
The analyses were adjusted for age, sex, education, follow-up duration, WMH-volume, stroke 
volume, lesion location, depressive symptoms, and fatigue. The analysis was thresholded at 
p<0.05 and corrected for multiple comparisons (in blue). The color bar denotes the lesion 
probability map (in red).
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Cognitively impaired patients more often had a stroke in the frontal lobe (p=0.02) and 
parietal lobe (p=0.004) compared with cognitively unimpaired patients (Table 3). 
Even almost 11 years after stroke, a significant lower ipsilateral and contralateral white 
matter FA and a higher MD was observed in cognitively impaired patients compared 
with cognitively unimpaired patients (Figure 4).
Stroke volume was associated with lower white matter FA and higher MD values in the 
ipsilateral and contralateral hemisphere, especially involving the corpus callosum 
(Figure 5). Cognitively impaired patients showed a significant higher median WMH- 
volume, a larger stroke volume, had a higher prevalence of ≥1 microbleed(s), not of 
Figure 3 | The relation between cognitive domain scores and white matter integrity 
Voxel-wise analysis of the FA, positively related with processing speed,  working memory, 
immediate memory, delayed memory, attention, and  executive functioning, and MD negatively 
related with working memory,  attention, and  executive functioning in the stroke population 
(n=117). The analyses were adjusted for age, sex, education, follow-up duration, WMH-volume, 
stroke volume, lesion location, depressive symptoms, and fatigue. The analysis was thresholded 
at p<0.05 and corrected for multiple comparisons (in blue). The color bar denotes the lesion 
probability map (in red). NS= no significant association found.
Processing speed 
Visuoconstruction 
Working memory 
Immediate memory 
Delayed memory 
Attention 
Executive functioning 
 FA                                  MD 
NS 
NS 
   x = 0                  y = -21               z = 28 
NS 
NS 
   x = -33               y = -20                z = 1  
NS 
   x = 0                  y = -21               z = 28 
   x = -33               y = -20                z = 1  
30% 
6% 
   x = 0                  y = -21               z = 28    x = 0                  y = -21                z = 28 
R R 
122
Chapter 7
Ta
bl
e 
3 
| D
em
og
ra
ph
ic
 a
nd
 c
lin
ic
al
 c
ha
ra
ct
er
is
ti
cs
, p
re
va
le
nc
e 
of
 c
er
eb
ra
l s
m
al
l v
es
se
l d
is
ea
se
, a
nd
 m
ed
ic
at
io
n 
us
e 
in
 
 pa
ti
en
ts
 w
it
h 
co
gn
it
iv
e 
im
pa
ir
m
en
t a
nd
 n
o 
co
gn
it
iv
e 
im
pa
ir
m
en
t
 C
ha
ra
ct
er
is
ti
cs
Is
ch
em
ic
 s
tr
ok
e 
p-
va
lu
eb
Co
gn
it
iv
el
y 
im
pa
ir
ed
Co
gn
it
iv
el
y 
 
un
im
pa
ir
ed
 
N
o.
25
71
Ag
e 
at
 fo
llo
w
-u
p,
 m
ea
n 
(S
D)
, y
53
.3
 (9
.7
)
48
.3
 (9
.0
)
  0
.2
5c
N
or
m
al
iz
ed
 s
tro
ke
 v
ol
um
e,
 m
ed
ia
n 
(Q
1-
Q
3)
, m
l
  1
1.1
 (0
.4
-5
1.3
)
 1
.7
 (0
.1-
15
.8
)
0.
04
Le
si
on
 lo
ca
tio
n,
 N
o.
 (%
)
0.
17
Le
ft 
he
m
is
ph
er
e
16
 (6
4.
0)
34
 (4
7.9
)
Ri
gh
t h
em
is
ph
er
e
9 
(3
6.
0)
37
 (5
2.
1)
Co
rt
ic
al
 s
tro
ke
, N
o.
 (%
)a
Fr
on
ta
l l
ob
e
18
 (7
2.
0)
32
 (4
5.
1)
0.
02
Pr
ef
ro
nt
al
 c
or
te
x
An
te
rio
r c
in
gu
la
te
 c
or
te
x
2 
(8
.0
)
1 
(1
.4
)
0.
10
M
ed
ia
l p
re
fro
nt
al
 c
or
te
x
2 
(8
.0
)
1 
(1
.4
)
0.
10
Do
rs
ol
at
er
al
 p
re
fro
nt
al
 c
or
te
x
4 
(1
6.
0)
6 
(8
.5
)
0.
01
Ve
nt
ro
la
te
ra
l p
re
fro
nt
al
 c
or
te
x
8 
(3
2.
0)
15
 (2
1.1
)
0.
27
Pa
rie
ta
l l
ob
e
16
 (6
4.
0)
23
 (3
2.
4)
0.
01
Pr
ec
un
eu
s
1 
(4
.0
)
2 
(2
.8
)
0.
77
In
tra
pa
rie
ta
l s
ul
cu
s
8 
(3
2.
0)
9 
(1
2.
7)
0.
03
Te
m
po
ra
l l
ob
e
10
 (4
0.
0)
30
 (4
2.
3)
0.
84
O
cc
ip
ita
l l
ob
e
7 
(2
8.
0)
11
 (1
5.
5)
0.
17
Su
bc
or
tic
al
 s
tro
ke
, N
o.
 (%
)a
Ba
sa
l g
an
gl
ia
 
10
 (4
0.
0)
29
 (4
0.
9)
0.
94
Th
al
am
us
4 
(1
6.
0)
11
 (1
5.
5)
0.
95
Ce
re
br
al
 s
m
al
l v
es
se
l d
is
ea
se
 a
t f
ol
lo
w
-u
p
N
or
m
al
iz
ed
 W
M
H
-v
ol
um
e,
 m
ed
ia
n 
(Q
1-
Q
3)
, m
l
2.
8 
(1
.7
-4
.0
)
1.2
 (0
.6
-2
.3
)
0.
01
Pr
ev
al
en
ce
 o
f ≥
1 
m
ic
ro
bl
ee
d(
s)
, N
o.
 (%
)
9 
(3
6.
0)
5 
(7
.0
)
0.
00
01
1 
m
ic
ro
bl
ee
d 
4 
(1
6.
0)
2 
(2
.8
)
2 
m
ic
ro
bl
ee
ds
3 
(1
2.
0)
3 
(4
.2
)
3 
m
ic
ro
bl
ee
ds
0 
(0
.0
)
0 
(0
.0
)
≥4
 m
ic
ro
bl
ee
ds
2 
(8
.0
)
0 
(0
.0
)
Pr
ev
al
en
ce
 o
f ≥
1 
la
cu
ne
(s
), 
N
o.
 (%
)
7 
(2
8.
0)
11
 (1
5.
5)
0.
17
1 
la
cu
ne
4 
(1
6.
0)
8 
(1
1.3
)
2 
la
cu
ne
s
3 
(1
2.
0)
1 
(1
.4
)
3 
la
cu
ne
s
0 
(0
.0
)
2 
(2
.8
)
Va
sc
ul
ar
 ri
sk
 fa
ct
or
s 
at
 fo
llo
w
-u
p
Sm
ok
in
g 
ev
er
, N
o.
 (%
)
21
 (8
4.
0)
49
 (6
9.
0)
0.
17
Sm
ok
in
g 
cu
rre
nt
, N
o.
 (%
)
11
 (4
4.
0)
17
 (2
3.
9)
0.
06
H
yp
er
te
ns
io
n,
 N
o.
 (%
)
16
 (6
4.
0)
38
 (5
3.
5)
0.
36
Dy
sl
ip
id
em
ia
, N
o.
 (%
)
23
 (9
2.
0)
64
 (9
0.
1)
0.
78
Di
ab
et
es
 m
el
lit
us
, N
o.
 (%
)
3 
(1
2.
0)
5 
(7
.0
)
0.
44
BM
I, 
m
ea
n 
(S
D)
26
.7
 (6
.4
)
25
.3
 (3
.9
)
0.
92
M
ed
ic
at
io
n 
at
 fo
llo
w
-u
p
O
ra
l a
nt
id
ia
be
tic
 m
ed
ic
at
io
n,
 N
o.
 (%
)
3 
(1
2.
0)
2 
(2
.8
)
0.
08
Bl
oo
d 
pr
es
su
re
-lo
w
er
in
g 
ag
en
ts
, N
o.
 (%
)
9 
(3
6.
0)
18
 (2
5.
4)
0.
31
In
su
lin
, N
o.
 (%
)
0 
(0
.0
)
3 
(4
.2
)
0.
30
St
at
in
, N
o.
 (%
)
16
 (6
4.
0)
28
 (3
9.
4)
0.
03
An
tip
la
te
le
t d
ru
gs
, N
o.
 (%
)
17
 (6
8.
0)
54
 (7
6.
1)
0.
43
W
M
H
, w
hi
te
 m
at
te
r h
yp
er
in
te
ns
iti
es
; B
M
I, 
Bo
dy
 M
as
s 
In
de
x;
 D
at
a 
on
 s
m
ok
in
g 
of
 o
ne
 p
at
ie
nt
 w
ith
ou
t c
og
ni
tiv
e 
im
pa
irm
en
t w
as
 m
is
si
ng
.
a  S
tr
ok
e 
co
ul
d 
be
 lo
ca
te
d 
in
 m
or
e 
th
an
 o
ne
 re
gi
on
 in
 a
 p
at
ie
nt
.
b 
St
at
is
tic
al
 c
om
pa
ris
on
 b
et
w
ee
n 
co
gn
iti
ve
ly
 im
pa
ire
d 
an
d 
un
im
pa
ire
d 
pa
tie
nt
s.
c  T
he
 a
na
ly
si
s 
w
as
 a
dj
us
te
d 
fo
r f
ol
lo
w
-u
p 
du
ra
tio
n.
123
Remote white matter integrity after stroke
7
Ta
bl
e 
3 
| D
em
og
ra
ph
ic
 a
nd
 c
lin
ic
al
 c
ha
ra
ct
er
is
ti
cs
, p
re
va
le
nc
e 
of
 c
er
eb
ra
l s
m
al
l v
es
se
l d
is
ea
se
, a
nd
 m
ed
ic
at
io
n 
us
e 
in
 
 pa
ti
en
ts
 w
it
h 
co
gn
it
iv
e 
im
pa
ir
m
en
t a
nd
 n
o 
co
gn
it
iv
e 
im
pa
ir
m
en
t
 C
ha
ra
ct
er
is
ti
cs
Is
ch
em
ic
 s
tr
ok
e 
p-
va
lu
eb
Co
gn
it
iv
el
y 
im
pa
ir
ed
Co
gn
it
iv
el
y 
 
un
im
pa
ir
ed
 
N
o.
25
71
Ag
e 
at
 fo
llo
w
-u
p,
 m
ea
n 
(S
D)
, y
53
.3
 (9
.7
)
48
.3
 (9
.0
)
  0
.2
5c
N
or
m
al
iz
ed
 s
tro
ke
 v
ol
um
e,
 m
ed
ia
n 
(Q
1-
Q
3)
, m
l
  1
1.1
 (0
.4
-5
1.3
)
 1
.7
 (0
.1-
15
.8
)
0.
04
Le
si
on
 lo
ca
tio
n,
 N
o.
 (%
)
0.
17
Le
ft 
he
m
is
ph
er
e
16
 (6
4.
0)
34
 (4
7.9
)
Ri
gh
t h
em
is
ph
er
e
9 
(3
6.
0)
37
 (5
2.
1)
Co
rt
ic
al
 s
tro
ke
, N
o.
 (%
)a
Fr
on
ta
l l
ob
e
18
 (7
2.
0)
32
 (4
5.
1)
0.
02
Pr
ef
ro
nt
al
 c
or
te
x
An
te
rio
r c
in
gu
la
te
 c
or
te
x
2 
(8
.0
)
1 
(1
.4
)
0.
10
M
ed
ia
l p
re
fro
nt
al
 c
or
te
x
2 
(8
.0
)
1 
(1
.4
)
0.
10
Do
rs
ol
at
er
al
 p
re
fro
nt
al
 c
or
te
x
4 
(1
6.
0)
6 
(8
.5
)
0.
01
Ve
nt
ro
la
te
ra
l p
re
fro
nt
al
 c
or
te
x
8 
(3
2.
0)
15
 (2
1.1
)
0.
27
Pa
rie
ta
l l
ob
e
16
 (6
4.
0)
23
 (3
2.
4)
0.
01
Pr
ec
un
eu
s
1 
(4
.0
)
2 
(2
.8
)
0.
77
In
tra
pa
rie
ta
l s
ul
cu
s
8 
(3
2.
0)
9 
(1
2.
7)
0.
03
Te
m
po
ra
l l
ob
e
10
 (4
0.
0)
30
 (4
2.
3)
0.
84
O
cc
ip
ita
l l
ob
e
7 
(2
8.
0)
11
 (1
5.
5)
0.
17
Su
bc
or
tic
al
 s
tro
ke
, N
o.
 (%
)a
Ba
sa
l g
an
gl
ia
 
10
 (4
0.
0)
29
 (4
0.
9)
0.
94
Th
al
am
us
4 
(1
6.
0)
11
 (1
5.
5)
0.
95
Ce
re
br
al
 s
m
al
l v
es
se
l d
is
ea
se
 a
t f
ol
lo
w
-u
p
N
or
m
al
iz
ed
 W
M
H
-v
ol
um
e,
 m
ed
ia
n 
(Q
1-
Q
3)
, m
l
2.
8 
(1
.7
-4
.0
)
1.2
 (0
.6
-2
.3
)
0.
01
Pr
ev
al
en
ce
 o
f ≥
1 
m
ic
ro
bl
ee
d(
s)
, N
o.
 (%
)
9 
(3
6.
0)
5 
(7
.0
)
0.
00
01
1 
m
ic
ro
bl
ee
d 
4 
(1
6.
0)
2 
(2
.8
)
2 
m
ic
ro
bl
ee
ds
3 
(1
2.
0)
3 
(4
.2
)
3 
m
ic
ro
bl
ee
ds
0 
(0
.0
)
0 
(0
.0
)
≥4
 m
ic
ro
bl
ee
ds
2 
(8
.0
)
0 
(0
.0
)
Pr
ev
al
en
ce
 o
f ≥
1 
la
cu
ne
(s
), 
N
o.
 (%
)
7 
(2
8.
0)
11
 (1
5.
5)
0.
17
1 
la
cu
ne
4 
(1
6.
0)
8 
(1
1.3
)
2 
la
cu
ne
s
3 
(1
2.
0)
1 
(1
.4
)
3 
la
cu
ne
s
0 
(0
.0
)
2 
(2
.8
)
Va
sc
ul
ar
 ri
sk
 fa
ct
or
s 
at
 fo
llo
w
-u
p
Sm
ok
in
g 
ev
er
, N
o.
 (%
)
21
 (8
4.
0)
49
 (6
9.
0)
0.
17
Sm
ok
in
g 
cu
rre
nt
, N
o.
 (%
)
11
 (4
4.
0)
17
 (2
3.
9)
0.
06
H
yp
er
te
ns
io
n,
 N
o.
 (%
)
16
 (6
4.
0)
38
 (5
3.
5)
0.
36
Dy
sl
ip
id
em
ia
, N
o.
 (%
)
23
 (9
2.
0)
64
 (9
0.
1)
0.
78
Di
ab
et
es
 m
el
lit
us
, N
o.
 (%
)
3 
(1
2.
0)
5 
(7
.0
)
0.
44
BM
I, 
m
ea
n 
(S
D)
26
.7
 (6
.4
)
25
.3
 (3
.9
)
0.
92
M
ed
ic
at
io
n 
at
 fo
llo
w
-u
p
O
ra
l a
nt
id
ia
be
tic
 m
ed
ic
at
io
n,
 N
o.
 (%
)
3 
(1
2.
0)
2 
(2
.8
)
0.
08
Bl
oo
d 
pr
es
su
re
-lo
w
er
in
g 
ag
en
ts
, N
o.
 (%
)
9 
(3
6.
0)
18
 (2
5.
4)
0.
31
In
su
lin
, N
o.
 (%
)
0 
(0
.0
)
3 
(4
.2
)
0.
30
St
at
in
, N
o.
 (%
)
16
 (6
4.
0)
28
 (3
9.
4)
0.
03
An
tip
la
te
le
t d
ru
gs
, N
o.
 (%
)
17
 (6
8.
0)
54
 (7
6.
1)
0.
43
W
M
H
, w
hi
te
 m
at
te
r h
yp
er
in
te
ns
iti
es
; B
M
I, 
Bo
dy
 M
as
s 
In
de
x;
 D
at
a 
on
 s
m
ok
in
g 
of
 o
ne
 p
at
ie
nt
 w
ith
ou
t c
og
ni
tiv
e 
im
pa
irm
en
t w
as
 m
is
si
ng
.
a  S
tr
ok
e 
co
ul
d 
be
 lo
ca
te
d 
in
 m
or
e 
th
an
 o
ne
 re
gi
on
 in
 a
 p
at
ie
nt
.
b 
St
at
is
tic
al
 c
om
pa
ris
on
 b
et
w
ee
n 
co
gn
iti
ve
ly
 im
pa
ire
d 
an
d 
un
im
pa
ire
d 
pa
tie
nt
s.
c  T
he
 a
na
ly
si
s 
w
as
 a
dj
us
te
d 
fo
r f
ol
lo
w
-u
p 
du
ra
tio
n.
124
Chapter 7
Figure 4 | White matter integrity in cognitively impaired patients compared with 
cognitively unimpaired patients 
Voxel-wise analysis of significant higher FA in cognitively  unimpaired  patients compared with 
impaired patients, and lower MD in cognitively  unimpaired patients compared with impaired 
patients. The analyses were adjusted for age, sex, education, follow-up duration, stroke volume, 
WMH- volume, lesion location, depressive symptoms, and fatigue. The analysis was thresholded at 
p<0.05 and corrected for multiple comparisons (in blue). The color bars denote the lesion 
probability maps of cognitively impaired patients (in red) and cognitively unimpaired patients 
(in green). 
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lacunes compared with cognitively unimpaired patients (Table 3). Cognitively impaired 
patients did not have a higher proportion of patients with vascular risk factors and 
treatment (except for statins) compared with unimpaired patients (Table 3).
Figure 5 | The association between stroke volume and white matter integrity 
Voxel-wise analysis of the FA, negatively related with normalized stroke volume, and MD 
positively related with stroke volume. The analyses were adjusted for age, sex, follow-up 
duration, WMH-volume, lesion location, depressive symptoms, and fatigue. The TBSS analysis 
was thresholded at p<0.05 and corrected for multiple comparisons (in blue). The color bar 
denotes the lesion probability map (in red).
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Discussion
This study showed that almost 11 years after ischemic stroke in young adults a lower 
white matter integrity remote from the index stroke area, which could be as remote as 
the contralateral hemisphere, was associated with an increased risk of long-term 
cognitive impairment. Conversely, higher remote white matter integrity was associated with 
a low risk of long-term cognitive impairment. A larger stroke volume was associated 
with lower remote white matter integrity, even in the contralateral hemisphere. The 
presence of concomitant cerebral small vessel disease was more frequently observed 
in cognitive impaired patients compared with unimpaired patients, however, after 
controlling for WMH-volume in the TBSS analysis this did not change the results on 
lower remote white matter integrity after stroke.
Although stroke has been associated with remote neurophysiological effects, termed as 
diaschisis, which tends to normalize over time,276 we now showed that about 
11 years after stroke a lower structural integrity of remote white matter is associated 
with long-term cognitive impairment.
There are some potential underlying mechanisms for lower remote white matter 
integrity and worse concomitant cognitive performance. As we adjusted for stroke 
volume in the analyses, stroke volume is not the only predictor for difference in remote 
white matter integrity and concomitant differences in long-term cognitive outcome. An 
alternative explanation could be the higher prevalence of cerebral small vessel disease 
in cognitively impaired patients compared with cognitively unimpaired patients. Lower 
white matter integrity, as measured by diffusion tensor imaging, could be an early 
marker of the pathogenic cerebral small vessel disease related mechanism before 
WMH, lacunes, and microbleeds occur on conventional MRI.292 However, the absolute 
number of microbleeds, lacunes, or WMH-volume was relatively low in both groups, as 
expected in these relatively young patients, and after adjustment for WMH-volume we 
still observed a lower remote white matter integrity in cognitively impaired patients 
compared with unimpaired patients. Therefore, it seems less likely that cerebral small 
vessel disease largely explained our results on remote white matter integrity and the 
concomitant worse cognitive performance. 
Another explanation might be that lower remote microstructural integrity is caused by 
vascular damage caused by being exposed to the same vascular risk factors that 
caused the initial stroke event. Furthermore, based on studies in rats, stroke itself 
might cause spreading depression in the ipsilateral hemisphere,221, 293 which may allow 
the onset of secondary (Wallerian) degeneration of remote white matter after ischemic 
stroke.294 However, the extent of this phenomenon should be further investigated to 
whether it also could explain the lower microstructural integrity in contralateral white 
matter as we observed in cognitively impaired patients. For instance, a lower white 
matter integrity of the corpus callosum in the contralateral hemisphere was associated 
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with cognitive impairment. It seems that beside cognitive outcome, microstructural 
integrity of the corpus callosum has been found to predict the degree of motor function 
after stroke,295 and therefore seems to be an important white matter structure for 
outcome after stroke.
Another important clinical finding is the higher remote white matter integrity in patients 
with preserved cognitive performance, which might be due to a different underlying 
mechanism compared with lower remote white matter integrity. Plasticity and 
vicariation (intact brain areas take over the functions of the stroke area) might have 
occurred in cognitively unimpaired patients.276 This idea is possibly supported by our 
findings that FA correlated better with remote white matter integrity compared with 
MD, as lower FA may not necessarily reflect lower underlying structural integrity since 
FA reflects the directionality of molecular displacement by diffusion and is influenced 
by crossing fibers.268 MD reflects the magnitude of water diffusion which is less 
influenced by direction of fibers and therefore MD remains relatively constant.268, 269 
Therefore, lower FA, but not higher MD in stroke patients may reflect plasticity, 
resulting into a reorganization of white matter and subsequently into more (new) 
crossing fibers.296 Caution must be taken in interpreting these findings as different 
pathologies, different stages of disease, or the rate of degeneration can lead to 
different tensor behaviors (FA and MD).269 Another possible explanation might be that 
no secondary neurodegeneration occurred in cognitively unimpaired patients as 
opposed to cognitively impaired patients. 
Strengths of our study include its large sample size and the long follow-up duration. 
We collected baseline and follow-up information according to identical procedures in 
all patients, used strict protocols for cognitive assessment, and researchers were 
trained, in order to reduce the risk of information bias. 
However, some methodological issues of the present study need to be considered. 
Although the FUTURE study has a prospective design, the current analysis is cross- 
sectional and we therefore can only report on lower microstructural integrity after 
stroke in cognitively impaired patients. While this lower integrity may be caused by 
post-stroke microstructural degradation of white matter, a longitudinal design is 
required to further support causality. However, our data clearly demonstrate a relation 
between stroke volume and reduced white matter integrity.
Although we have tried to statistically correct for differences in stroke characteristics 
(volume and location) as thoroughly as possible between cognitively impaired patients 
and unimpaired patients, there still might be some residual confounding between 
these two groups. For instance, we observed a higher proportion of cognitively 
impaired patients with a stroke in the dorsolateral prefrontal cortex and intraparietal 
sulcus compared with unimpaired patients. These areas have been found to be 
“connector hubs”,297 which play a central role in integrating information from multiple 
networks.298 A stroke in these areas is considered as a strategic lesion, as it hampers 
128
Chapter 7
the communication between different networks important for multiple cognitive 
components. Consequently, this may result into deterioration of multiple remote white 
matter fibers, which in turn more severely affects post-stroke cognitive functioning.
Also, selection might have occurred, since patients who participated in the FUTURE 
study, but could not participate in the present DTI study, had a poorer outcome 
compared with participants. However, selection bias seems unlikely as both the 
direction and magnitude of the association between white matter integrity and 
cognitive performance will not be selectively different in participants and non-partici-
pants.
Another limitation of the present study is the exclusion of patients with severe aphasia 
from cognitive testing. This might have potentially limited the generalizability of our 
present results on cognitive tests to a young first-ever ischemic stroke population in 
general. However, our previous work on long-term cognitive outcome in these young 
ischemic stroke patients showed a low number of patients with aphasia.255 Therefore, 
it seems unlikely that excluding these small number of patients largely influenced the 
generalizability of present results to young patients with ischemic stroke.
In conclusion, our results implicate that remote structural integrity of the white matter 
is associated with cognitive performance 11 years after stroke. Longitudinal studies are 
needed to investigate the course of remote lower white matter integrity and 
concomitant cognitive performance after onset of stroke, which might reveal early 
individual treatment opportunities after stroke.
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Summary
The aim of the present thesis was to describe the spectrum and severity of long-term 
cognitive impairments after first-ever ischemic stroke in young adults, using MRI 
biomarkers to understand the underlying mechanisms of cognitive impairments that 
cannot always be explained by lesion characteristics itself. Stroke frequently occurs in 
older adults 299, but up to 14% of all ischemic strokes occur in young adults (18 through 
50 years of age). This thesis is part of the FUTURE study, a prospective cohort study on 
causes and long-term consequences of a young stroke (chapter 2). Data on long-term 
cognitive outcome and underlying MRI biomarkers are lacking in these young adults. 
A better understanding of the etiology of post-stroke cognitive impairment and its 
possible recovery is especially important in young stroke survivors, as they are in a 
demanding phase of their lives with respect to educational, vocational, and family- 
related functioning. 
Chapter 3 provides a critical overview on the etiology and long-term perspective of 
stroke in young adults. Although stroke in young adults often is associated with rare 
causes, we postulated that the traditional vascular risk factors, often observed in older 
stroke patients, may explain a considerable proportion of stroke in young adults as 
well. Furthermore, the long-term prognosis with respect to cardiovascular disease, 
mortality, and psychosocial consequences is less favorable than previously thought. 
Long-term cognitive impairment after a young ischemic stroke
In chapter 4 the cognitive performance of young-stroke patients about 11 years after 
first-ever ischemic stroke is compared with a stroke-free population. Up to 50% of the 
patients (dependent on the cognitive domain examined) showed a below-average 
performance (>1 SD below the average of the performance of controls) or a cognitive 
impairment (>1.5 SD). Deficits in processing speed, working memory, and attention 
were most commonly observed. A negative relation was found between longer follow- 
up duration and the performance in the domains immediate memory, delayed memory, 
and executive functioning. 
Remote structural changes underlying a worse post-stroke cognitive performance
We focused on structural changes in the brain remote from the ischemic stroke that 
might explain cognitive impairments that frequently cannot solely (if at all) be 
explained by the stroke volume and location itself. In chapter 5 we demonstrated that 
the ipsilateral, and not the contralateral hippocampal volume was smaller compared 
with controls. In the patients with smaller ipsilateral hippocampal volume, we observed 
a worse memory performance compared with controls, although still within the clinically 
unimpaired range (i.e., less than 1.5 standard deviations below the mean of the 
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controls). A larger stroke volume was associated with a lower ipsilateral hippocampal 
volume. In left-hemispheric stroke patients a positive association was found between 
left hippocampal volume and lower immediate and delayed visual memory performance. 
Chapter 6 describes hippocampal integrity after ischemic stroke. Using Diffusion 
Tensor Imaging (DTI), a lower ipsilateral hippocampal integrity (Fractional Anisotropy 
[FA] and Mean Diffusivity [MD]), not contralateral hippocampal integrity was found in 
hemispheric stroke patients compared with a non-stroke population. A larger stroke 
volume was associated with a lower ipsilateral hippocampal integrity after ischemic 
stroke in one of the hemispheres. We did not observe a reduced verbal and visual 
memory performance in patients with “normal” ipsilateral hippocampal volume but a 
reduced hippocampal integrity compared with controls. 
Chapter 7 describes the white matter integrity remote from the ischemic lesion which 
could contribute to a better understanding of long-term cognitive impairments, but 
perhaps also of recovery after ischemic stroke in young adults. Even on average 11 
years after ischemic stroke we found that a higher remote white matter integrity was 
associated with a better cognitive outcome. This relation was independent of stroke 
volume, WMH-volume, and other confounders. We found a lower white matter integrity 
in areas remote from the stroke area in cognitively impaired patients compared with 
cognitively unimpaired patients, after adjustment for cerebral small vessel disease, 
stroke volume, and other confounders. Areas involved white matter in the ipsilateral 
hemisphere, but also the contralateral stroke-free hemisphere. Stroke volume was 
negatively associated with remote white matter integrity, also in white matter areas in 
the contralateral hemisphere (corpus callosum). In addition, we showed that the 
prevalence of cerebral small vessels disease was higher in cognitively impaired 
patients compared with cognitively unimpaired patients, but the severity was low. 
Based on the findings of this study it seems less likely that cerebral small vessel 
disease largely explained the worse cognitive outcome and concomitant lower remote 
white matter integrity.
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General discussion 
This thesis is embedded within the FUTURE study, which is a large prospective cohort 
study on etiology and long-term prognosis of stroke in young adults (aged 18 through 
50 years). This chapter provides the most important methodological considerations 
and discussion of the main findings presented in this thesis. Thereafter, the clinical 
implications and suggestions are described for future research.
Methodological considerations
Study design
The studies presented in this thesis had a prospective design, which means that 
cognitive performance and neuroimaging data of all patients and controls were 
measured at one time point after stroke. Due to this design we were not able to 
determine the exact course of the cognitive prognosis after ischemic stroke in young 
adults and the relation with the associated imaging biomarkers over time. However, 
the follow-up duration between stroke onset and long-term outcome measures varied 
from less than a year to up to 30 years. As a result, we were able to gain important 
insights into the time course of the outcome after stroke. The present design also has 
a major advantage, as it enabled the collection of all the data in a standardized way 
within a relatively short period of time. Furthermore, cross-sectional data are also 
essential for generating hypotheses for future studies. 
Internal validity
The internal validity of the present cohort study is determined by our understanding 
and inclusion of relevant predictors and confounding variables (confounding), the 
validity of the measurements (information bias) and sampling (selection bias). There 
are ways to minimize their impact before the start of the study or due to adjustment in 
the analyses or even by choosing proper measurements.
A selection bias may have been present.300 For instance, we consistently observed that 
non-participants had a more severe stroke according to the NIHSS score, had a lower 
mRS at follow-up, were older at the time of the stroke, and less often had an unknown 
cause according to the TOAST etiology criteria compared with participants. Although 
it seems unlikely that observed associations in participants were different from those 
in non-participants, it is possible that we have missed the patients with an even worse 
cognitive outcome after stroke, which might have underestimated the strength of 
present associations. 
Information bias occurs when there is a flaw in measuring the exposure, covariate, 
or outcome variables that subsequently results in different quality (accuracy) of 
information.300 Misclassification can be divided into differential and non-differential 
misclassification. Differential misclassification arises when the degree of misclassifi-
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cation differs between groups, which results into an over- or underestimation of the 
true association. Non-differential misclassification arises when categories of a variable 
have the same error rate of being misclassified, which often leads to an underestima-
tion of the true association. 
The FUTURE study consisted of a long-term follow-up, which inevitably leads to 
differences in diagnostic work-up and acute treatments due to improvements over the 
last decades, which is an example of non-differential misclassification. However, with 
respect to mortality, the etiology of the stroke, and recurrent vascular events no cohort 
effects were found in the FUTURE study.23 Still, differences in treatment methods over 
time might have had an influence on cognitive outcome after ischemic stroke. For 
instance, since the beginning of the year 2000 intravenous recombinant tissue 
plasminogen activator (rt-PA) has been the first choice of acute stroke treatment in 
Europe (treatment < 4.5 hours arriving at the hospital after stroke) and is associated 
with a reduction of lesion volume.301 Although this treatment has been associated with 
a better functional outcome at follow-up,301 a favorable basic and instrumental ADL 
outcome,302 improvement of aphasia and neglect symptoms,2, 303-305 no beneficial effect 
of this treatment has been found with respect to memory, speed of information 
processing, executive functioning, and attention six months after stroke.302 However, it 
should be mentioned that patients treated in the study of Nys et al. (2006) had more 
severe stroke symptoms after stroke onset than patients not treated with rt-PA.302 After 
repeating the analyses with comparable groups with regard to stroke severity Nys et 
al. (2006) obtained essentially the same results, suggesting that the bias in stroke 
severity cannot fully explain their results. Nys et al. (2006) suggests that their still 
might be some residual confounding of baseline differences between the two patient 
groups and therefore the authors suggest that future studies on cognitive outcome 
after rt-PA treatment should include more representative patients who are typically 
enrolled in acute stroke trials.303 Thus, at present the exact impact of this treatment on 
neuropsychological functioning remains unknown, and to what extent this may have 
affected the prevalence of long-term cognitive impairment in young adults is yet 
unclear. However, it should be noted that in 2004 this treatment was introduced in our 
center, which resulted in only 16 ischemic stroke patients (2.7% of total ischemic stroke 
population in the FUTURE study) who received thrombolytic therapy.23 It seems 
unlikely, that these few cases largely influenced the prevalence of cognitive impairment 
in our cohort if there is an effect of rt-PA on cognitive outcome at all. Future large 
cohort studies should unravel whether rt-PA benefits cognitive function, especially in 
young adults. 
In most human beings the left hemisphere of the brain is dominant for language. 
Therefore, decrements in expression or comprehension of language due to stroke 
(aphasia) might hamper the performance on the neuropsychological tests, more in 
left-hemispheric stroke patients compared with right-hemispheric stroke patients. For 
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this reason, differential misclassification might have occurred in left-hemispheric 
stroke patients compared with right-hemispheric stroke patients with respect to 
cognitive outcome. However, we re-ran our analyses on (verbal and visual) memory 
performance and hippocampal volume and integrity after excluding the patients with 
aphasia at discharge, which did not alter our conclusions. Furthermore, researchers 
indicated during the neuropsychological screening whether the test administration 
was valid or not and severe aphasia was an exclusion for verbal tests. 
Another example of differential misclassification in cognitive functioning might have 
been caused by the fact that researchers who assessed cognitive functioning could 
not be blinded for stroke or a non-stroke subject, as stroke is often associated 
with visible physical impairments. However, we used strict administration protocols 
for the cognitive tests and all researchers were trained to reduce the risk of information 
bias. 
As for the neuroimaging data, manual segmentation of the hippocampus, stroke 
volume, but also small vessel disease characteristics could not have been done blindly 
to the side of the stroke. However, researchers were blinded for other demographical 
data, clinical outcome measures, and cognitive performance. Furthermore, the  intra- 
rater and inter-rater reliability of a random set of hippocampal manual segmentations and 
small vessel disease segmentations were high, therefore differential misclassification 
does not seem likely. 
Smaller hippocampal volumes have a higher risk of partial volume effects when 
investigating hippocampal integrity, especially increasing the risk of including CSF in 
the hippocampal mask. This might have influenced the reliability of the hippocampal 
integrity index observed in smaller hippocampal volumes. We have minimized this risk 
of differential misclassification by eroding the hippocampal mask by one voxel in all 
directions. 
Also, one can argue that the associations we observed were the result of confounding 
variables. 
Confounding occurs when the association between the determinant and outcome is 
caused by a third variable that is not an intermediate factor between the determinant 
and the outcome.300 In our analyses we adjusted for major confounding factors (such 
as age, sex, education, depressive symptoms, fatigue), which might have influenced 
cognitive outcome, hippocampal volume, hippocampal integrity, and white matter 
integrity. 
Another potential confounding factor is that we do not have data on the patients’ 
pre-stroke cognitive performance, which could have influenced post-stroke cognitive 
performance. Thus, some people can tolerate more of these brain changes than others 
and maintain function.306 In addition, it is possible that young stroke patients also have 
other diseases or for example vascular risk factors, which may also affect both 
cognitive performance and white matter integrity prior and after stroke. We have tried 
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to overcome these problems by using an age, sex, and education matched stroke-free 
control group, which were recruited among patients’ spouses, relatives, or social 
environment. We have therefore included a control group with approximately the same 
environmental exposure as the patients. It was our intention not to include completely 
healthy controls as this would have resulted in an overestimation of the between 
group differences. 
Also, when measuring post-stroke cognitive performance the performance on cognitive 
domains may influence one another. For instance, a worse memory performance could 
be influenced by decrements in attention and/or processing speed. Due to an inability 
to concentrate or a slower processing speed the to be remembered information is not 
well encoded in the first place. Moreover, a lower executive functioning might cause an 
inability to organize the to be encoded and remembered information efficiently, which 
also could hamper memory functioning. Still, despite cognitive decrements in multiple 
cognitive domains, an actual memory impairment may also exist. Also, a larger stroke 
volume is likely to cause cognitive impairments in multiple cognitive domains, beside 
the cognitive domain of memory for instance. Adjusting in the statistical analyses for 
other cognitive domains and thereby adjusting indirectly for the severity of the stroke 
may be less appropriate, as stroke severity is also part of the cause of post-stroke 
memory impairment. For these reasons, we intentionally did not adjust for other 
cognitive domains in the analyses between memory performance and hippocampal 
volume and integrity. 
Neuropsychological assessment
The neuropsychological tests used in the present thesis covered the main cognitive 
domains and all tests have been previously applied in large-scale epidemiological 
studies of cerebrovascular disease, producing reliable findings.42, 43 The neuropsycho-
logical assessment in total was feasible and the length was about 45 minutes. In order 
to keep the administration duration feasible and to be able to examine as much 
patients as possible (e.g., patients with fatigue or limited motivation), not all aspects 
of cognitive function could be assessed in detail. For instance, the domain of executive 
functioning was investigated by a fluency test and the abbreviated Stroop test, but did 
not include tests that measure planning (e.g., subtests of the Behavioural Assessment 
of the Dysexecutive Syndrome battery) or mental flexibility (such as the Trail Making 
Test). This might have led to an underestimation of patients with impairments in 
executive functioning. Also, language comprehension was not objectively assessed in 
our neuropsychological assessment, which might have underestimated the number of 
patients with subtle language problems. However, we have tried to identify patients 
during neuropsychological assessment that were not able to complete neuropsycho-
logical tests due to language problems. We then excluded these patients with 
post-stroke language disorders from verbal testing. Future studies on cognitive 
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outcome after ischemic stroke in young adults are encouraged to incorporate language 
as an outcome measure. 
External validity
External validity is the extent to whether present results obtained in our sample 
population can be generalized to make predictions about the Dutch young stroke 
population in general.300 The studies presented in this thesis were academic-hospital 
based, not community-based. Consequently, our sample may not represent all cases 
of young stroke in our catchment area. However, those who survive usually visit a 
university medical center during the course of their disease and we included all 
consecutive cases admitted to our hospital in the FUTURE study. Moreover, the age- 
and sex- standardized prevalence of stroke in the catchment area equals that of the 
age- and sex- standardized prevalence of stroke in the Netherlands.205 Therefore, for 
the FUTURE study in general (N = 606 first-ever ischemic stroke patients) it seems that 
the stroke population is representative to the wider Dutch stroke population. However, 
we showed that patients not participating in the present MRI studies were somewhat 
older at stroke onset, had a higher NIHSS score at event, a lower education, and less 
frequently had an unknown cause according to the TOAST criteria. It does not seem 
likely that present observed associations in participants were different in non-participants, 
but it might have underestimated the strength of the real associations.
Precision 
Precision reflects the repeatability of a measure, but in essence does not need to 
reflect accuracy.300 Flaws in precision of a measure are caused by random error. 
Random error may result into high sampling variance and underestimation of the 
effects. We have tried to reduce the sampling variability by investigating a large sample 
size, using a single scanner with the same hard- and software during our inclusion 
period, and showed high inter- and intrarater reliability of hippocampal volumes and 
cerebral small vessel disease markers. Possibly, in some subanalyses with smaller 
sample sizes a reduction in power might have occurred, which resulted in an under-
estimation true association. 
Underestimation of the effects might be caused by within-person variability, for 
example in cognitive performance due to random error (i.e., bad night’s sleep). Patients 
and controls were measured once, but we used compound scores instead of neuro-
psychological test scores, which was an average of a larger number of observations, 
that mainly measured the same cognitive domain. In this way, we have tried to reduce 
the risk of random error. 
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Pathogenesis of long-term post-stroke cognitive impairment
Based on the studies presented in this thesis, some potential underlying neuroimaging 
biomarkers have been identified that could account for long-term cognitive impairment 
in these young stroke patients. We have clearly demonstrated that stroke volume is 
associated with a smaller ipsilateral hippocampal volume, lower ipsilateral hippo - 
campal and thalamic integrity, and remote white matter integrity. 
As we adjusted for stroke volume in the analyses, stroke volume is not the only 
predictor for differences in remote white matter integrity and concomitant differences 
in long-term cognitive outcome. An alternative explanation could be the higher 
prevalence of cerebral small vessel disease in cognitively impaired patients compared 
with cognitively unimpaired patients. Lower white matter integrity could be part of the 
pathogenic cerebral small vessel disease related mechanism even before WMH, 
lacunes, and microbleeds occur.292 However, the absolute number of microbleeds, 
lacunes, or WMH-volume was relatively low in the cognitively impaired and cognitive 
unimpaired patient groups, as expected in these relatively young patients. Furthermore, 
we still observed a lower remote white matter integrity in cognitively impaired patients 
after adjustment for WMH-volume. Therefore, it seems less likely that cerebral small 
vessel disease largely explained the results on remote white matter integrity and a 
concomitant worse memory performance. 
Another explanation might be that lower remote microstructural integrity is caused 
by vascular damage by being exposed to the same vascular risk factors that caused 
the initial stroke event. Furthermore, based on studies in rats, stroke itself might 
cause spreading depression in the ipsilateral hemisphere,221, 293 which may allow the 
onset of secondary (Wallerian) degeneration of remote white matter after ischemic 
stroke.294, 307 However, the extent of this phenomenon should be further investigated to 
whether it also could explain the lower white matter integrity in the contralateral 
hemisphere as we observed in cognitively impaired patients. Lastly, cognitively 
impaired patients might have had pre-existing lower white matter integrity before 
stroke onset due to a genetic predisposition,308 which may influence post-stroke 
cognitive recovery. This needs further investigation.
Clinical relevance
Our results contribute to the understanding of the spectrum of cognitive impairments 
in young ischemic stroke patients. We further identified imaging biomarkers that were 
associated with a lower long-term post-stroke cognitive performance. In clinical 
practice this information could be used by doctors and neuropsychologists to inform 
their patients on the long-term cognitive prognosis. 
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Future directions
Although the studies described in this thesis yielded important findings, some recom-
mendations for future research can be made. First, a longitudinal design can provide 
valuable insights into changes in cognitive function over time after stroke in young 
adults, as well as their relation with the course of structural brain changes. For 
instance, at present it remains unknown whether the ischemic stroke itself induced 
remote structural changes or whether these remote structural effects develop over a 
longer period of time. 
Second, more research should focus on a personalized approach. That is, it is unknown 
which patients exactly are at risk for remote structural changes with an attendant 
worse cognitive performance. For instance, it might be interesting to investigate 
whether patients with similar stroke volumes and location show differences in 
cognitive decline over time after ischemic stroke and subsequent remote lower white 
matter integrity. Some patients might be more vulnerable for cognitive decline than 
others. Also, the concept of cognitive reserve may explain the large individual 
differences in cognitive (dys)function after stroke, as patients with better cognitive 
reserve may be able to successfully compensate for cognitive decrements, resulting in 
better outcome. Ideally, a large community-based cohort is followed over time with 
cognitive assessment, incorporating information on pre-stroke cognitive functioning, 
neuroimaging data (DTI, T1, FLAIR, SWI) and incident ischemic stroke patients are 
compared with stroke-free individuals. 
Finally, another important target for future research is to investigate whether these 
young ischemic stroke patients become demented earlier in life than their stroke-free 
peers. Interestingly, stroke in older individuals often co-occurs with Alzheimer 
pathology,309 but in our young stroke patients (about 50 years at follow-up assessment) 
the co-occurrence of Alzheimer pathology is very unlikely given their young age (about 
10%).19, 20 Dementia possibly occurs after a much longer interval after ischemic stroke 
in these young adults compared with ischemic stroke in older individuals. This might 
therefore contribute to the understanding of stroke as a risk factor itself for developing 
dementia. Longitudinal studies may also be able to identify additional risk factors for 
developing dementia after a stroke at young age.
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Het doel van dit proefschrift is inzicht te verschaffen in het spectrum en de ernst van 
de cognitieve stoornissen, die gemiddeld 11 jaar na een herseninfarct op jonge leeftijd 
op kunnen treden. In dit proefschrift zijn MRI-biomarkers onderzocht om cognitieve 
problemen te begrijpen, aangezien deze niet altijd goed verklaard kunnen worden 
door de karakteristieken van het herseninfarct zelf, zoals de grootte en de locatie. De 
incidentie van een herseninfarct neemt toe met leeftijd. Uit epidemiologisch onderzoek 
blijkt echter dat ongeveer 14% van alle patiënten met een herseninfarct tussen de 18 
en 50 jaar is. In de Engelse wetenschappelijke literatuur wordt dit ook wel een “young 
stroke” genoemd. Dit proefschrift is een onderdeel van de FUTURE-studie, een 
prospectieve cohortstudie naar de oorzaken en gevolgen van een herseninfarct bij 
volwassenen van 18 tot en met 50 jaar (hoofstuk 2).
Onderzoeken naar gevolgen wat betreft cognitief functioneren na het doormaken van 
een herseninfarct in deze leeftijdsgroep waren beperkt tot één jaar follow-up. Echter, 
deze volwassenen hebben gezien hun jonge leeftijd een relatief lange levensverwach-
ting. Het herseninfarct treedt op in een periode van hun leven waarin een groot beroep 
gedaan wordt op hun cognitieve vermogens; studie, werk, gezin en een sociaal leven. 
De bevindingen van dit proefschrift dragen daarom bij aan een beter begrip van deze 
lange termijn cognitieve prognose.
Hoofdstuk 3 bestaat uit een kritische review die een overzicht geeft van de etiologie 
en langetermijnprognose van een herseninfarct op volwassen leeftijd. Een herseninfarct 
op jonge leeftijd wordt vaak geassocieerd met een zeldzamere oorzaak, maar het blijkt 
echter dat een substantieel deel van deze jonge patiënten (tenminste 50%) toch één of 
meer veel voorkomende vasculaire risicofactoren heeft, zoals hypertensie en diabetes. 
Daarnaast is de langetermijnprognose met betrekking tot cardiovasculaire ziekten, 
sterfte, en psychosociale gevolgen minder gunstig dan eerder werd aangenomen. 
Cognitieve stoornissen jaren na een herseninfarct op volwassen leeftijd
In hoofdstuk 4 wordt de cognitieve prestatie ongeveer 11 jaar na een herseninfarct 
beschreven en vergeleken met een controlegroep. De resultaten laten zien dat 
ongeveer de helft van de patiënten een beneden gemiddelde prestatie of zelfs een 
cognitieve stoornis heeft op tenminste één van de cognitieve domeinen. Stoornissen 
in snelheid van informatieverwerking, werkgeheugen en aandacht komen het meeste 
voor. We hebben vastgesteld dat een langere follow-up-duur (in jaren) gerelateerd is 
aan een verminderde prestatie op neuropsychologische testen die een beroep doen 
op de geheugenfunctie en executieve functies. Deze resultaten laten zien dat bij deze 
nog relatief jonge patiënten -met een over het algemeen goed motorisch herstel - 
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verminderde cognitieve prestaties aanwezig zijn op de langere termijn ten opzichte 
van een controlegroep zonder herseninfarct.
Structurele veranderingen op afstand van het herseninfarct  
en de relatie met cognitie
In deel III ligt de focus op structurele veranderingen in hersengebieden op afstand van 
het gebied waar het herseninfarct zich bevindt. De cognitieve stoornissen na een 
herseninfarct kunnen immers vaak niet helemaal verklaard worden door het volume of 
locatie van het infarct zelf.
In hoofdstuk 5 wordt beschreven dat het volume van de ipsilaterale hippocampus 
kleiner is na een herseninfarct in één van de hemisferen vergeleken met een controle-
groep. Er is echter geen verschil gevonden in het volume van de contralaterale hippo - 
campus van deze patiënten vergeleken met een controlegroep. We laten zien dat deze 
patiënten ook een verminderde geheugenprestatie hebben ten opzichte van een 
controlegroep zonder herseninfarct. Echter, deze verminderde geheugenprestatie is 
op groepsniveau niet dermate afwijkend dat er sprake is van een stoornis.
Een groter herseninfarct wordt geassocieerd met een kleiner volume van de ipsilaterale 
hippocampus na een herseninfarct in de linker of rechter hemisfeer. Bij patiënten met 
een herseninfarct in de linker hemisfeer is een positieve relatie tussen de het volume 
van de linker hippocampus en een onmiddellijke en uitgestelde herinnering van 
visuele informatie aangetoond. 
In hoofdstuk 6 wordt de microstructurele integriteit van de hippocampus beschreven 
gemiddeld 10 jaar na een herseninfarct. Na een herseninfarct in de linker of rechter 
hemisfeer is er een verminderde integriteit van de ipsilaterale hippocampus aangetoond 
ten opzichte van de controlegroep. Ook hier is er echter geen sprake van een verschil 
in de integriteit van de contralaterale hippocampus tussen patiënten en de controle-
groep. Ook hier is er een negatieve relatie aangetoond tussen de grootte van het 
herseninfarct en de integriteit van de ipsilaterale hippocampus. Opvallend is ook dat 
patiënten met een “normaal” volume van de ipsilaterale hippocampus, maar een 
verminderde integriteit van de ipsilaterale hippocampus geen significant verminderde 
verbale en visuele geheugenprestatie laten zien. 
In hoofdstuk 7 zijn de veranderingen in de integriteit van de witte stof op afstand van 
het herseninfarct onderzocht. We hebben daarbij de prevalentie en ernst van ‘cerebral 
small vessel disease’ onderzocht (schade aan de kleine bloedvaten in de hersenen die 
zich uit in microbloedingen, lacunes en wittestofafwijkingen). Ongeveer 10 jaar na een 
herseninfarct op volwassen leeftijd blijkt dat patiënten met cognitieve stoornissen een 
verminderde integriteit van de witte stof hebben op afstand van het gebied waarin het 
herseninfarct is opgestreden in vergelijking met patiënten zonder cognitieve 
stoornissen. Dit is zelfs zichtbaar in witte stofbanen in de contralaterale hemisfeer, 
mogelijk ontstaan via het corpus callosum. De resultaten zijn onafhankelijk van het 
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volume van het herseninfarct, het volume van de wittestofafwijkingen en andere 
verstorende factoren. Wel blijkt, dat hoe groter het herseninfarct is, des te groter zijn 
de afwijkingen in de integriteit van de witte stof op afstand, zelfs in de contralaterale 
hemisfeer. Patiënten met cognitieve stoornissen na een herseninfarct hebben vaker 
microbloedingen en wittestofafwijkingen dan patiënten zonder cognitieve stoornissen, 
maar de ernst van deze afwijkingen is gering. 
Conclusie
De studies beschreven in dit proefschrift laten zien dat cognitieve stoornissen op de 
lange termijn na een herseninfarct op volwassen leeftijd (18 tot en met 50 jaar) frequent 
voorkomen, waarbij over het algemeen een goed motorisch herstel plaatsvindt. Er zijn 
verminderde cognitieve prestaties gevonden in bijna alle cognitieve domeinen en 
vooral op het gebied van tempo van informatieverwerking, werkgeheugen en aandacht. 
We hebben verder aangetoond dat er structurele veranderingen plaatsvinden op 
afstand van het herseninfarct die gerelateerd zijn aan een verminderde cognitieve 
prestatie op de lange termijn, zelfs na het corrigeren voor het volume van het 
herseninfarct, het volume van de wittestofafwijkingen en andere verstorende factoren. 
Het infarctvolume is een consistente voorspeller voor structurele veranderingen op 
afstand van het herseninfarct. De ernst van schade aan de kleine vaten is gering in 
patiënten met stoornissen in meerdere cognitieve domeinen. Hierdoor lijkt het minder 
waarschijnlijk dat schade aan de kleine vaten een belangrijke rol speelt bij het 
gevonden resultaat van verminderde wittestofintegriteit op afstand van het hersen-
infarct.
Toekomstige studies met een longitudinaal design kunnen onderzoeken of patiënten 
met een verminderde integriteit van de witte stof op afstand van het herseninfarct 
een verhoogd risico lopen op vervroegd ontstaan van dementie vergeleken met een 
controlegroep zonder herseninfarct. Het is verder interessant om te onderzoeken of 
en welke patiënten met een vergelijkbare grootte van het herseninfarct en dezelfde 
lokalisatie verschillende cognitieve uitkomsten laten zien, met mogelijk daarbij 
verschillen in wittestofintegriteit op afstand. Mogelijk zijn sommige patiënten extra 
kwetsbaar voor cognitieve achteruitgang en structurele veranderingen op afstand van 
het herseninfarct. Dit kan implicaties hebben voor individuele preventie en behandeling 
van cognitieve achteruitgang na een hersen -infarct op jonge leeftijd. 
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Na vele segmentaties, Matlab analyses, buitenlandse congressen en drie Internationale 
Vierdaagse Afstandsmarsen Nijmegen te hebben volbracht is het moment daar: HET 
BOEKJE IS AF!
Op de eerste plaats wil ik alle patiënten en controlepersonen van de FUTURE-studie 
bedanken voor hun deelname aan het onderzoek. Zonder hen waren er niet al vele 
“Young stroke” publicaties verschenen die elk hebben getracht een stuk van de puzzel 
op te lossen en het belang van verder onderzoek naar deze patiëntengroep hebben 
gestimuleerd. 
Een aantal mensen wil ik persoonlijk bedanken. Ik wil in het bijzonder mijn eerste 
promotor bedanken, prof. dr. Frank-Erik de Leeuw. Ik ben van mening dat een promotie 
staat of valt met de begeleiding. Beste Frank-Erik, bedankt voor je enorme inzet en 
gedrevenheid. Je had altijd het beste met mij voor en dat was in vele opzichten te 
merken. De vele snelle reacties op de vrijdagavond of in het weekend lieten zien hoe 
betrokken je was en hierdoor kende het traject zelfs in de weekenden voortgang. 
Naast de inhoudelijke begeleiding heb ik jouw belangstelling in mij als persoon ook 
zeer gewaardeerd. Dank voor het vertrouwen de afgelopen jaren. 
Mijn tweede promotor prof. dr. Roy Kessels wil ik eveneens heel hartelijk bedanken voor de 
kans die hij mij bood om dit PhD traject te doen. Beste Roy, ik heb het zeer gewaardeerd 
dat je altijd open stond voor overleg, overstijgend meedacht over het traject en de 
tijdlijn goed in de gaten hield. Naast het PhD traject heb ik dankzij jou gedurende ruim 
drie jaar veel over de neuropsychologie geleerd op de afdeling Geriatrie en Neurologie 
in het Radboudumc.
De leden van de leescommissie, prof. dr. Mathias Prokop, prof. dr. Edward de Haan 
en dr. Edo Richard, wil ik hartelijk bedanken voor het lezen en beoordelen van dit 
proefschrift.
Loes en Noortje, bij jullie begon de FUTURE studie en later kwam Renate erbij. Ik ben 
als vierde toegevoegd aan jullie team. Loes, jij hebt mij veel geleerd over de statistiek 
in het kader van epidemiologisch onderzoek. Ik heb je wetenschappelijke kennis, 
je gedrevenheid en blijvende belangstelling, ook nadat je zelf klaar was met je PhD, 
zeer gewaardeerd. Ik zal de slingers en “hoera de hippocampi zijn klaar!” op mijn 
computerscherm ook niet gauw vergeten. Noortje, je was een prettige “FUTURE 
collega” en ik heb veel van je geleerd over cerebrovasculaire ziekten. Renate, bedankt 
voor jouw bijdrage aan dit boekje. Je verfrissende input en belangstelling hebben 
mij veel geholpen.
Inge (hippo collega), bedankt voor jouw waardevolle bijdrage tijdens de segmentaties 
van de hippocampi! Jij begrijpt als geen ander wat handmatig segmenteren werkelijk 
inhoudt. 
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Anil, ook jij stond onvoorwaardelijk klaar als ik weer met vragen zat betreffende de 
hersenanalyses of een error in Matlab. Je maakte altijd wel even tijd tussendoor en 
daarnaast was je gewoonweg een hele fijne collega. Ik kon met jou bijzonder prettig 
overleggen over de vele analyses in FSL, SPM en Matlab. Je begreep altijd direct wat 
ik bedoelde. Het was mooi om te zien hoe enthousiast je was als een analyse lukte. 
Ik heb veel van je geleerd en ik vind het een hele eer dat je vandaag naast mij staat 
als paranimf.
Lieve Yvonne, je bent een hele dierbare vriendin! De vele borrelavonden en gezellige 
praat over van alles en nog wat tussendoor hebben gezorgd voor de nodige afleiding. 
Ook jouw enthousiasme en je belangstelling heb ik erg op prijs gesteld. Super dat jij 
mijn tweede paranimf wilt zijn. 
De velen collega psychologen uit die tijd in het Radboudumc wil ik ook bedanken voor 
de leerzame en prettige samenwerking: Danielle Boelen, Sandra Vos, Liesbeth Joosten 
en Nelleke van Schuylenborgh.
Daarnaast wil ik ook prof. dr. Gilles van Luijtelaar bedanken, omdat mijn enthousiasme voor 
onderzoek ooit bij hem allemaal begon in het lab met de WAG/Rij ratten.
Marcel Zwiers, dank voor het meedenken met de DTI analyses en het gebruik kunnen 
maken van jouw toolbox voor het preprocessen van de DTI data. Ook wil ik het Donders 
centrum bedanken voor de goede faciliteiten voor het uitvoeren van MRI analyses. 
Tevens wil ik de collega’s op de kamer en vele onderzoekers die ik heb leren kennen 
bedanken voor de mooie tijd, in het bijzonder Merel, Willemijn, Esther, Sieske, Saskia 
en Karlien. 
Lieve Geert, Joyce, Cassandra, Marilijn, Julija, Laura, Madeleine, Nadja, Jos, Carolien, 
Martine en Margit, bedankt voor jullie steun en gezelligheid tijdens dit traject. 
Lieve mama en papa, ik weet niet waar ik moet beginnen om jullie te bedanken. Jullie 
onvoorwaardelijke steun en toeverlaat hebben er mede toe geleid dat dit proefschrift 
nu af is. Zonder jullie had ik niet gestaan waar ik nu vandaag sta. De humor, de positieve 
levenshouding in huis en de gedeelde interesse voor de pianomuziek zorgden op zijn 
tijd voor de nodige relativering en ontspanning. Ik ben heel dankbaar dat jullie mijn 
ouders zijn en dat jullie op deze dag aanwezig zijn. Papa, bedankt voor de afsluitende 
noten in dit boekje. Lieve Joep, als broer heb je altijd achter mij gestaan in dit traject, 
dankjewel hiervoor.
Rest mij alleen nog:
arr. Frank Schaapsmeerders
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After completing secondary school she started studying Psychology at the Radboud 
University, with a special interest in neuropsychology. She completed her Masters’s 
degree cum laude in 2011 after four years of studying. During that time she followed 
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The first internship was on the underlying neural mechanisms of the placebo effect 
at the Radboud University (prof. dr. M. Kompier). The second internship was at the 
department of Biological Psychology at the Radboud University, where she studied 
the behavioral consequences of chronic ethosuximide treatment on the anti-epilepto-
genesis in WAG/Rij rats (prof. dr. G. van Luijtelaar). During this internship the enthusiasm 
for conducting research on the diseased brain with clinical correlates began to grow. 
Afterwards, the third research internship was at the department of Neurology on 
cerebro vascular disease in young patients, at the Radboudumc collaborating with 
prof. dr. F-E de Leeuw and prof. dr. R. Kessels. The result of this internship was the start of 
a PhD project in 2011 with a main focus on neuroimaging biomarkers for long-term 
cognitive impairments after a stroke at young age. In July 2013 she won a research 
award for the best abstract at the International Neuropsychological Society meeting 
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In 2015 she already started working as a researcher at the department of Neuro - 
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data of glioma patients with different clinical outcomes. 
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as a psychologist for several years now with a special interest in cerebro vascular 
disease and dementia. 
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For a successful research Institute, it is vital to train the next generation of young 
scientists. To achieve this goal, the Donders Institute for Brain, Cognition and Behaviour 
established the Donders Graduate School for Cognitive Neuroscience (DGCN), which 
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related disciplines. Selective admission and assessment centers guarantee the 
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environment as lab coordinators, technical support or policy advisors. Upcoming 
possibilities are positions in the IT sector and management position in pharmaceutical 
industry. In general, the PhDs graduates almost invariably continue with high-quality 
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